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STELLINGEN 
1. De frequentie van zowel K-ras mutaties als p53 overexpressie is niet duidelijk verschillend 
in de vroege adenoom-fase van Hereditair Non-Polyposis Colorectale Carcinogenese 
(HNPCC) en sporadische colorectale carcinogenese. (dit proefschrift) 
2. De positieve associatie tussen vleesconsumptie en colorectale adenomen en carcinomen 
is duidelijker wanneer de vleesbereiding hierbij wordt betrokken. (dit proefschrift) 
3. Associates tussen genmutaties en voedingsfactoren worden niet gevonden als alle 
mutaties samen worden bestudeerd, daar carcinogenen in de voeding mogelijk zeer 
specifieke mutaties (fingerprints) in een gen veroorzaken. (dit proefschrift) 
4. Mutatie-analyse van het p53-gen is nodig ter bevestiging van de hypothese dat 
voedingsfactoren mutaties in p53 kunnen veroorzaken. Daarentegen is vaststelling van 
overexpressie van het p53 eiwittoereikend om aan te tonen dat p53 status het effect van 
voedingsfactoren kan modificeren. (dit proefschrift) 
5. Men kan het ook te bruin bakken. 
6. Het gebruikelijke onderscheid tussen endogene processen en exogene (voedings-) 
factoren houdt onvoldoende rekening met het concept "gen-omgeving-interacties". 
7. Afhankelijk van de fase waarin wetenschappelijk onderzoek zich bevindt, dient het 
belang van een studie niet alleen afgewogen te worden aan de statistische "power" van 
de studie. 
8. "Collectebusfondsen" zijn onontbeerlijk voor het onderzoek naar de rol van voeding bij 
de preventie van kanker; en moeten ook wetenschappelijk onderzoek mogelijk maken 
naar de rol van voeding bij de behandeling van kankerpatienten. 
9. Het is onterecht als mensen met een erfelijke aandoening daar extra onder moeten lijden 
doordatzij geen levensverzekering kunnen afsluiten. Bij HNPCC patienten geldt dit in het 
bijzonder, omdat door screening het risico aan de ziekte te overlijden sterk afneemt. 
10. De wetenschapper die de beste kansen heeft voor een hogere wetenschappelijke functie 
is degene die al zijn tijd en inzet daartoe aangewend heeft en niet afgeleid wordt door 
welke wereldse zaak dan ook. (Barbara van Balen, 1998, in De universiteit als modern 
mannenklooster.) 
11. De begrippen "poliep" en "kanker" krijgen een andere lading als ze te dichtbij komen. 
12. De overeenkomst tussen dikke darmpoliepen en koraalpoliepen is niet alleen hun 
uitstulpende vorm, maar ook de mate waarin ze de aandacht vast kunnen houden van 
respectievelijk een duikende onderzoeker en een onderzoekende duiker. 
Stellingen behorend bij het proefschrift 'Diet-gene interactions in sporadic and hereditary 
colorectal carcinogenesis. Epidemiological perspectives'. 
Dorien Voskuil, 12 mei 1999 
ABSTRACT 
Thesis Diet-gene interactions in sporadic and hereditary colorectal carcinogenesis 
Epidemiological perspectives 
Dorien Voskuil 
Colorectal cancer is known to develop by accumulation of alterations in regulatory genes. 
Both familial and environmental factors play a role in the etiology of colorectal cancer 
and its adenomatous precursor lesions. This thesis examines diet-gene interactions in 
sporadic and hereditary colorectal carcinogenesis, from two different epidemiological 
perspectives, as outlined in AIMS 1 and 2. 
AIM 1: to examine evidence for a role of dietary risk factors in the etiology of Hereditary 
Non-Polyposis Colorectal Cancer (HNPCC); are some aspects of the etiology similar to 
sporadic colorectal carcinogenesis? 
In a descriptive epidemiological study of HNPCC first degree relatives, the cumulative 
incidence of colorectal cancer at age 75 increased from 19% in ancestors, to 32% in the 
first generation and 55% in the second generation, which is largely attributable to a birth 
cohort effect. The earlier age of onset in successive HNPCC generations thus appears not 
to be a biological feature of HNPCC but reflects a time trend in cancer occurrence which 
is similar to trends in the general population. 
Subsequently, we assessed frequencies of mutations in the K-ras gene and overexpression 
of the p53 protein, in 48 HNPCC and 59 sporadic adenomas. Frequencies of these 
abnormalities were indeed similar in HNPCC (31% and 25% for K-ras and p53 
respectively) and sporadic (32% and 25% for K-ras and p53 respectively) adenomas. This 
points towards similar molecular pathways to early stages of colorectal carcinogenesis 
with regard to K-ras and p53, and therefore suggests that environmental factors may play 
a similar role. 
To study the association between risk of HNPCC colorectal adenomas and dietary factors 
related to meat consumption and preparation directly, we conducted a case control study 
of HNPCC and sporadic adenomas (n=62 and 57 respectively), and endoscopy control 
groups for both (n=83 and 65 for HNPCC and sporadic respectively). We observed red 
meat consumption and darkly browned meat surface to be positively associated with risk 
of adenomas in the sporadic group (Odds Ratio (OR) 4.1 and 3.0 respectively, 95% 
confidence interval (95% CI) 0.7-23.0 and 1.2-7.5 respectively), but not in the HNPCC 
group (OR 0.4 and 0.7, 95% CI 0.1-2.2 and 0.3-1.4 respectively). Although this may 
suggest that meat consumption and preparation are only relevant in the etiology of 
sporadic adenomas, it does not exclude that (other) dietary factors play a role in some 
phases of HNPCC colorectal carcinogenesis. 
AIM 2: to examine evidence for a differential effect of dietary risk factors on K-ras/p53 
dependent and independent pathways to colorectal carcinogenesis. 
In a case control study on dietary factors and the risk of sporadic colon cancer, we 
examined carcinoma tissue (n=185) for mutations in the K-ras and p53 genes. 
We found high intakes of animal protein and calcium to be positively associated with 
carcinomas harboring K-ras codon 12 mutations (OR 1.5 and 1.2, 95% CI 1.0-2.1 and 
0.9-1.6 respectively), but inversely with carcinomas harboring codon 13 mutations (OR 
0.4 and 0.6, 95% CI 0.2-1.0 and 0.3-1.2 respectively). Transition and transversion 
mutations were not differently associated with diet. 
We examined both p53 mutations and p53 overexpression in relation to diet, and 
observed a positive association for (saturated) fat, only in the p53-independent pathway 
(for saturated fat, no overexpression OR 1.5, 95% CI 1.1-2.0) and not in the p53-
dependent pathway (for saturated fat, with overexpression OR 1.1, 95% CI 0.8-1.5). This 
difference was more pronounced with p53 overexpression than with p53 mutation as 
endpoint. Interestingly, when examining specific mutations we found similar dietary 
factors only to be associated with transversion mutations (for saturated fat, OR 2.0, 95% 
CI 1.0-4.1), and not with mutations at CpG islands (for saturated fat, OR 0.9, 95% CI 0.6-
1.6). 
Both studies suggest that if diet is associated with K-ras and p53 mutations in colon 
cancer, very specific types of mutations may be involved. 
Our studies have been among the first to examine diet-gene interactions in colorectal 
carcinogenesis, using an epidemiological approach. Such "early" studies into a new area, 
tend to be of small size, and they are therefore not sufficient to provide "proof" of diet-
gene interactions. However, these studies have served well to to suggest directions for 
future research, and to develop and expand the relevant research infrastructures. 
Future studies on diet-gene interactions in colorectal carcinogenesis should continue to 
aim at disentangling the effects of diet in all molecular phases of the adenoma-carcinoma 
sequence, and additionally, clarifying the possible role of environmental factors in 
hereditary colorectal cancer. 
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CHAPTER 1 INTRODUCTION 
BACKGROUND 
Cancer of the colon and rectum is the fourth most common type of cancer throughout 
the world \ Large differences in incidence have been observed between countries (e.g. 
45, 36 and 4 per 100.000 person-years in North-America, The Netherlands and India, 
respectively). Colorectal cancer incidence in The Netherlands has increased gradually 
since the 1970s, especially with increasing age 2. Mean age at diagnosis increased from 61 
in the 1960s to about 67 more recently. 
Migrant studies have shown that the rates in groups moving from low-risk to high-risk 
areas adapt to the rates of the high-risk areas within one or two generations 3, suggesting 
this cancer is largely determined by environmental factors. Doll and Peto (1981) have 
estimated 90% of colorectal cancer risk to be attributable to environmental factors, 
especially dietary factors 4. A hereditary component is likely as well, as a positive family 
history of colorectal cancer increases the relative risk about two-fold 5. Epidemiological 
studies suggest that 5-10% of colorectal cancer incidence can be attributed to dominantly 
inherited susceptibility genes6. 
Interaction between genetic and dietary factors in the etiology of colorectal 
carcinogenesis is the subject of this thesis. This is studied from two epidemiological 
perspectives: 
• possible role of dietary factors in the etiology of Hereditary Non-Polyposis Colorectal 
Carcinogenesis (HNPCC) (as environmental factors may also play a role in HNPCC, 
and if so, HNPCC may function as a model for sporadic colorectal carcinogenesis) 
• differential effect of diet in sporadic colorectal cancer, depending on mutational status 
of K-ras and p53 genes (to provide further clues to specific effects of diet in the 
etiology of colorectal carcinogenesis) 
In the following paragraphs of this introductory chapter, the main concepts of the etiology 
of colorectal carcinogenesis will be described. The last paragraph provides an outline of 
the thesis and the aims of the studies described. 
COLORECTAL CARCINOGENESIS 
The adenoma-carcinoma sequence 
Colorectal cancer can be seen as a genetic disease, i.e. requiring alteration, mutation or 
loss of at least 4 to 5 oncogenes and tumor-suppressor genes for a malignant tumor to 
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develop 7. The products of these regulatory genes normally mediate signal transduction, 
control the cell cycle, maintain genomic stability, and mediate programmed cell death 
(apoptosis). Through clonal evolution a malignant tumor develops out of one single cell 
which acquires a mutation in one regulatory gene, thereby gaining growth advantage. 
One cell in this clone may then acquire a mutation in another regulatory gene, and so on. 
Malignant cells fail to respond to regulatory mechanisms, leading to uncontrolled and 
excessive tissue growth and spread to distant sites. 
During this process of accumulation of alterations, mutations or loss of key genes (Figure 
1.1), the normal colonic epithelium goes through several phases: hyperproliferation, a 
benign tumor or adenoma will form; growth, the adenoma can transform into a malignant 
carcinoma; metastasis, the carcinoma spreads to distant sites in the body 8. Although 
some (epi)genetic abnormalities occur mostly in specific stages of colorectal 
carcinogenesis, the order in which they may occur is basically random. 
The Adenomatous Polyposis Coli gene. Mutations or loss of the APC gene, also known as 
a "gatekeeper gene", is frequently one of the first steps in colorectal carcinogenesis, and 
occurs in 70-80% of sporadic colorectal cancers 9. Subsequent to a mutation in this 
"gatekeeper", mutations in other oncogenes and tumor-suppressor genes may occur, 
such as K-ras and p53. If mutated in germline cells, APC is responsible for the autosomal 
dominantly inherited form of cancer called Familial Adenomatous Polyposis, which is 
characterized by multiple adenomas (>100) at a very young age. 
Diet ca rc inogens 
Figure 1.1. The adenoma-carcinoma sequence, as derived from Voge/ste/n et a/. 
The K-ras oncogene. The K-ras gene, also called Ki-ras or Kirsten-ras, is mutated in 
approximately 40-50% of colorectal carcinomas and large adenomas and in a lower 
Introduction 
percentage of small adenomas 8. K-ras mutations are therefore thought to occur early in 
the colorectal carcinogenic process, during the progression from small to large adenoma. 
The gene product functions as a molecular switch in signal transduction pathways of 
growth factors. Normal functioning K-ras can switch between its active and inactive form. 
However, a mutation in at least one allele of K-ras causes the gene to remain in its active 
form, thereby stimulating cell growth and tissue proliferation 10. 
Most mutations (90-95%) occur in codon 12 and 13 of the K-ras gene, and few in codon 
61. Some mutations can be found in the N-ras and H-ras genes, which have the same 
function as K-ras 10. Frequency and type of K-ras mutations vary substantially between 
different types of cancer. Environmental factors may play a role in inducing mutations. 
Interestingly, the type of mutation characteristically caused by mutagenic alkylating agents 
(C-A transitions at the second base), occurs most frequently 11. Tumors with this type of 
mutation are thought to be more invasive 12. As there are some suggestions that tumor 
characteristics and prognosis may differ for tumors with or without K-ras mutations and 
for tumors with different types of K-ras mutations, K-ras may also play a role in the 
promotion and progression phases of colorectal carcinogenesis. 
The p53 tumor suppressor gene. Mutation or loss of the p53 tumor-suppressor gene is 
observed in about 50% of colorectal carcinomas but in a lower percentage of adenomas 
8
. Therefore, p53 mutations are thought to occur during transformation from adenoma to 
carcinoma. P53 plays a major role in many types of cancer and is involved in gene 
transcription, DNA synthesis and repair, and programmed cell death (apoptosis)13. When 
functioning normally the p53 protein puts a halt to the cell cycle if DNA is damaged, 
thereby providing the cell with time to repair the DNA damage or to go into apoptosis if 
the damage is too severe. When one allele of the p53 gene is mutated, the other one is 
usually lost by allelic deletion, leaving the cell without p53 tumor suppressor function. 
The frequency and type of mutations vary strongly between different types of cancers 
(Figure 1.2)14. 
These different mutation spectra presumably reflect differences in exogenous carcinogens 
and endogenous biological processes known to cause mutations. In lung cancer G:C-T:A 
transversion mutations occur in high frequencies and are thought to be caused by 
smoking 15. Although G:C-T:A transversions also occur in colorectal cancer, the most 
frequent type of mutation in colorectal cancer is the G:C-A:T transition at CpG 
dinucleotides, which is known to be the result of spontaneous deamination of methylated 
CpG sites14. The environmental or nutritional determinants of this genetic instability are 
not known yet. 
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Figure 1.2. Mutation spectra of the p53 gene in several types of cancer (derived from Creenblatt et al.) u. 
Mismatch repair genes. Mutation or inactivation due to methylation, of one of the 
mismatch repair genes, results in microsatellite instability. About 10 to 15% of sporadic 
colorectal cancer show this microsatellite instability 16;17. However, this frequency is much 
higher (80-90%) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) 17;18, where a 
germline mutation in one of the mismatch repair genes is responsible for this type of 
genetic instability. 
Hereditary Non-Polyposis Colorectal Cancer 
Approximately 1 to 5% of colorectal cancer is due to a genetic disorder called Hereditary 
Non-Polyposis Colorectal Cancer (HNPCC) 19. HNPCC was first described by Warthin in 
1913 2G, and was named 'cancer family syndrome' in the 1960s 21. This disease is 
characterized by a susceptibility to colorectal cancer, frequently localized in the proximal 
colon and is characterized by an early age of onset 22;23. Furthermore, members of 
HNPCC families appear to develop extracolonic tumors (e.g. of the endometrium, 
stomach, urinary tract) more often than the general population 2224. Until recently the 
genetic background of this disease was largely unknown, therefore only clinical 
characteristics could be used for diagnosis. In 1990 the International Collaborative Croup 
on HNPCC proposed a set of clinical diagnostic criteria, later named the Amsterdam 
criteria (Figure 1.3)25. 
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Amsterdam Criteria 
1. At least three relatives should have histologically verified colorectal adenocarcinoma, one of 
them should be a first degree relative of the other two, and Familial Adenomatous Polyposis 
should be excluded. 
At least two successive generations should be affected. 
In at least one relative colorectal cancer should have been diagnosed before age 50. 
Figure 1.3. Genealogical tree of a HNPCC family fulfilling the Amsterdam criteria. 
The disease follows an autosomal dominant inheritance pattern, caused by a germline 
mutation in one of at least five mismatch repair genes (MSH2, MLH1, PMS1, PMS2, and 
MSH6/GTBP) 18. Errors in microsatellites, which are short repeated sequences of DNA, 
occur often, but are usually repaired during normal DNA replication. Due to the 
mutational inactivation of one of the mismatch repair genes these replication errors (RER) 
are not repaired in HNPCC, leading to widespread genetic instability, also called 
microsatellite instability (MSI). This "mutator phenotype" expresses itself by the rapid 
accumulation of somatic mutations in oncogenes and tumor-suppressor genes, thereby 
rapidly progressing through the adenoma-carcinoma sequence. 
The tumors in HNPCC not only develop in the colon and rectum, but also at many other 
sites. Interestingly, the tumor spectrum has changed over several generations 26, which 
suggests a role of environmental factors in the etiology of this hereditary disease. 
Additionally, incomplete penetrance of the disease (80-90%)22, earlier onset of disease in 
successive generations (anticipation) 23;27, and occurrence of somatic gene mutations 
generally thought to be exogenous of origin (e.g. APC, K-ras, p53) 12;28;29, are 
characteristics which support a role for environmental factors in the etiology of HNPCC. 
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ENVIRONMENTAL RISK FACTORS 
Lifestyle and dietary risk factors 
Many studies have been conducted on the association between diet and the risk of 
colorectal cancer. As mentioned, already in the early 1980s Doll & Peto (1981) estimated 
that 90% of the risk of colorectal cancer could be attributed to environmental factors, 
most likely dietary factors 4. Recently two reports have been published on diet and 
cancer: one by the Committee on Medical Aspects of Food and Nutrition Policy in the 
UK 30, and the other by the World Cancer Research Fund in the USA 1. Both have drawn 
conclusions on the evidence from epidemiological studies regarding dietary risk factors 
for colorectal cancer (summarized in Table 1.1). 
High vegetable consumption is supported by the strongest evidence, and may possibly 
prevent half of the colorectal cancer cases. Vegetables are also considered protective in 
colorectal adenoma etiology, although evidence is somewhat weaker. So far it is 
unknown which components in vegetables account for the decrease in risk. Possible 
candidates could be bioactive compounds such as antioxidants and folate. However, 
evidence is inconsistent and insufficient to draw conclusions about a protective role for 
these specific dietary factors. Fiber may decrease the risk of colorectal cancer by dilution 
of carcinogens in the bowel and/or by decreasing bowel transit time and thus decreasing 
duration of exposure of bowel epithelium to carcinogens. The expected decrease in risk 
due to fiber intake is similar to that of vegetables, but the evidence is somewhat weaker. 
Evidence for a protective role of fruit is inconsistent and insufficient. For lifestyle related 
factors such as physical activity and aspirin or other NSAID intake, moderate to strong 
evidence points towards a protective role in the etiology of both colorectal adenomas and 
carcinomas. 
With respect to positive risk factors, a diet high in fat and meat is thought to increase risk, 
although, evidence is only moderate. The classic hypothesis was that a diet high in meat 
elevates the risk of colorectal cancer through a high intake of fat, which increases bile 
acid production and the luminal concentration of free fatty acids 3. More recently it has 
been suggested that the increased risk is related to other components of meat, e.g. 
heterocyclic amines 31, N-nitroso compounds 32, and iron 33. Some experimental studies 
have shown that these components possibly increase risk of colorectal cancer by causing 
mutations in genes such as APC and K-ras 11;34;35. 
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Meat consumption in relation to colorectal adenomas and carcinomas 
The epidemiological evidence regarding meat consumption and the risk of colorectal 
adenomas and carcinomas is summarized in Table 1.2 (see also Appendixes 1.1 and 1.2) 
Table 1.2. Summary of results from cohort and case-control studies on the association between meat 
consumption and the risk of colorectal adenomas and carcinomas*. 
type of study 
cohort 
case-control 
cohort 
case-control 
endpoint 
carcinomas 
carcinomas 
adenomas 
adenomas 
number 
of studies 
8 
25 
1 
6 
mean RR+ 
1.2 
1.5 
1.2 
1.6 
range RRst 
0.8-1.9 
0.4-3.3 
-
0.8-2.4 
% RRst positive 
54% 
64% 
-
57% 
% significant RRft 
25% 
47% 
-
33% 
* Overview of studies in Appendix 1.1 (cohort studies) and Appendix 1.2 (case-control studies) 
t RR=relative risk, or OR (odds ratio) for case-control studies), using 95% Confidence Interval 
1 % studies reporting significantly positive RR (based on 8, 17 and 3 studies respectively which reported CI) 
In eight cohort studies total meat or red meat intake were examined in relation to risk of 
colon or colorectal cancer (see Appendix 1.1). In two large United States cohort studies 
high intake of red meat was found to be associated with increased risk in both women 
(RR, 95% CI: 1.8, 1.1-2.9)36 and men (RR, 95% CI: 1.7, 1.2-2.6)37, while in two other US 
prospective studies no increased risk was found (RR, 95% CI: 1.0, 0.6-1.8) 38 and (RR, 
95% CI: 1.2, 0.7-2.0) 39. Caard et a/, found in a Norwegian cohort study that total meat 
intake was associated with colon cancer risk, but only in women (RR, 95% CI: 1.9, 0.8-
4.9) and not in men 40. Three other cohort studies also reported no increased risk with 
intake of total meat41, red meat42, and fresh meat43. In the latter, a Dutch cohort study, 
an increased risk with consumption of processed meat was found 43. Giovannucci et a/, 
reported on the only cohort study on colorectal adenomas so far, and failed to show an 
increased risk (RR, 95% CI: 1.2, 0.7-2.1)44. 
Since 1980, in 25 case control studies the association of total meat intake or several other 
indices of red meat intake and the risk of colon or colorectal cancer has been examined. 
The risk of colorectal adenomas was examined in 6 case control studies (Table 1.2, see 
also Appendix 1.2) 45"75. The mean Odds Ratio in these studies was about 1.5, both for 
colorectal adenomas (range 0.8-2.4) and carcinomas (range 0.4-3.3). Overall, the findings 
are somewhat more consistent for the risk of colorectal carcinomas, with almost half of 
the studies reporting a significantly increased risk. 
Risk associated with meat preparation and heterocyclic amines 
As mentioned, the risk associated with consumption of meat may also be related to meat 
preparation. In the past ten years twelve studies reported on varying factors related to the 
preparation of meat and their association with colorectal adenomas or carcinomas (Table 
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1.3). In four studies (including two cohort studies in Finland and Norway) the risk of 
colorectal cancer was found not to increase with increasing frequency of eating fried 
meat or well-done meat 40;76-78. The remaining eight studies all reported risk to be 
increased with one or more factors relating to meat preparation. Young & Wolf found the 
risk of colorectal cancer to be increased (RR=1.3, 95% Cl=1.0-1.8) with high vs low 
consumption of pan-fried foods79. Peters et a/, observed an increased risk with frequent 
consumption (a5x/week) of fried ham or bacon and barbecued or smoked meat, and 
Welfare et a/, with frequent consumption of gravy (>2x/week) and roast meat 
(a1x/week), only for proximal colon cancer 53;8°. Relative risks of similar magnitude 
(around RR=3) were reported for increased consumption of barbequed meat and bacon 
54
, well done meat 81, and fried meat 72. Gerhardsson de Verdier et a/, explored the 
association with several indicators of meat preparation in a Swedish case control study 58. 
They found increased risks of both colon and rectum cancer with frequent use of brown 
gravy, heavily browned meat surface and high frying temperature. Frequent consumption 
of fried or roasted meat did not increase the risk of colorectal cancer in this study. Probst-
Hensch et al. reported an increased risk of colorectal adenomas with a combination of 
several factors related to meat consumption and preparation 82. Consumption of red meat 
more than once a week, of which at least 10% is fried, with a preference for a dark 
surface, is associated with a two-fold increased risk (OR, 95% CI: 2.2, 1.1-4.3) as 
compared to consuming red meat less than once a week, of which less than 10% is fried, 
with a preference for a light surface. 
Summarizing, in 8 of 12 studies significantly increased risks relating to meat preparation 
were found. For the two cohort studies no increase in risk was reported. On average a 
two-fold increase in risk was reported, with relative risk estimates between 0.6 and 5.0. 
Recently, attention has been focused on the interaction between genetic polymorphisms 
of metabolic enzymes (N-acetyltransferase, Cytochrome P450, Glutathion-S-
Transpherase), and the consumption of meat in relation to the risk of colorectal 
adenomas and carcinomas. Of the five studies conducted, four found significantly 
increased risk of colorectal adenomas and/or carcinomas with rapid NAT2 polymorphism 
(in combination with NAT1 or CYP1A2) and frequent consumption of total meat, red 
meat, well done meat or fried meat39'80'8384. in one study only a marginally increased risk 
with processed meat intake in the intermediate or rapid NAT2 group was found 75 
Concluding, an increase in risk of colorectal adenomas and carcinomas with red meat 
consumption seems to be more consistent when factors relating to preparation are taken 
into account. Possibly, the increase in risk is higher for those who are genetically 
susceptible to (pre)carcinogens from meat. 
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Table 1.3. Meat preparation related factors and the risk of colorectal adenomas and carcinomas: case control 
and cohort studies. 
Author 
year, country 
Lyon & Mahoney 76 
1988 
Young & Wolf7 9 
1988, USA 
Peters et al. " 
1989, USA 
Wohl lebeta l . 5 4 
1990, USA 
Schiffman & Felton 81 
1990, USA 
Cerhardsson etal . S8 
1991, Sweden 
Muscat & W y n d e r " 
1994, USA 
Knekt et a l . 7 8 
1994, Finland 
Gaard et a l . 4 0 
1996, Norway 
Welfare et a l . 8 0 
1997, England 
De Stefani et al. " 
1997, Uruguay 
Probst-H.etal.82 
1997, USA 
cases/ contr 
source contr 
246/484 
population 
353/618 
population 
147/147men 
population 
43/41 men 
hospital 
50 
559/505 
population 
511/500 
hospital 
853 men 
9,990, 24 yr 
143 
50,535, 11y 
1 74/174 
population 
250/500 
hospital 
488/488 
adenomas* 
type of 
exposure 
fried meat 
broiled meat 
pan-fried 
foods 
fried ham/ 
bacon 
meat bbq or 
smoked 
bbq meat 
bacon 
doneness 
brown gravy 
meat surface 
frying temp 
meat fried or 
roasted 
doneness 
fried meat 
meat fried or 
roasted 
gravy 
roast meat 
fried meat 
red meat incl. 
preparation 
contrast in exposure 
a11.5 vs s6x/wk 
&8 vs <4x/wk 
> 1 vs s/wk 
>1.5 vss0.25x 
high vs low 
a5 vs s1 x/wk 
a5 vs s1 x/wk 
a1 vs <1 x/wk 
&1 vs <1 x/wk 
well done vs rare to 
med rare 
> 1 x/wk vs 
<3/month 
heavily vs 
lightly browned 
high vs 
med/low 
highest vs 
lowest quintile 
well done vs rare 
highest vs lowest 
tertile 
a5 vs <1x/wk 
>2 vs <1 x/wk 
a1 vs <1 x/wk 
highest vs lowest 
quartile 
high risk vs low risk 
category* 
relative risk estimates 
1.2 men 
1.3 women 
0.7 men 
1.1 women 
1.3 
1.0 all 
2.6 prox.colon 
1.3 all 
2.9 prox.colon 
3.3 
5.0 
3.5 
1.6 colon 
1.9 rectum 
2.0 colon 
3.4 rectum 
1.9 colon 
1.5 rectum 
0.9 colon 
1.4 rectum 
1.2 men 
1.0 women 
1.0 
0.6 men 
0.9 women 
3.2 prox col 
3.0 prox col 
2.6 
2.2 
(0.8-1.9) 
(0.8-2.1) 
(0.5-1.0) 
(0.7-1.7) 
(1.0-1.8) 
(0.4-2.4) 
(0.9-7.9) 
(0.6-2.7) 
(1.2-7.3) 
(1.2-9.2) 
(1.0-25.0) 
(1.3-9.6) 
(1.1-2.3) 
(1.2-3.0) 
(1.2-3.6) 
(1.7-6.7) 
(1.4-2.5) 
(1.1-2.1) 
NC 
NC 
(0.6-2.4) 
(0.6-1.5) 
(0.6-1.9) 
(0.2-1.7) 
(0.3-3.3) 
(1.1-11.2) 
(1.1-9.2) 
(1.6-4.1) 
(1.1-4.3) 
NC= Confidence Interval not given 
* 488 adenoma cases vs 488 sigmoidoscopy controls; red meat >1x/wk, >10% fried, and dark surface 
preference vs red meat <1 x/wk, <10% fried, light surface preference 
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AIMS AND OUTLINE OF THE THESIS 
The aims of the studies described in this thesis were: 
AIM 1 :to examine evidence for a role of dietary risk factors in the etiology of HNPCC, are 
some aspects of the etiology similar to sporadic colorectal carcinogenesis? 
AIM 2 to examine evidence for a differential effect of dietary risk factors on K-ras-/p53-
dependent and -independent pathways to colorectal carcinogenesis. 
K-ras and diet 
CHAPTER 6 
p53 and diet 
CHAPTER 7 
initiation 
> 
SPORADIC 
ADENOMAS 
progression 
> 
SPORADIC 
CARCINOMAS 
frequency and 
type of mutations 
CHAPTER 3 
association with meat 
consumption and preparation 
CHAPTER 4 
desciptive epidemiology 
CHAPTER 2 
— \ 
itiation y 
HNPCC 
ADENOMAS 
progression 
> 
HNPCC 
CARCINOMAS 
Figure 1.4. Schematic overview of the studies described in chapters 2, 3, 5-7 of this thesis. Chapter 4 
describes a methodological study and is therefore not included in this scheme. 
CHAPTER 2 How much higher is the risk of colorectal cancer in HNPCC families, as 
compared to the general population, and does the risk increase over successive 
generations? To answer these questions descriptive analyses have been conducted on 
data from the Netherlands Foundation for the Detection of Hereditary Tumors, which 
13 
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keeps a registry of HNPCC families in the Netherlands, and the population-based 
Netherlands Cancer Registry, which collects data on all malignant neoplasms occurring in 
The Netherlands since 1989. 
CHAPTER 3 Do frequencies of K-ras and p53 abnormalities differ between sporadic and 
HNPCC adenomas? In a case control study on dietary risk factors, genetic susceptibility, 
and DNA-damage in colorectal adenomas, we collected adenomatous tissue from 59 
sporadic and 48 HNPCC cases in order to detect K-ras mutations and p53 protein 
overexpression. 
CHAPTER 4 Would a substantial amount of information be lost when using a reduced 
questionnaire on meat consumption and preparation? Analyses for this methodological 
study were performed on the data from a Swedish case control study on the relation 
between the intake of heterocyclic amines and the risk of cancer in a population of 
Stockholm elderly, using a very extensive questionnaire to assess the intake of 
heterocyclic amines. 
CHAPTER 5 Are meat consumption and preparation associated with the risk of sporadic 
and HNPCC colorectal adenomas in a similar fashion? In the case-control study of 
sporadic and HNPCC colorectal adenomas we studied the association with factors 
relating to meat consumption and preparation, as assessed by a questionnaire especially 
developed for this purpose. 
CHAPTER 6 Is diet differently associated with colon cancer with or without (specific) 
mutations in K-ras? In a previously conducted case-control study on dietary risk factors in 
colon cancer, archival tumor tissue was retrieved to detect mutations in codon 12 and 13 
of the K-ras gene. We studied whether differences in intake of nutrients and foods of 
animal origin are related to (specific) mutations in K-ras. 
CHAPTER 7 Is diet differently associated with colon cancer with or without (specific) p53 
abnormalities? In the same case-control study of colon cancer, p53 protein 
overexpression and p53 gene mutations were detected in archival tumor tissue. Nutrients 
and food groups of both animal and plant origin were studied in relation to p53 
abnormalities in colon cancer. Both p53 protein overexpression and p53 gene mutations 
were assessed to examine whether the use of either of these endpoints would lead to 
different results in an epidemiological study. 
14 
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CHAPTER 8 The integrated results of CHAPTERS 2-7 are discussed in the light of the 
strengths and limitations of the studies. The biological plausibility of the examined diet-
gene interactions is outlined, and results from previously published observational and 
experimental studies are discussed. Finally, some general remarks are made about our 
studies and possible lines of future research into diet-gene interactions are presented. 
15 
3^ 
t ; 
o 
1 
•*3 
c: 
O 
c 
•8 
P 
T3 
C 
& 
O. 
< 
II 
ti 
0) >. 
S t 
° -s 
C> 
* 
d 
oi 
d 
z z 
c E 
CJ o 
E I 
I 
4 
1 > 
E 
a 
Q 
03 
I-
8 S 
CO LO 
T— t N 
1 
01 
1, 
c O 
o i 
o _ 
O >\ 
m co 
r - CO 
o 
ai 
01 
< 
1/5 
D 
01 
en 
a j 
t/1 
Q. 
1, 
m 
E 
o 
01 
d 
c
 9 
P m 
1-
oi 
01 
o 
<ii 
<N 
N . 
<-
1 
^r 
*— iA 
d 
CO 
d 
0 1 
r -
4 
d 
c 
CJ 
E 
CO 
d 
0 1 
CO 
o 
c 
OJ 
S 
1 0 1 
<-
o 
<N 
r v 
d 
<N 
<-
_^  4 
V 
2 
> 
3J 
^B 
ITi 
< j i 
( N 
T— 
C 
£ 
01 
•a 
c 
>~ 
T 3 
-£ ^0 
= s .— i n 
2- «> 
ex > 
tn O CJ m 
-2 «j 
4-> C 
$ .2 
_* 
J 
> 
VI 
> 
^ 4 
>~ m 
- D 
U 1 
d 
VI c/i > 
ra S 
CJ 
E 
D q 
c j 
E 
fl p 
n j 
CJ 
E 
T 3 
OJ 
01 
01 
u O 
01 
01 
' 
*-> 
cj 
E 
_c 
o 
- O 
• a 
o (J 
c 
-2 
4-< 
2 
a> J Z 
t— 
o 
Z 
v© 
"rt 
0) 
-o 
f5 
fO 
O 
t O T— CN 
CO 
01 
01 
CJ 
C 
u 
'oo 
o 
c 
r3 
£ OJ 
<-J 
c 
o 
o 
c CJ 
T 3 
c ^ 
c 
o 
CJ 
II 
U 
Z 
o 
• a 
<u 
c 
o 
c 
a j 
E 
4 j 
o 
c 
n 
£ 
o 
c 
"y 
n) 
U 
Chapter 1 
Appendix 1.2. Meat intake and the risk of colorectal adenomas and carcinomas: 
Author 
year, country 
Manousos et a l . 4 5 
1983, Greece 
Miller et a l . 4 6 
1983, Canada 
casesVcontr 
source contr 
100/100 
hospital 
542/ 
542+535 
population + 
hospital 
type of 
meat 
beef 
beef 
pork 
contrast in 
meat intake 
from 1 x to 2x /wk 
>110 vs <64.2 g/day (m) 
>42.4 vs 0 
g/day (f) 
>23.1 vs <6.9 
g/day (m) 
>14.0vs <4.3 
g/day (f) 
case control studies 
relative risk estimates 
1.8 NC 
1.2 colon, men NG 
1.7 rectum, men 
1.0 colon, women 
1.7 rectum, women 
1.1 colon, men 
1.3 rectum, men 
1.4 colon, women 
2.7 rectum, women 
Macquart-M. et a l . 4 7 
1986, France 
Kuneeta l . 4 8 
1987, Australia 
Macquart-M. et al. "9 
1987, France 
La Vecchia et a l . 5 0 
1988, Italy 
Tuyns et a l .5 1 
1988, Belgium 
Lee et a l .5 2 
1989, Singapore 
Peters et al. " 
1989, USA 
Wohlleb et a l . 5 4 
1990, USA 
Benito et a l . 5 5 
1990, Spain 
Kato et al.5fb 
1990, Japan 
Kune et a l . ! 7 
1991, Australia 
Gerhardsson et a l . 5 8 
1991, Sweden 
Bidol ie ta l . 5 9 
1992, Italy 
399/399 
hospital 
715/727 
population 
252/238 
adenomas 
hospital 
575/778 
hospital 
818/2,851 
population 
203/425 
hospital 
147/147men 
population 
43/41 men 
hospital 
286/295 
population 
adenoma+ 
carcinoma 
49/727 
adenomas 
population 
559/505 
population 
248/699 
hospital 
total meat 
beef 
pork 
total meat 
beef/veal 
beef 
pork 
red meat 
beef 
pork 
total meat 
beef 
total meat 
red meat 
highest vs lowest quartile 
highest vs lowest quintile 
highest vs lowest quartile 
highest vs lowest fertile 
>538g/wkvs <226g/wk 
>509g/wkvs <200g/wk 
highest vs lowest tertile 
a5x/wk vs s1 x/wk 
a1x/wk vs <1x/wk 
highest vs lowest quartile 
>360g/wkvs <360g/wk 
highest vs lowest quintile 
highest vs lowest tertile 
0.9 
1.8 
0.6 
0.8 
2.1 colon 
2.3 rectum 
2.1 colon 
0.7 rectum 
0.4 colon 
0.7 rectum 
1.3 
1.0 
3.3 
2.9 colon 
2.4 rectum 
NG 
(1.2-2.4) 
(0.4-0.7) 
NG 
NC 
NC 
NC 
NG 
NG 
NC 
(0.8-2.0) 
(0.6-1.6) 
(1.3-8.1) 
NG 
NG 
inverse association* 
2.4 men 
1.9 colon 
3.2 rectum 
1.6 colon 
2.0 rectum 
(1.0-5.8) 
NG 
NC 
NC 
NC 
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Iscovich etal . w 
1992, Argentina 
Peters et a l . 6 1 
1992, USA 
Zar idzeetal .6 2 
1992, Russia 
Steinmetz& Potter63 
1993, Australia 
Sandler e ta l . 6 4 
1993, USA 
Konoeta l . 6 5 
1993, Japan 
Benito e ta l . 6 6 
1993, Spain 
Centonze et a l . 6 7 
1994, Italy 
Kampman et a l . 6 8 
1995, Netherland 
Kotake et a l . 6 9 
1995 
LaVecchiaetal. ™ 
1996, Italy 
Shannon e ta l . 7 1 
1996, USA 
DeStefanieta l .7 2 
1997, Uruguay 
Franceschi et al. n 
1997, Italy 
LeMarchand et a l . 7 4 
1997,Hawaii(US) 
Kampman et al. " 
1999, USA 
110/220 
population 
746/746 
population 
217/217 
population 
220/438 
population 
236/409 
adenomas 
colonoscopy 
187/1,557 
adenomas 
colonoscopy 
adenomas 
119/119 
population 
232/259 
population 
363/363 
1,326/2,024 
hospital 
424/414 
population 
250/500 
hospital 
1,953/4,154 
hospital 
1,192/1,192 
population 
1,542/1,860 
population 
red meat 
red meat 
total meat 
red meat 
beef 
total meat 
'fresh' meat 
red meat 
beef 
pork 
red meat 
red meat 
red meat 
red meat 
red meat 
red meat 
highest vs lowest terile 
per 10x/month 
highest vs lowest quartile 
a8.3 vs s3.9 x/wk 
a7.2 vs s3.4 x/wk 
a2.6 vs s0.6 x/wk 
a2.3 vs s0.5 x/wk 
&4 vs <2 x/wk 
a132 vs <88g/day 
>94 vs <52 g/day 
a4x/wk vs <4x/wk 
highest vs lowest quartile 
highest vs lowest quartile 
a6.3 vs <3.5 x/wk 
a82 vs <23 g/day 
>8.8x/wk vs vs s2.2 x/wk 
>6.2x/wk vs vs s1.5 x/wk 
0.8 
1.2 
1.0 
1.6 men 
1.5 women 
2.1 men 
1.6 women 
1.5 
no association" 
0.7 
0.9 men 
2.4 women 
1.7 colon 
0.8 rectum 
0.8 colon 
1.6 rectum 
1.6 
1.5 men 
0.7 women 
2.6 colon 
2.9 rectum 
1.1 
1.8 men 
1.0 women 
0.9 men 
1.0 
(0.4-1.7) 
(1.1-1.3) 
(0.5-2.0) 
(0.8-3.1) 
(0.7-3.0) 
(0.8-5.2) 
(0.7-3.5) 
(0.9-2.4) 
(0.4-1.4) 
(0.4-1.8) 
(1.0-5.7) 
ns * 
ns 
ns 
s 
(1.4-1.9) 
(0.8-2.7) 
(0.4-1.4) 
(1.5-4.5) 
(1.5-5.5) 
(0.9-1.4) 
(1.2-2.7) 
(0.6-1.5) 
(0.7-1.3) 
(0.7-1.5) 
NG= Confidence Interval not given 
* paper not available 
* carcinoma if not mentioned otherwise 
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CHAPTER 2 COLORECTAL CANCER RISK IN HNPCC FAMILIES: 
DEVELOPMENT DURING LIFETIME AND IN SUCCESSIVE 
GENERATIONS 
Members of hereditary non-polyposis colorectal cancer (HNPCC) families 
develop colorectal cancer at a much higher rate, and at a much younger age, 
than the general population. To quantify lifetime colorectal cancer risk in 
HNPCC family members, we calculated the cumulative incidence (CI) in 
different age categories, and compared this to the general population. 
Furthermore, we investigated whether successive generations of HNPCC 
families had earlier onset of disease. 
In 51 HNPCC families, selected according to the "Amsterdam criteria", the CI of 
colorectal cancer at age 75 was 40%, compared to only 4% in the general 
population. The CI ratio (CIR) of HNPCC family members relative to the general 
population was 148 at age 40, 79 at age 50 and 11 at age 75. Comparing 
successive generations of HNPCC families, the CI at age 75 increases from 19% 
in the ancestors to 32% in the first generation and 55% in the second generation. 
However, Cox proportional hazard analysis showed that this generation effect (RR 
per generation: 1.8, 95% CL = 1.4-2.2) largely disappears after adjustment for 
year of birth. 
In summary, at young ages, HNPCC family members experience an up-to-150 
times higher risk for colorectal cancer than the general population. This risk 
difference declines from age 60 onwards. The earlier age of onset in successive 
HNPCC generations does not appear to be a biological feature of HNPCC, but 
reflects a secular time trend in cancer occurrence in these families, similar to that 
in the general population. 
INTRODUCTION 
Colorectal cancer is one of the most common types of cancer in the Western wor ld. 
Besides environmental and dietary factors, genetic or hereditary factors are considered 
relevant, both with respect to adenomatous precursors and the malignancy itself. Fuchs et 
a/, found, in the Nurses' Health Study and the Health Professionals Follow-up Study, a 
1.7-fold increased risk of colorectal cancer in subjects with a family history of colorectal 
cancer in first-degree relatives, as compared with those wi thout a family history of the 
disease 5. Besides this increased risk in the general population, some cancer-prone 
families experience an extremely high risk of colorectal carcinomas. There are several 
hereditary diseases wi th an excess risk of colorectal cancer, e.g., familial adenomatous 
polyposis (FAP) and hereditary non-polyposis colorectal cancer (HNPCC). HNPCC, which 
23 
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was first described by Warthin (1913)20 and named cancer family syndrome in the 1960s 
21
, is a disease with a definite hereditary component. This autosomal-dominant disease is 
caused by a germline mutation in one of at least 4 known mismatch repair genes 
(UMSH2, hM/.H1, hPMS1, hPMS2) 85. It is characterised by susceptibility to colorectal 
cancer, frequently localised in the proximal colon, and with an early age of onset 22;23. 
HNPCC probably accounts for about 1-5% of cases of colorectal cancer 86;87. Age at 
diagnosis of colorectal cancer in individuals from HNPCC families is approximately 45 
years 22-2";88-92/ whereas only 5% of the colorectal cancer patients in the general 
population is diagnosed before the age of 45 (Netherlands Cancer Registry, 1989-1992). 
Furthermore, members of HNPCC families appear to develop extracolonic tumours more 
often than the general population. In particular, tumours of the stomach, urinary tract and 
endometrium belong to the HNPCC tumour spectrum 22;24. In HNPCC families, an earlier 
age at diagnosis in successive generations has been described 23;27, which might reflect an 
earlier onset of disease, ;'.e. anticipation. 
The presence of a registry of hereditary tumours, as well as a complete nationwide cancer 
registry in The Netherlands, provides the opportunity to compare colorectal cancer risk in 
HNPCC families and in the general population. The purpose of our study was 2-fold: first, 
to quantitatively assess the risk of colorectal carcinomas in HNPCC families, and to 
compare this risk with the risk of colorectal carcinomas in the general population; and 
second, to investigate the development of colorectal cancer risk over a lifetime, and to 
determine whether this risk differs in successive generations of HNPCC families. 
POPULATION A N D METHODS 
HNPCC families 
In the Netherlands, registration and screening of HNPCC families is coordinated by the 
Foundation for the Detection of Hereditary Tumours. If HNPCC is suspected in a family, 
a genealogical tree of the family is constructed. For inclusion of a family in this study, the 
"Amsterdam criteria" proposed by the International Collaborative Group on HNPCC 
(ICG-HNPCC) in 1991 were used. These are as follows: 1) at least three relatives with 
histologically verified colorectal cancer, one of them being a first-degree relative of the 
other two; 2) at least two successive generations should be affected; 3) in one of the 
relatives colorectal cancer should be diagnosed before age 50; and 4) Familial 
Adenomatous Polyposis should be excluded 93. 
In September 1994, 51 registered families, consisting of 313 cases and their 1,108 non-
affected first-degree relatives, were included on the basis of the "Amsterdam criteria". All 
families met these criteria except that in 14 of them the diagnosis was confirmed by 
medical reports instead of pathological reports. Small families with few cases and families 
24 
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with the majority of colorectal cancer patients in the older generations could not be 
included exclusively on the basis of histological verifications. Excluding these families from 
the analyses did not notably change the results. Therefore, in all analyses presented, these 
14 families are included. Mutation analysis of the UMSH2 and hMZ.H1 mismatch repair 
genes was conducted in a clinical setting in 23 families, in 12 of which a mutated gene 
could be detected. This number of families is too small to allow separate analyses of 
families with and without a mutation. 
Colorectal cancer in the general population 
The Netherlands Cancer Registry (NCR) is a population-based cancer registry which 
systematically collects data on all malignant neoplasms occurring in The Netherlands since 
1989 94. After notification, mainly by pathology and haematology departments, the 
medical records of newly diagnosed patients (and tumours) are collected. Relevant 
information for the cancer registry is abstracted by trained registration clerks and 
submitted to a regional cancer registry. After extensive checks for duplicate records, the 
data are entered into the national database. The systematic completeness of the 
registration is estimated to be 98.5%. We used incidence data from the NCR in 1989-
1992, as well as information on the age distribution of the population of The Netherlands 
in 1992 94. 
Data analysis 
From the 51 genealogical trees, only those cases of colorectal cancer for which a 
pathological-anatomical or other medical report was available, were included in the 
analyses. Thus, subjects whose colorectal cancer could only be based on family history 
information were excluded (n=41). Because the data used in this study are partly derived 
from genealogical trees that go back to the beginning of this century, not all information on 
age at diagnosis and death is available. As these dates are required to determine the person 
years of observation, people for whom this information was missing could not be included 
(60 cases, 134 relatives) in the analyses. This resulted in inclusion of a total of 212 patients 
with verified colorectal cancer and 974 non-affected first-degree relatives. Whenever date 
of birth was included in the survival analysis, another 24 (of the 974) non-affected relatives, 
of whom age at diagnosis or death was known but not their date of birth, were excluded. 
To quantify lifetime risk, we calculated the cumulative incidence (CI,), being the probability 
for an individual to develop the disease before age t9S. The estimated CI at a certain age 
(CI,) is based on the age-specific incidence rates, taking into account the length of the age 
categories as well as the proportion of people at risk at the beginning of each subsequent 
age category %. The 95% confidence limits (95% CL) of CI, are derived from the Poisson 
distribution of the observed number of cases 97. In the data from The Netherlands Cancer 
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Registry, the age-specific incidence rate is the number of new cases, in 1989-1992, in a 5-
year age group per 100,000 individuals of that 5-year age group. To study anticipation, we 
calculated CI, for successive generations in HNPCC families. Each family was subdivided 
into generations, starting with one (or a pair of) common ancestor(s), and each following 
generation being the next horizontal line in the genealogical tree. The first generation 
consists of the children of the ancestors, the second generation consists of all the children of 
the cases in the first generation, and so on. 
Time from date of birth until diagnosis was used as survival time. Subjects who were not 
affected by colorectal cancer or had died from other causes before the end of the study 
period were treated as "censored" observations. To account for differences in gender, year 
of birth and year of diagnosis, we conducted survival analysis using Cox proportional 
hazards regression modelling9B. Generation, birth cohort or year of birth, and gender, were 
entered in the model separately and in combination. The proportional hazards assumptions 
were found to be valid for each of the variables. 
RESULTS 
Description of the HNPCC population 
Table 2.1. Descriptive data of histologically verified colorectal cancer patients in 51 HNPCC families. 
Total Men Women General 
Characteristics (n=212) (n = 115) (n = 97) Population* 
Age at diagnosis mean 
Localization tumour 
Proximal 
Distal 
Unknown 
Stage at diagnosis 
A 
B 
C 
D 
Unknown 
±sd 
n (%) 
n (%) 
43.6 
112 
87 
13 
10 
90 
58 
17 
37 
±12.4 
(52.8) 
(41.0) 
(5.6) 
(4.7) 
(42.4) 
(27.4) 
(8.0) 
(17.4) 
44. : 
62 
45 
8 
7 
49 
33 
7 
19 
±12.5 
(53.9) 
(39.1) 
(7.0) 
(6.1) 
(42.6) 
(28.7) 
(6.1) 
(16.5) 
42.9 ±12.1 
50 
42 
5 
3 
41 
25 
10 
18 
(51.5) 
(43.3) 
(5.2) 
(3.1) 
(42.3) 
(25.8) 
(10.3) 
(18.6) 
69 ± 1 3 
817 (31.6) 
1767 (68.4) 
n.a.t 
434 (16.2) 
822 (30.8) 
538 (20.1) 
481 (18.0) 
397 (14.8) 
* General population data, from "Comprehensive Cancer Centre Middle Netherlands" 
+ n.a., not applicable 
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Fifty-one HNPCC families consisted on average of 3 generations, with 28 first-degree at-
risk members per family, of which an average of 6 had a colorectal carcinoma. Table 2.1 
describes the characteristics of the histologically verified colorectal cancer patients in the 
51 HNPCC families. Mean age at diagnosis of patients with colorectal cancer was 43.6 
years in the overall group, whereas it was 65 (n=3), 49 (n=73), 41 (n = 116) and 33 
(n=20) years in the ancestors, and first, second and third generation, respectively. No 
cases have occurred in the fourth generation so far. More than 50% of the tumours were 
localised in the proximal colon. The majority of the tumours (70%) were in Dukes stage B 
and C at diagnosis. Of the patients with colorectal cancer, 24% (n=51, data not shown) 
developed more than one colorectal carcinoma. Sixty-two other primary, extra-colonic, 
tumours were diagnosed before or after the colorectal tumour in these patients. Twenty-
one were tumours located in the endometrium, 5 in the urinary tract including the 
bladder, 6 in the stomach, 3 in the small intestine, 3 in the prostate, 4 in the ovaries, 4 in 
the breast, 1 in the lung, 9 at other sites and 6 at unknown sites. 
Table 2.2. Cumulative incidence data (95% confidence limits) for colorectal cancer in 51 HNPCC families in 
comparison with the general population (NCR, 1995). 
Age 
(years) 
0-19 
20-24 
25-29 
30-34 
35-39 
40-44 
45-49 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
80-84 
85 + 
HNPCC families 
Cumulative 
# of cases 
2 
6 
24 
55 
90 
122 
153 
167 
184 
195 
207 
210 
212 
212 
212 
Initially 
at risk 
1186 
1071 
1007 
905 
799 
662 
517 
395 
301 
233 
171 
123 
81 
43 
17 
CI at age t (Cit) 
(95% confidence limits) 
HNPCC (per (1000) 
1.8 
5.6 
(0-4.2) 
(1.8-9.4) 
24.3(15.7-32.8) 
59.6(47.4-71.7) 
104 
153 
210 
242 
291 
331 
386 
405 
425 
_* 
_* 
(90-118) 
(136-169) 
(190-229) 
(226-259) 
(268-313) 
(308-353) 
(355-415) 
(383-426) 
(397-451) 
NCR 
0.1 
0.2 
0.3 
0.4 
0.7 
1.4 
2.7 
5.0 
8.8 
14.9 
24.2 
36.7 
53.2 
72.6 
108 
(per 1000) 
(0.06-0.16) 
(0.15-0.21) 
(0.23-0.30) 
(0.36-0.46) 
(0.63-0.77) 
(1.3-1.5) 
(2.5-2.8) 
(4.7-5.2) 
(8.5-9.4) 
(14.5-15.3) 
(23.7-24.8) 
(36.0-37.3) 
(52.3-54.1) 
(71.4-73.7) 
(105-110) 
Cumulative 
Incidence 
Ratio (CIR) 
16.4 
31.2 
92.5 
144.3 
148.4 
110.7 
78.9 
48.7 
33.0 
22.2 
15.9 
11.0 
8.0 
.* 
_* 
:
 Not calculated because of the small number of subjects initially at risk in HNPCC families. 
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Comparison of lifetime risk to the general population 
In HNPCC families the CI of colorectal cancer at age 75 (Cl75) is 40.5% (Table 2.2), 
whereas in the general population it is only 3.7% at that age. In the general population 
the C\mime is about 10% and increases most clearly after age 65 (Figure 2.1). In HNPCC 
families CI7S exceeds 40% and increases mainly in the age categories from 30-65 years. 
The CI is somewhat higher among men than among women, both in HNPCC families and 
the general population (Figure 2.1). 
Due to the above pattern the CIR of HNPCC families relative to the general population is 
highest in the younger categories (CIR = 148.4). Because of the increase in colorectal 
cancer incidence in the general population after age 60, the CIR decreases over lifetime to 
about 10. 
Cumulative 
Incidence (%) 
60 
-NCR(all) 
-HNPCC(all) 
-NCR(men) 
- HNPCC(men) 
-NCR(women) 
-HNPCC(women) 
Figure 2.1 . CI of colorectal cancer by gender in HNPCC families and the general population. 
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Anticipation within successive HNPCC generations 
Figure 2.2 shows the CI according to age in successive generations of HNPCC families. 
The CI increases in each successive generation, which indicates that the age-specific 
incidence rates tend to increase more rapidly. In the ancestors there are no histologically 
verified cases before age 55; the CI7J is 18.9%. In the first generation the CI is 14.6% at age 
50 and increases further to 32.4% at age 75. Clso in the second generation is 26.8% and CI7S 
is 55.0%. In the third generation Cl45 is 27.8%. No estimate can be given for the Clso and 
CI7S since there has been no observation time in the older age categories so far. To account 
for the differences in observation time within the different generations, survival analysis was 
conducted. The survival curves of time from birth until diagnosis of colorectal cancer differ 
significantly between the successive generations in HNPCC families. Hazard rate ratios (RR) 
increase significantly in the second and third generation, as compared to the first generation 
in a univariate model (Table 2.3). There is an increasing trend over successive generations 
(RR per generation: 1.78; 95% CL 1.43-2.20). 
Cumulative 
Incidence (%) 
20 25 30 35 40 45 50 55 60 65 70 75 80 85 85 + 
Age (Yrs) 
—•—ancestors — • — 1 st generation —A—2nd generation # 3rd generation 
Figure 2.2. CI of colorectal cancer in successive generations of HNPCC families. 
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To study whether the generation effect can be explained by a secular time trend, we 
repeated the analysis using birth cohorts, categorised in five 25-year intervals for year of 
birth, as the explanatory variable. We observed an increase in RRs over successive birth 
cohorts (Table 2.3), with a significant trend (RR per birth cohort: 1.72; 95% CL 1.40-2.10). 
Moreover, when adding both generation and year of birth to the model, the RRs for 
generation effect were no longer significant (Table 2.3, RR third generation: 1.21), whereas 
year of birth remained significant. Since the colorectal cancer risk in the general population 
is slightly lower for women (Figure 2.1), and to compensate for potentially different sex 
distributions in successive HNPCC generations, the multivariate model was gender-
adjusted. Estimates were not notably affected, although we indeed observed a 20% lower 
risk in women (95% CL = 0.61-1.06). 
Table 2.3. Cox proportional hazards regression model comparing HNPCC generations. 
generation!! 
ancestors 
first 
second 
third 
birthcohort 
< 1899 
1900-1924 
1925-1949 
1950-1974 
number of 
total no. 
of cases 
3 
37 
116 
20 
5 
64 
108 
35 
subjects 
initially 
at risk 
37 
311 
529 
291 
55 
235 
395 
418 
RR (95% confidence limits) 
univariate 
Model 
0.31 
1.00* 
1.93 
2.47 
0.34 
1.00* 
1.86 
2.34 
* 
(0.10-0.97) 
(1.42-2.64) 
(1.44-4.22) 
(0.14-0.85) 
(1.32-2.62) 
(1.44-3.81) 
multivariate 
modelt 
0.71 (0.21-2.42) 
1.00* 
1.25 (0.85-1.84) 
1.21 (0.63-2.32) 
* RR=1.78 (95% CL = 1.43-2.20) when generations scored 1-5; for birth cohort RR=1.72 (95% CL = 
1.40-2.10) 
t adjustment of generation for birth cohort was done using year of birth as a continuous variable 
11 the fourth generation contributed 'survival time' but no cases 
* reference category 
DISCUSSION 
In this population of Dutch HNPCC families, cancers of the colon and rectum occur up to 
150 times more frequently than in the general Dutch population, especially at younger 
ages. In the general population, the majority of colorectal cancer cases develop after age 65, 
whereas in HNPCC family members, most tumours develop before this age. The earlier age 
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at diagnosis in successive generations of these families appears to result from a secular trend 
in cancer occurrence and not from a biological feature of HNPCC. 
Risk of cancer in HNPCC families 
We found a 40% CI of colorectal cancer at age 75 in first-degree HNPCC family members, 
theoretically consisting of 50% gene carriers and 50% non-carriers. Vasen et a/, assessed 
cancer risk in a large series of gene carriers and estimated the lifetime risk of colorectal 
cancer to be 80% " . Aarnio et a/, observed a similar cumulative lifetime risk of 78% in 
putative HNPCC gene carriers88. 
Due to the sources of the incidence data, differences in the selection of subjects might have 
led to biases in the CIR, due to either over- or underestimation of the CI in HNPCC families 
and/or the general population. The HNPCC families are a fixed cohort, showing an 
increasing trend in the risk of cancer over several decades, whereas the incidence figures in 
the general population were based on cross-sectional data (1989-1992) of a dynamic 
population. Therefore, the time period of diagnosis in younger cohorts of HNPCC families 
largely corresponds to that of the NCR 94. However, the older cohorts of HNPCC families 
have also been compared to recent incidence data of the general population. Data from the 
oldest regional cancer registry in The Netherlands, the Eindhoven Cancer Registry2, show a 
marked gradual increase in incidence of colorectal cancer since the 1970s, especially in the 
higher age categories. Therefore, the true incidence in the older age categories of the 
general population may be overestimated. The CIR of 148 at age 40 is probably reasonably 
realistic, whereas the CIRs in the older age categories are underestimated. 
Overestimation of risk in HNPCC family members may occur since families were only 
included in the study if they had the required minimum of 3 cases of colorectal cancer. 
Since the average HNPCC family has an average of 6 colorectal cancer cases, the CIR might 
theoretically be overestimated by a factor 2, but even this would still leave a very large risk 
difference between HNPCC families and the general population. 
The use of the "Amsterdam criteria" may have resulted in false-positive families, based on 
chance aggregation of tumours, as well as false-negative families, due to the low probability 
of finding 3 cases of colorectal cancer within small families 1C0. DNA analyses of the 
mismatch repair genes may resolve this problem in the future. Until now, DNA analysis has 
only been successfully performed in a limited number of families. Therefore, our results 
reflect colorectal cancer risk for all first-degree family members and not only for gene 
carriers. 
Smaller biases may be related to the methods of calculation of CIs and of data analysis. First, 
we did not strictly adhere to the "Amsterdam Criteria" since we included 14 HNPCC 
families, in which some diagnoses were based on medical reports only, without histological 
verification. It is not likely that this has seriously affected the CIR, since the results of the 
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survival analysis were not markedly affected by excluding these families. Second, the 
incidence rates of the NCR include 1-5% HNPCC cases B6;87 in the rates' numerator, as well 
as observation time of prevalent cancer cases in the denominator. This may have had a 
small but unknown net effect on the incidence rate and, consequently, on the CIR. 
Anticipation of cancer in HNPCC 
As observed by others 23;27, the age at diagnosis decreases in successive generations within 
HNPCC families. This might reflect an earlier onset of disease in successive generations (i.e. 
anticipation), but it could also be due to ascertainment bias: the chance of finding HNPCC 
families with young cases in recent generations is larger than that of finding HNPCC families 
with young cases in older generations. Furthermore, follow-up of the younger birth cohorts 
does not exceed the first 5 decades of life, whereas it covers the entire life span in the older 
birth cohorts. Consequently, the mean age at diagnosis in the younger birth cohorts is 
necessarily restricted to the younger age range, whereas it can be much higher in older 
generations. When survival analysis was used to account for these differences in observation 
time, we did observe an increasing relative risk of colorectal cancer in successive 
generations of HNPCC families. However, RRs found for generations were similar to those 
found for birth cohorts in univariate analyses. Adjusting the effect of generation for the 
secular trend resulted in non-significant RRs close to unity, suggesting that the higher risk at 
younger ages in successive generations can be attributed to a secular trend in cancer rather 
than to a generation effect. 
In other hereditary forms of cancer such as melanoma and breast cancer, similar findings of 
generation and birth cohort effects have been found 101;102. 
In the general population, an increase in incidence of colorectal cancer, although less 
marked, has also been observed over the last decades, especially in the older age categories 
2
. The survival analyses show that the increasing disease risk in successive HNPCC 
generations is not a disease characteristic per se, but is likely to reflect a secular trend of 
colorectal cancer risk within these families. This suggests that both hereditary and sporadic 
colorectal carcinoma have shared etiologic factors, e.g. in terms of dietary and 
environmental exposure patterns that changed during the past century. 
However, it could also be postulated that part of the trend in HNPCC is due to progress in 
medicine. Diagnostic procedures have changed during the century, colonoscopy has 
become more widely available, and health awareness has increased, the latter two factors 
particularly in HNPCC families. First, HNPCC cases were included only when the diagnosis 
was histologically verified. Because of the smaller percentage of histologically verified 
diagnoses in the older generations in our HNPCC families, this may partially account for the 
generation effect observed. The number of ancestors was small, however, and we used the 
first generation as the reference category in the survival analysis. Second, screening of 
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HNPCC family members may have contributed to the younger age at diagnosis. However, 
there were only 11 screening-detected cases in the dataset, too few to justify separate 
analyses or to account for serious bias in the observed associations. On the other hand, 
HNPCC family members may have undergone colonoscopy and prophylactic polypectomy, 
which may have led to an underestimation of the true colorectal cancer risk. 
In conclusion, our data confirm that HNPCC families have a very high risk of colorectal 
carcinoma as compared to the general population, especially before age 50, with a trend 
toward higher incidence in successive generations. This, however, is not necessarily a 
genetic characteristic of the disease, but may simply reflect the same secular trend as 
observed in sporadic colorectal carcinoma. 
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K-ras and p53 in sporadic and HNPCC adenomas 
CHAPTER 3 NO MAJOR DIFFERENCE 
IN K-RAS AND P53 ABNORMALITIES IN 
SPORADIC AND HEREDITARY NON-POLYPOSIS 
COLORECTAL ADENOMAS 
K-ras and p53 gene mutations are known to occur in high frequencies in 
sporadic colorectal cancers, but findings are inconsistent in Hereditary Non 
Polyposis Colorectal Cancer. We compared K-ras and p53 abnormalities in 
colorectal adenomas from HNPCC and sporadic patients, to examine whether 
they may represent similar or different molecular pathways to cancer. 
In 48 HNPCC and 59 sporadic colorectal adenomas codon 12 and 13 of the K-
ras gene were examined for mutations using Mutant Allele Specific 
Amplification (MASA)-PCR, and p53 protein overexpression was assessed using 
immunohistochemical methods. 
In sporadic adenomas K-ras mutations were detected in 32% and p53 
overexpression in 31% of the cases. Similarly, K-ras mutations and p53 
overexpression were both found in 25% of HNPCC adenomas. The frequencies 
of these abnormalities were not significantly different between HNPCC and 
sporadic adenomas. When taking differences in adenoma size into account, 
the frequencies were even more similar. The type of mutations in K-ras 
(transversion vs transition) did differ between HNPCC and sporadic adenomas. 
These results provide evidence for a similar molecular pathway to adenomas in 
HNPCC and sporadic carcinogenesis, with respect to involvement of K-ras and 
p53. 
INTRODUCTION 
Hereditary as well as environmental factors play an important role in the etiology of 
colorectal adenomas and subsequently colorectal cancer. During the adenoma-carcinoma 
sequence several mutations in oncogenes and tumor-suppressor-genes are acquired. In 
sporadic colorectal cancer the Adenomatous Polyposis Coli (APC)-"gatekeeper"-gene, 
underlying Familial Adenomatous Polyposis, is one of the first targets for a somatic 
mutation 9; subsequently mutations in other genes (e.g. K-ras, p53) may occur 7. 
Hereditary Non Polyposis Colorectal Cancer (HNPCC), is a distinct hereditary disease 
leading to colorectal cancer. HNPCC is caused by germline mutation in one of at least 
four mismatch repair genes85. Mismatches in microsatellite sequences, which often occur 
during normal DNA replication, are not repaired if one of the mismatch repair genes is 
mutated 103. This microsatellite instability gives rise to a mutator phenotype and occurs in 
about 80-90% of HNPCC tumors and also in a small proportion (10-15%) of sporadic 
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colorectal cancers 16;17;18. The genetic instability reflected in replication errors (RER), the 
frequent mutations in the Transforming Growth Factor B type II receptor (TGFB-RII) 104, 
and the more favorable prognosis of HNPCC patients versus sporadic patients 10S, suggest 
different molecular pathways of sporadic and HNPCC carcinogenesis. On the other hand, 
the initiating mutation in the APC gene in sporadic carcinogenesis is also frequent in RER 
positive carcinomas 28. Moreover, RER positive carcinomas are also reported to harbor 
somatic mutations in the K-ras and p53 genes 16;106. In sporadic colorectal cancer K-ras 
and p53 are both involved in about 50% of the tumors, K-ras also occurring in about half 
of the large adenomas and p53 in a lower percentage of adenomas 7. 
Recently a few studies have addressed the issue of K-ras and p53 mutation frequencies in 
HNPCC or mismatch repair related carcinomas 29-106'107. However, these studies were 
often relatively small (18-27 HNPCC or RER+ cases) and may therefore have resulted in 
inconsistent findings as to the frequency of these mutations (varying from 6-61% for K-ras 
mutations and 12-64% for p53 mutations or overexpression). Frequencies of K-ras and 
p53 abnormalities in earlier stages of HNPCC carcinogenesis have not been studied 
systematically. We have conducted a study of HNPCC as well as sporadic colorectal 
adenomas and examined whether these adenomas develop by distinctly different 
molecular pathways, with respect to acquired abnormalities in the K-ras and p53 genes. 
MATERIALS A N D METHODS 
Study population 
A case control study on dietary factors, genetic susceptibility and DNA-damage in 
colorectal adenomas was conducted between December 1995 and February 1998. 
Histological material was obtained from 59 sporadic and 48 HNPCC colorectal adenomas 
resected at endoscopy. Sporadic cases were recruited by the Departments of 
Gastroenterology of the Nijmegen University Hospital and two regional hospitals 
(Rivierenland, Tiel; Gelderse Vallei, Ede-Wageningen-Bennekom). The families of all 
HNPCC cases fulfilled the Amsterdam criteria for HNPCC 2S: at least three members in at 
least two successive generations must have colorectal cancer, with at least one case 
diagnosed before the age of 50 years; one of the affected members should be a first-
degree relative of the other two; Familial Adenomatous Polyposis should be ruled out. 
HNPCC cases were first-degree relatives of colorectal or endometrium cancer cases, and 
were recruited in a similar fashion, either by the Nijmegen University Hospital or the 
Netherlands Foundation for the Detection of Hereditary Tumors which keeps a registry of 
HNPCC families in The Netherlands. For most HNPCC participants no information was 
available on their gene carrier status for the mismatch repair genes. 
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All participants were Dutch-speaking and of Western European origin, diagnosed before 
the age of 75, without a history of colorectal cancer, colon resection, polyposis coli, or 
inflammatory bowel disease. Sporadic cases were excluded if they had had previous 
adenomas more than 3 years before entrance to the study. Eligible patients were 
informed about the study by the gastroenterologist participating in the conduct of this 
study or by the Netherlands Foundation for the Detection of Hereditary Tumors, after 
approval of their 'physician in attendance'. Of the 319 subjects who initially agreed to 
participate in the study 22, (7%) did not return questionnaires (on dietary and lifestyle 
factors, family history of cancer, bowel complaints, etc.) and 21 (6%) appeared not to 
meet the eligibility criteria retrospectively, resulting in 122 cases and 154 controls 
available for further study. Only adenoma cases were used in the analyses described in 
this paper. From 15 of the 122 cases no tumor material could be retrieved and they were 
therefore excluded from the current analyses. 
Tumors 
Clinical information, regarding the part of the colon inspected, the location of adenoma, 
and possible other abnormalities, was retrieved at endoscopy. In each subject who had 
adenomas at more than one endoscopy, the adenomas diagnosed closest to the date of 
entrance to the study were used. Characteristics of these adenomas were retrieved from 
histology reports. Adenoma characteristics and information on K-ras and p53 
abnormalities were recorded for the largest adenoma diagnosed during that endoscopy. 
K-ras mutation analysis 
DNA was isolated from paraffin sections. After deparaffination and rehydration, tissue was 
incubated for 18 hours at 56°C with 0.5 mg/ml proteinase K (Boehringer Mannheim, 
Almere, The Netherlands) in 500 |xl cell lysis solution (DNA-isolation kit; PureCene 
Gentra Systems Inc., Landgraaf, The Netherlands) and additionally 72 hours at 37°C. After 
cooling the samples to 4°C, protein was precipitated. To the supernatant, 500 ui 
isopropanol was added for DNA precipitation. After washing the pellet with 70% ethanol 
at 4°C and centrifugation, DNA was air-dried and rehydrated. 
Codon 12 and 13 of the K-ras gene were examined for mutations by Mutant Allele 
Specific Amplification (MASA)-PCR. A mixture of primers corresponds to variants of the 
first (set A) and second (set B) nucleotide of codon 12, or the first (set C) or the second 
(set D) nucleotide of codon 13. The following primers were used: 
for wild-type Ki-ras: 5'TGTCCTAGTTGCACCTG; 
Set A 5'TGTGGTAGTTGGAGCTC, 5'TGTGGTAGTTGGAGCTA, and 
5 'TGTGGTAGTTGGAGCTT; 
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Set B 5'CTGGTAGTTGGAGCTGT, 5'GTGGTAGTTGGAGCTGA, and 
5 'GTGGTAGTTGGAGCTGC; 
Set C 5'GGTAGTTGGAGCTGGTC, 5'GGTAGTTGGAGCTGGTA, and 
5 'GGTAGTTGG AGCTGGTT; 
Set D 5'GTAGTTGGAGCTGGTGC, 5'CTAGTTGGAGCTGCTGA, and 
5 'GTAGTTGGAGCTGGTGT. 
For all PCRs the same 3'-primer was used: 3'TCAAAAGAATGGTCCTGGACC. 
MASA-PCR was performed in 35 cycles (0.5', 94°C; 0.5', 60°C; 1' , 72°C) using 300 ng 
DNA, 200 u.M of each dNTP, 20 pmol of each primer, 0.3 U of Thermoperfect Plus DNA 
polymerase (Integra BV, Zaandam, The Netherlands), 20 mM (NH4)S04, 75 mM Tris-HCL 
pH 9.0, 0.01%Tween and 2.5 mM MgCI2. Following amplification, 15 (LL) of each reaction 
mixture was loaded on a 2% agarose gel, electrophoresed and stained with ethidium 
bromide. 
On those samples that gave negative results with one single round of PCR, a nested PCR 
was performed. In the first round of this nested PCR (35 cycles; 0.5', 94QC; 0.5', 55QC; 
1' , 72QC) we added 100 ng of DNA and used ACTCATGAAAATGGTCAGAG (3'-primer) 
and GTACTGGTGGAGTATTTGATAG (5'-primer) as primers. For the second round (25 
cycles; 0.5', 94QC; 0.5', 60SC; 1', 72SC) primers sets and reaction conditions were the 
same as described above for the MASA-PCR. The only difference was that 1 (xl of a 1:100 
dilution of the first PCR product was used instead of 300 ng DNA. 
P53 immunohistochemical analysis 
As many adenomas were too small to provide sufficient amounts of DNA for performing 
p53 mutation analysis, immunohistochemistry methods were used to assess p53 
overexpression. Paraffin sections were mounted on charged glass slides (Superfrost) and 
dried overnight at 60°C. Sections were deparaffinized and rehydrated. Microwave antigen 
retrieval was performed by boiling the sections in 10 mM citrate-buffer pH 6,0 for 5 min. 
Additional buffer was added and the sections were boiled for another 5 min. and then 
allowed to cool to room temperature for 45 min. Sections were rinsed in PBS. 
Endogenous avidin/biotin was blocked with an Avidin/Biotin Blocking Kit (Vector 
Laboratories, Burlingame CA, USA). Endogenous peroxidase activity was blocked by 
incubation in 0,6 % H202 for 30 min. Sections were rinsed in PBS. Aspecific antibody 
binding was blocked by pre-incubation of the sections with 10% normal horse serum in 
PBS/BSA for 10 min. Sections were incubated overnight at 4°C with a cocktail of two anti-
p53 antibodies: 0,4 jug/ml DO-7 (Neomarkers, Fremont, USA) which recognizes both 
mutant and wild forms of p53, and 1 A/g/ml 240 (Neomarkers, Fremont, USA) which 
recognizes only the mutant form of p53. Negative control sections were treated with 
PBS/BSA alone. Sections were rinsed in PBS, and antibody binding was visualized using 
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the Vector ABC Elite kit (Vector Laboratories, Burlingame CA, USA) using 3,3'-
diaminobenzidine as substrate and copper enhancement according to the manufacturer's 
protocol. Finally, sections were dehydrated through graded concentrations of ethanol, 
incubated in xylol and mounted with permount. 
Stained sections were scored independently by a pathologist and one of the investigators 
(C.N.P. v.M.). Inconsistencies (<10%) were discussed together to mutual agreement. We 
have used two cut-off points for determining p53 overexpression. Tumors were scored as 
p53 positive if more than 20% of the cells displayed nuclear positivity. As p53 
overexpression in adenomas often takes a focal pattern 108;109/ adenomas with strong 
staining in 5-20% of cells were also considered positive. 
Data analysis 
To test differences in tumor characteristics and frequencies of molecular abnormalities (K-
ras mutations and p53 overexpression) between the sporadic and the HNPCC groups, 
Chi-square tests were used for categorical variables, or t-tests in case of a continuous 
variable. Logistic regression was used to estimate the relative risk of a K-ras mutation or 
p53 overexpression in HNPCC vs sporadic adenomas and to adjust for possible 
confounding by tumor characteristics. As the indications for having an endoscopy may 
differ for sporadic and HNPCC cases, factors related to the indication for endoscopy 
(bowel complaints versus routine screening), such as presence of bowel complaints 
(assessed by questionnaire), and part of colon visualized (type of colonic examination), 
were also taken into account. 
RESULTS 
Table 3.1 shows the general characteristics of the study population. As expected, the 
HNPCC cases were younger than the sporadic cases, while gender distribution was 
similar in both groups. Sporadic cases more often reported having bowel complaints prior 
to diagnosis of the adenoma(s). HNPCC cases often had small solitary adenomas, whereas 
the sporadic cases harbored larger adenomas accompanied by one or more other 
adenomas. The adenomas in HNPCC patients were more often localized in the proximal 
colon, while on the contrary sporadic adenomas were mainly found in the distal colon 
and rectum. As some of these characteristics may be related to frequency of endoscopy 
and the part of the colon visualized, we adjusted these analyses for 'type of colonic 
examination' (full colonoscopy including coecum versus sigmoidoscopy or partial 
colonoscopy combined with barium enema) and presence of bowel complaints. This did 
not markedly change the association between adenoma characteristics and hereditary 
(HNPCC) versus sporadic status of the cases (data not shown). 
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K-ras mutations and p53 overexpression occur in similar frequencies in these adenomas 
and do not significantly differ between sporadic and HNPCC adenomas (Table 1). In 
HNPCC patients K-ras mutations were detected in 12 of 48 (25%) of adenomas. Of 59 
adenomas in the sporadic group, 19 (32%) harbor at least one mutation in the K-ras gene. 
The frequency of p53 protein overexpression was also similar in HNPCC (25%) and 
sporadic adenomas (31%). 
Table 3.1. General characteristics of the study population and frequencies of K-ras gene mutations and p53 
protein overexpression; associations with sporadic vs HNPCC adenomas. 
age (mean ± SD) 
gender 
bowel complaintsll 
full colonoscopy^ 
men 
women 
no 
yes 
yes 
no 
adenoma characteristics* 
adenoma size 
single adenoma 
multiple adenomas 
localization!! 
1-4 mm 
5-9 mm 
alO mm 
distal colon + rectum 
proximal colon 
molecular abnormalities* 
K-ras gene mutations 
no 
yes 
p53 protein overexpression 
no 
yes 
Sporadic 
(n= 59) 
n <%) 
55 
34 
25 
20 
18 
50 
9 
16 
18 
25 
34 
25 
43 
11 
40 
19 
41 
18 
±11 
(58) 
(42) 
(53) 
(47) 
(85) 
(15) 
(27) 
(30) 
(42) 
(58) 
(42) 
(80) 
(20) 
(68) 
(32) 
(69) 
(31) 
HNPCC 
(n = 48) 
n (%) 
46 
25 
23 
32 
9 
43 
4 
27 
11 
9 
35 
13 
26 
17 
36 
12 
36 
12 
±10t 
(52) 
(48) 
(78) 
(22) 
(91) 
(8) 
(57)t 
(23) 
(19) 
(73) 
(27) 
(60)t 
(40) 
(75) 
(25) 
(75) 
(25) 
OR (95% CI)* 
HNPCC vs 
sporadic 
0.93 
1.0 
1.2 
1.0 
0.3 
1.0 
0.5 
1.0 
0.4 
0.2 
1.0 
0.5 
1.0 
2.6 
1.0 
0.7 
1.0 
0.8 
(0.89-0.97) 
(0.6-2.7) 
(0.1-0.8) 
(0.1-1.8) 
(0.1-1.0) 
(0.1-0.6) 
(0.2-1.1) 
(1.0-6.3) 
(0.3-1.6) 
(0.3-1.8) 
• OR=Odds Ratio, 95% Cl=95% Confidence Interval 
t p<0.05, T-test for continuous, and Chi-square test for categorial variables 
1 presence of bowel complaints (as reported by questionnaire) was unknown for 21 sporadic and 7 HNPCC 
cases; the type of endoscopy (full colonoscopy: yes, including coecum; no, sigmoidoscopy or partial 
colonoscopy combined with barium enema) was unknown for 1 HNPCC case; exact location of the 
adenoma (proximal: coecum, ascendens, hepatic flexure, transverse; distal: splenic flexure, descendens, 
sigmoid, rectosigmoid, rectum) was unknown for 5 sporadic and 5 HNPCC adenomas 
t characteristics and molecular abnormalities of the largest adenoma (in case of multiple adenomas) 
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Crude logistic models showed slightly lower non significant odds ratios for the association 
between family history (HNPCC versus sporadic) and molecular abnormalities (K-ras 
mutation and p53 overexpression). 
As shown in Table 3.2, increasing adenoma size is positively associated with harboring K-
ras or p53 abnormalities in the sporadic group. In the HNPCC group the association with 
adenoma size was of similar magnitude but not statistically significant. Having multiple 
adenomas was positively associated with p53 overexpression in the HNPCC cases. The 
location of the adenoma in the colon was not associated with differences in K-ras and 
p53 abnormalities, neither in HNPCC nor in sporadic cases. 
Table 3.2. Association between molecular and clinical tumor characteristics in HNPCC and sporadic 
adenomas. 
clinical tumor 
and case 
characteristics contrast 
OR (95% CI)* of molecular tumor characteristics 
K-ras mutation p53 overexpression 
sporadic HNPCC sporadic HNPCC 
age 
gender 
adenoma size 
No. of adenomas 
location in colon 
per 10 years 
female vs male 
per 5 mm 
multiple vs single 
Proximal vs distal 
1.2 (0.7-1.9) 
1.0 (0.3-3.0) 
1.5 (1.1-2.2) 
1.4 (0.4-4.0) 
0.6 (0.1-2.7) 
1.0 (0.5-1.9) 
0.4 (0.1-1.8) 
1.5 (0.7-3.1) 
2.5(0.6-10.0) 
1.4 (0.3-5.6) 
0.8 (0.5-1.4) 
0.6 (0.2-1.8) 
1.4 (1.0-2.0) 
1.6 (0.5-4.8) 
0.4 (0.1-2.0) 
1.8 (0.9-3.6) 
2.8(0.7-11.0) 
1.5 (0.7-3.1) 
4.1 (1.0-16.0) 
0.4 (0.1-1.8) 
' OR=Odds Ratio; 95% Cl = 95% Confidence Interval 
Table 3.3. Association between molecular adenoma characteristics and HNPCC vs sporadic colorectal 
adenomas. 
Model including 
adjustments K-ras 
OR (95% CI) HNPCC vs sporadic 
p53 K-ras or p53 K-ras and p53 
crude model 0.7 (0.3-1.6) 
of HNPCC vs sporadic adenomas 
model of HNPCC vs sporadic adenomas 
adjusted for: 
adenoma size 0.9 (0.3-2.2) 
location adenoma 0.6 (0.2-1.6) 
multiple adenomas 0.8(0.3-1.8) 
age 0.8 (0.3-1.9) 
gender 0.7 (0.3-1.7) 
bowel complaints 0.5(0.2-1.4) 
type of endoscopy 0.7(0.3-1.8) 
size + complaints 0.9 (0.4-2.4) 
0.8 (0.3-1.8) 1.1 (0.5-2.5) 0.4 (0.1-1.6) 
1.2 (0.5-3.1) 
0.9 (0.4-2.2) 
0.9 (0.4-2.1) 
0.8 (0.3-2.0) 
0.8 (0.3-1.8) 
0.4 (0.1-1.1) 
0.8 (0.3-1.8) 
1.2 (0.5-3.2) 
1.4 (0.5-3.4) 
1.0 (0.4-2.6) 
1.2 (0.5-2.7) 
1.1 (0.4-2.7) 
1.1 (0.5-2.5) 
0.5 (0.2-1.5) 
1.1 (0.4-2.5) 
1.4 (0.5-3.6) 
0.8 (0.2-3.3) 
0.5 (0.1-1.9) 
0.5 (0.1-2.0) 
0.6 (0.1-2.1) 
0.5 (0.1-1.6) 
0.2 (0.0-1.1) 
0.5 (0.1-1.8) 
0.9 (0.2-3.6) 
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We further examined whether differences in adenoma characteristics contributed to the 
slightly lower frequencies of K-ras mutations and p53 overexpression in HNPCC 
adenomas as compared to sporadic adenomas (Table 3.3). When taking differences in 
adenoma size into account the frequencies of K-ras mutation, p53 overexpression, or 
both, were even more similar between HNPCC and sporadic adenomas. Other 
characteristics of the adenomas and age and gender of the patients changed the odds 
ratios only slightly. Adjustment for the presence of bowel complaints slightly and non-
significantly lowered the odds ratios. Adjustment for type of endoscopy did not markedly 
change the odds ratios. When adenoma size and presence of bowel complaints were 
added to the models simultaneously, the odds ratios showed no difference in frequencies 
of K-ras and p53 abnormalities, but only adenoma size remained significant in the model. 
Details about the type of K-ras mutations in the 19 sporadic and 12 HNPCC adenomas 
with K-ras mutations, are shown in Table 3.4. Multiple mutations in the K-ras gene were 
detected in 9 (29%) of these 31 adenomas. The majority of adenomas with K-ras 
mutations (94%) harbor a mutation in codon 12. Mutations in codon 13 occur in about 
25% of adenomas with K-ras mutations, both in the sporadic and the HNPCC group. 
Mutations in the second nucleotide of codon 12 and 13 were most common: CAT in 
codon 12 (Gly-Asp), GTT in codon 12 (Cly-Val), and GAC in codon 13 (Cly-Asp), 
consisting of 31%, 24% and 19% of all 42 mutations respectively. Sporadic adenomas 
harbored transversion mutations more often (63%) than HNPCC adenomas (33%), 
whereas transition mutations occurred more often in HNPCC (75%) than sporadic 
adenomas (58%). Interestingly, all eight adenomas with K-ras mutations which were 
located in the proximal colon, harbored a transition mutation, whereas only about half of 
the distal adenomas with K-ras mutations harbored a transition. 
DISCUSSION 
In this study similar frequencies of both K-ras and p53 abnormalities could be observed in 
HNPCC and sporadic colorectal adenomas. If the size of the adenomas was taken into 
account, frequencies of K-ras and p53 abnormalities were even more similar between 
HNPCC and sporadic adenomas. These results do not provide evidence for a different 
molecular pathway to colorectal carcinogenesis in HNPCC, as far as involvement of K-ras 
and p53 is concerned. 
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Table 3.4. Specific K-ras mutations in sporadic and HNPCC colorectal adenomas*. 
case 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
age 
yrs 
74 
54 
46 
70 
40 
51 
64 
53 
64 
50 
58 
50 
62 
74 
61 
56 
53 
41 
47 
56 
43 
53 
64 
28 
51 
52 
29 
47 
57 
38 
37 
gender 
M/F 
M 
M 
M 
F 
M 
F 
F 
F 
M 
M 
F 
F 
M 
M 
M 
F 
F 
M 
M 
M 
F 
M 
M 
M 
F 
F 
M 
F 
M 
M 
M 
no. 
of 
size 
in mm 
adenomas 
7 
3 
1 
1 
1 
1 
1 
2 
6 
2 
3 
1 
3 
1 
3 
3 
1 
1 
1 
1 
6 
2 
1 
1 
6 
1 
1 
3 
1 
9 
1 
20 
15 
25 
3 
2 
20 
2 
20 
10 
25 
5 
10 
13 
7 
20 
30 
8 
20 
5 
3 
15 
10 
2 
2 
4 
10 
-
8 
3 
4 
10 
location 
in colon 
sporadic 
ascending 
sigmoid 
rectum 
sigmoid 
rectum 
rectosigmoid 
ascending 
splenic flexure 
sigmoid 
rectosigmoid 
rectum 
sigmoid 
sigmoid 
sigmoid 
rectum 
rectum 
ascending 
sigmoid 
sigmoid 
type of 
mutation 
adenomas 
transition 
transition+transversion 
transversion 
transversion 
transition 
transversion 
transition 
transversion 
transversion 
transition+transversion 
transversion 
transition 
transition 
transition 
transition+transversion 
transition 
transition+transversion 
transversion 
transversion 
HNPCC adenomas 
hepatic flexure 
ascending 
coecum 
transverse 
overlapping 
coecum 
descending 
rectosigmoid 
descending 
sigmoid 
sigmoid 
rectum 
transition 
transition 
transition 
transition 
transition 
transition 
transition+transversion 
transversion 
transversion 
transversion 
transition 
transition 
K-ras-12 
(CCT= 
wildtype) 
CAT 
TCT/CAT 
GCT 
CCT 
CAT 
CTT 
-
CTT 
TCT 
CTT/CAT 
CTT 
CAT 
CAT 
-
CTT/CAT 
CAT 
CTT 
CCT/CCT 
CTT 
GAT 
ACT 
CAT 
CAT 
CAT 
ACT 
CGT/ACT 
CTT 
CTT 
CTT 
ACT 
CAT 
K-ras-13 
(GCC= 
wildtype) 
-
-
-
-
-
-
GAC 
-
-
GAC 
-
-
-
GAC 
GAC 
-
GAC 
-
-
-
-
GAC 
GAC 
-
-
-
-
-
-
GAC 
-
* adenoma characteristics and K-ras mutations are described for the largest adenoma. Regarding the location 
in the colon: coecum, ascending colon, hepatic flexure and transverse colon are considered proximal colon; 
splenic flexure, sigmoid, rectosigmoid and rectum are considered distal colon. 
We examined whether HNPCC and sporadic tumors develop by different molecular 
pathways in the early stages of carcinogenesis. If HNPCC adenomas develop by a K-ras 
and p53 independent pathway, one would expect a very low frequency of mutations in 
these tumors. Our study of 59 sporadic and 48 HNPCC adenoma patients provides us 
with a power of 80% (with 95% CI) to detect a difference, if the frequency of either 
abnormality would be 35% in sporadic adenomas and 10% or less in HNPCC adenomas. 
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The HNPCC status of the cases in this study was determined by family history 
(Amsterdam criteria)25. Occurrence of the RER phenotype and mutations in the mismatch 
repair genes are only known in a small number of cases, and were therefore not taken 
into account in the results presented. In a recent study by Brown et a/, no correlation was 
seen between RER status and strength of family history except in HNPCC families 110. 
Moreover, in a recent study consisting mainly of HNPCC families from The Netherlands, 
fulfillment of the Amsterdam criteria was strongly associated with germ-line mutations in 
MSH2 and MLH1 " \ However, our group of HNPCC cases may include some cases 
without a germline mutation in one of the mismatch repair genes. In addition, our group 
of sporadic cases may include some cases with the RER phenotype. Therefore, some bias 
resulting from misclassification may have diluted the differences between sporadic and 
HNPCC adenomas. 
K-ras mutations were assessed using the MASA method, a method more sensitive than the 
SSCP method which is often used 112. We evaluated mutations in codon 12 and 13, and 
thereby may have missed a small number of potential mutations in codon 61, as they 
account for up to 5% of the total number of mutations in colorectal cancer B. Of the 
sporadic adenomas in this study 32% harbored a K-ras mutation, which is within the 
range of frequencies (15-75%) found in other studies 113'114'115. The spectrum of mutations 
is also similar to that observed in other studies of colorectal adenomas and carcinomas. In 
a large multi-center study of 2721 colorectal carcinomas the most frequently occurring 
mutations were the CAT transition (31%) and the GTT transversion (23%) in codon 12, 
and the GAC transition (17%) in codon 13 12. Frequencies in our study of adenomas were 
31%, 24% and 19% of the 42 detected mutations, respectively. Noticeably, Andreyev et 
a/, reported 81% mutations in codon 12 and 19% in codon 13, and only rarely multiple 
mutations in one carcinoma 12. However, of the adenomas with K-ras mutations in our 
study 94% harbor mutations in codon 12 and 26% in codon 13, with 9 of 31 adenomas 
(29%) harboring multiple mutations. 
To assess overexpression of the p53 protein we used standard immunohistochemical 
methods. In a study of colon carcinomas we found the concordance between p53 
mutation analysis (SSCP of exon 5 to 8, followed by sequencing) and 
immunohistochemical detection of p53 overexpression (same method as in this study, 
using 20% cut-off point) to be 72%. In studies of carcinomas a cut-off point of 20% of 
cells positively stained is often used to categorize overexpression 116;117. However, Yao et 
al. and Shan et a/, described that adenomas often have a more focal pattern of staining, 
with only a small percentage of cells with strong staining 108;109. We have therefore used 
two cut-off points for scoring p53 overexpression: 5-20% of cells with strong staining, 
46 
K-ras and p53 in sporadic and HNPCC adenomas 
which contributed about 25% to the total number of adenomas with overexpression, and 
more than 20% of cells staining, which contributed about 75% to positive adenomas. In 
total, we observed p53 overexpression in 31% of sporadic colorectal adenomas, which is 
within the wide range of 9-46% found in smaller studies of adenomas ^ n * ; " * " 0 ; 1 2 ' ; 1 2 2 .
 | p 
colorectal carcinomas, overexpression of the p53 protein is found in 40-50% 116>123'124/ 
which is somewhat higher than observed in adenomas, agreeing with the concept that 
p53 is mutated in a later phase of colorectal carcinogenesis 7. 
In carcinomas marked differences in mutation frequencies of K-ras and p53 have been 
reported in HNPCC subjects. Two studies have reported low frequencies (6-17%) of K-ras 
and p53 abnormalities in HNPCC carcinomas 29;107. In contrast, others reported relatively 
high frequencies (25-64%) of these abnormalities 12'106-125. Inconsistencies between studies 
may be due to selection of patients and laboratory methods used, as well as to the limited 
size of most studies. 
This study of adenomas, as early stages in hereditary as well as sporadic colorectal 
carcinogenesis, provides further clues to molecular pathways. We observed 25% of 
HNPCC adenomas to harbor a K-ras mutation and also 25% with p53 overexpression, 
frequencies similar to those observed in the sporadic adenomas. As harboring either of 
these molecular abnormalities is significantly associated with the size of the adenoma, 
frequencies were even more similar between these two groups if adenoma size was taken 
into account. Not accounted for in these analyses is the grade of dysplasia of the 
adenomas, which may also be associated with molecular abnormalities 115-118'126. part of 
the similarity in frequencies of K-ras mutations and p53 overexpression may therefore be 
explained by the generally higher grade of dysplasia of HNPCC adenomas 127. However, 
taking this into consideration, the results still point towards similar pathways in the 
adenomatous stage of carcinogenesis, with respect to K-ras and p53 abnormalities. 
Some differences in the type of K-ras mutations were observed between HNPCC and 
sporadic adenomas. Transversion mutations occurred slightly more often in sporadic 
adenomas, whereas transition mutations occurred more often in HNPCC adenomas 
especially in adenomas in the proximal colon. This might point at a difference in the 
cause of mutations between HNPCC and sporadic adenomas. 
The similar frequencies of K-ras and p53 abnormalities in HNPCC and sporadic 
adenomas may seem at variance with the differences in mutation frequencies found in 
some studies in sporadic and HNPCC carcinomas, and the distinct clinical and prognostic 
differences in HNPCC adenomas and carcinomas. We therefore postulate that, with 
respect to K-ras and p53, the molecular pathways of HNPCC and sporadic colorectal 
carcinogenesis diverge only in the development from large adenoma to carcinoma. 
47 
Chapter 3 
Sporadic and HNPCC colorectal adenomas may develop through similar molecular 
pathways, both starting with an initiating event like an APC mutation, which may occur at 
an earlier age in HNPCC subjects who are mismatch repair deficient. Both types of 
adenomas accumulate mutations in K-ras and p53 at similar rates; due to their mutator 
phenotype, HNPCC adenomas also accumulate other mutations like those in TGFfi-RII 
leading to a growth advantage, and from that point onwards they progress to malignancy 
much faster. It may be postulated that during this rapid progression to malignancy there is 
less time to accumulate a higher percentage of additional mutations in K-ras and p53, 
leading to larger differences in mutation frequencies between HNPCC and sporadic 
tumors in later stages of carcinogenesis. 
In conclusion, the results of this study do not provide evidence for differences between 
sporadic and HNPCC subjects in the molecular pathway to the early stage of colorectal 
carcinogenesis, with respect to K-ras and p53 abnormalities. Possibly, similar endogenous 
or exogenous factors may play a role in the etiology of sporadic and HNPCC colorectal 
carcinogenesis. More carcinomas as well as adenomas of different size and grade of 
dysplasia need to be evaluated before any definite conclusions about the molecular 
pathways in sporadic and hereditary colorectal cancer can be drawn. 
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CHAPTER 4 ASSESSING THE HUMAN INTAKE 
OF HETEROCYCLIC AMINES: 
LIMITED LOSS OF INFORMATION 
USING REDUCED SETS OF QUESTIONS 
The aim of this study was to evaluate loss of information of a reduced food 
frequency questionnaire, as compared to an extensive reference method, 
developed to assess the intake of heterocyclic amines (HCAs). Food frequency 
data were linked to concentrations of HCAs in cooked foods to estimate the 
individual daily exposure to a combination of five HCAs. 
The number of food items in the questionnaire was reduced and selected in 
three ways: according to the contribution to the estimated total intake, the 
between-person variance, or dishes included in other studies. The effect on 
sensitivity, specificity, concordance, the correlation coefficient, kappa, and 
simulated relative risks was determined using information from a population-
based study conducted in Stockholm. 
Only a limited amount of misclassification was introduced when the number of 
dishes was reduced from 39 to 15 or 20, and no major difference was seen 
when dishes were selected according to the total intake or to the between-
person variance. 
Our data indicate that for a specific exposure, such as HCAs, the loss of 
accuracy in an analytical epidemiological study is small, and may not be 
relevant, when the number of dishes in a food frequency questionnaire is 
decreased - if the initially chosen dishes are carefully selected, and cover a 
reasonable part of the total intake or between-person variance. 
INTRODUCTION 
High consumption of meat has been associated with an increased risk of colorectal cancer 
36;37;58;70;72 £ u c n a ^ ^ m a y ^ e (jjUe t 0 S U D S t a n c e s naturally occurring in the meat per se, 
agents added to the meat, or compounds formed during cooking. Mutagenic heterocyclic 
amines (HCAs) are formed from amino acids, creatine/creatinine and sugar 128;129 and 
were first measured in the charred parts of cooked meat and fish 13°. In order to assess the 
intake of HCAs, factors to be considered include not only the type of dish ingested, 
portion size, and frequency of consumption, but also cooking methods, cooking 
temperature, intake of gravy, and the concentration of HCAs in each dish. The validity of 
assessing cancer risks in relation to a dietary intake, such as HCAs, in an observational 
study can be distorted by systematic errors such as misclassification, misrepresentation, 
and confounding 131;132. The extent of misclassification depends on the sensitivity and 
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specificity of the dietary assessment method. In epidemiological research, the trade-off 
between an extensive, accurate, and time consuming method for a shorter version is 
often guided by practical and financial considerations. When reducing the number of 
items in a questionnaire, identifying a method to select the most informative food items 
may reduce the resulting systematic error. The magnitude of misclassification introduced 
when making these compromises, and the effect on risk estimates, must be considered 
for different reduction methods. There are alternative means of identifying informative 
food items in order to design reduced sets of questions. One may choose food items that 
contribute most to the total intake of the nutrient of interest in the study population, or 
select food items that vary most between subjects. The latter way is thought to be an 
effective method when the aim is to rank people according to their intake, and when the 
absolute level of intake is of less importance, as often is the case in epidemiological 
analytical studies133. 
In a Swedish population-based study, the intake of HCAs was estimated by linking 
consumption data collected by means of an extensive food frequency questionnaire to 
concentrations of HCAs in cooked meat and fish dishes 134. In the present analysis, we 
simulated three different reduced sets of questions, and assessed the degree of 
misclassification as compared to the original questionnaire. In addition, to elucidate the 
effect on risk estimates, we simulated relative risks using the reduced sets of questions. 
SUBJECTS A N D METHODS 
Study population 
In this study, data were used from a previously conducted case control study on exposure 
to food mutagens and cancer risk. Subjects were born in Sweden between 1918 and 
1942, having a permanent address in a demarcated geographical region in and around 
Stockholm for at least one month during the observation period from November 1, 1992, 
to December 31, 1994. Information about cases was retrieved from the population-based 
cancer register in Stockholm. Notification to the registry is mandatory by law both for 
attending physicians and pathologists. Controls were randomly selected from a population 
register during the observation period and frequency-matched according to age (five-year 
intervals) and gender distribution among the cases of colon cancer. 
A questionnaire was mailed to the subjects after they had received an introductory letter. 
After returning the questionnaire, missing information was completed by telephone 
interviews. Altogether, information was retrieved from 548 controls and 1056 cases of 
cancer of the colon (ICD=153), rectum (ICD=154), bladder (ICD=188), or kidney 
(ICD=189), according to the International Classification of Diseases, Injuries and Causes 
of Death 135. 
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The referent dietary assessment method 
The extensive dietary assessment method is described in detail elsewhere 134. In brief, diet 
was assessed by means of a semiquantitative food frequency questionnaire including a 
total of 188 food items, 27 of which were fried meat dishes, 16 oven-roasted meat 
dishes, 11 boiled meat dishes, 4 grilled meat dishes, 7 fish dishes, 2 egg dishes and 1 
blood pudding, as well as 4 different types of gravy/sauce. All questions took account of 
eating habits five years previously. Ten categories of intake frequencies ranged from '2-3 
times per day' to 'never'. Variables used to assess the intake of HCAs from meat and fish 
were type of meat/fish ingested, frequency of consumption, portion size, cooking 
method, degree of surface browning, and concentration of HCAs. Color photos showed 6 
dishes, each fried at 4 different temperatures, giving varying degrees of surface browning. 
Each photo corresponds to a known frying temperature. 
To assess concentrations of HCAs, 22 dishes with pan residues were cooked and 
analyzed, 15 of them being fried meat dishes, 3 baked/roasted meat dishes, 2 fried fish 
dishes, 1 fried eggs, and 1 blood pudding. Nineteen dishes were fried in a standardized 
manner at 150, 175, 200 and 225°C, and 3 were roasted/baked in a normal household 
oven at 150 and 200°C. Chemical analyses and the obtained concentrations of HCAs (2-
amino-3-rnethylimidazo[4,5-f]quinoline (IQ), 2-amino-3,4-dimethylimidazo[4,5-f]quino-
line (MelQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MelQx), 2-amino-3,4,8-
trimethylimidazo[4,5-f]quinoxaline (DiMelQx), and 2-amino-1-methyl-6-phenylimidazo-
[4,5-b]pyridine (PhIP)) in the cooked foods, have been reported in detail elsewhere 136"138. 
The classification of surface browning and concentration of HCAs for the remaining fried 
dishes in the questionnaire were linked to the 6 photos and the 22 analyzed dishes, 
respectively. The intake of HCAs from pan residue and gravy was calculated using a 
method previously described, which gives the concentration in one individually 
calculated standard serving134. 
The reduced dietary assessment methods 
In order to reduce the set of questions on intake frequency of fried/baked/grilled dishes, 
we computed the mean contribution of each dish to the total intake of HCAs among 
controls. After this, sets of informative dishes were generated using three alternative 
principles. First, all meat and fish dishes were ordered according to their contribution to 
the total mean daily intake of heterocyclic amines 139. This ranking was done for the 
meat/fish dishes and the corresponding gravy separately and combined. Secondly, the 
dishes were ordered according to their contribution to the between-person variance, 
using stepwise regression 133. Thirdly, groupings of dishes of special interest were formed, 
i.e. dishes used in another Swedish study (the 6 photographed dishes) and in Dutch 
studies (a set of 18 dishes that approximate habitual meat dishes in The Netherlands, and 
53 
Chapter 4 
are part of a 22-dish questionnaire used in a case control study on dietary factors and 
colorectal adenomas). 
Data analysis 
To explore misclassification by the reduced sets of questions, controls and cases were 
categorized into quintiles, based on the distribution of the intake of HCAs in controls. The 
ability of the reduced sets of questions to categorize subjects into the same quintile as the 
reference method was estimated in terms of sensitivity and specificity. Sensitivity is 
defined as the probability of a positive test result (e.g. quintile 1 according to the reduced 
method), provided the exposure is truly present (i.e. quintile 1 according to the reference 
method). Analogously, specificity is the proportion of truly non exposed subjects (quintiles 
2 to 5 according to reference method), who are correctly categorized as non exposed by 
the test (same quintiles according to reduced method). Furthermore, Pearson correlation 
coefficients for quintiles were calculated, as well as Kappa, a measure of concordance in 
contingency tables, taking into account agreement on the basis of chance alone 133. In 
order to explore the effect of misclassification on the range of relative risks that may be 
anticipated in epidemiological studies, relative risks of magnitude RR=2 and RR=3 were 
simulated. Using the reference method, the exposure to HCAs was categorized into 
quintiles, based on the distribution among controls, resulting in equal numbers of controls 
in each category of intake. The case distribution over the quintiles was selected to 
simulate "true" relative risks of 2.0 and 3.0 for the highest versus the lowest quintile of 
intake. These selected cases, and all controls, were subsequently categorized into new 
quintiles, based on the distribution of the intake of HCAs, using the reduced methods. 
Logistic regression was used to model the odds ratio 98, estimating the incidence rate ratio 
(relative risk) between the exposed and unexposed in the study population. 
RESULTS 
Table 4.1 shows the mean amount of heterocyclic amines {IQ, MelQ, MelQx, DiMelQx 
and PhIP), contributed by each dish to the total mean intake among controls. Considering 
the contribution stemming from meat and gravy combined, the 10 dishes contributing the 
most were fried bacon, ground beef patties, pork filet, chicken/turkey, meat balls, pork 
belly, loin of pork, entrecote and minced meat sauce. These dishes contributed 77 
percent of the total intake of HCAs among controls, as obtained using the extensive 
method. The top 15 and 20 dishes contributed 88 and 94 percent of the total intake, 
respectively. The remaining 6 percent of the intake was generated by an additional 20 
dishes. The total mean intake of HCAs from all 39 meat and fish dishes was 157 ng per 
day. MelQx and PhIP each comprised of 45% DiMelQx 10% and IQ and MelQ both less 
than 1 % of the total intake of HCAs (data not shown). 
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Table 4.1. Contribution of meat and fish dishes and gravy to the total intake of heterocyclic amines in an 
elderly population in Stockholm. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
bacon, fried 
minced beef patties, fried 
pork fillet, fried 
chicken/turkey, fried 
meat balls, fried 
pork belly, fried 
loin of pork, fried 
pork chops, fried 
entrecote, fried 
minced meat sauce 
beef steak, fried 
beef fillet, fried 
smoked pork, fried 
stew, browned 
fish, fried (breaded) 
lamb, fried 
minute beef, fried 
game, fried 
beef, grilled 
ham, fried 
pork stew, browned 
pork, grilled 
minced meat dish, grilled 
meat loaf, roasted 
black pudding, fried 
beef patties, roasted 
meat balls, roasted 
'falu'sausage, fried 
fish sticks, fried 
chicken/turkey, roasted 
'wiener'sausage, fried 
'chipolata'sausage, fried 
smoked sausage, fried 
fish, fried (not breaded) 
'stang'sausage, fried 
sausage, grilled 
sausage, fried 
'falu'sausage, roasted 
'wiener'sausage, roasted 
total 
meat intake 
ng 
26.1 
6.8 
5.3 
11.1 
8.8 
8.9 
4.1 
4.9 
3.9 
5.3 
2.9 
2.1 
1.5 
1.1 
2.2 
1.8 
0.9 
1.2 
1.2 
0.7 
0.6 
0.7 
0.6 
0.9 
0.8 
0.3 
0.6 
0.0 
0.4 
0.1 
0.0 
0.2 
0.0 
0.2 
0.0 
0.0 
0.0 
0.0 
0.0 
106.2 
%meat 
24.6 
6.5 
5.0 
10.5 
8.3 
8.3 
3.9 
4.6 
3.7 
5.0 
2.7 
1.9 
1.4 
1.0 
2.0 
1.7 
0.8 
1.1 
1.1 
0.7 
0.5 
0.7 
0.5 
0.9 
0.8 
0.3 
0.5 
0.0 
0.4 
0.1 
0.0 
0.2 
0.0 
0.2 
0.0 
0.0 
0.0 
0.0 
0.0 
gravy 
ng 
0.5 
10.4 
7.1 
0.5 
2.3 
1.5 
6.0 
5.2 
3.1 
0.0 
2.2 
1.6 
1.3 
1.6 
0.2 
0.3 
1.1 
0.6 
0.6 
0.9 
0.9 
0.5 
0.4 
0.0 
0.0 
0.5 
0.1 
0.5 
0.1 
0.4 
0.2 
0.0 
0.2 
0.0 
0.1 
0.0 
0.1 
0.0 
0.0 
50.9 
ntake 
%gravy 
1.0 
20.4 
13.9 
1.0 
4.5 
2.9 
11.8 
10.2 
6.1 
0.0 
4.3 
3.1 
2.5 
3.1 
0.4 
0.6 
2.2 
1.2 
1.2 
1.8 
1.7 
1.0 
0.8 
0.1 
0.0 
1.0 
0.2 
1.0 
0.1 
0.8 
0.4 
0.0 
0.3 
0.0 
0.2 
0.1 
0.1 
0.0 
0.0 
total intake 
ng 
26.6 
17.3 
12.4 
11.6 
11.1 
10.3 
10.1 
10.1 
7 0 
5.3 
5.1 
3.6 
2.7 
2.7 
2.4 
2.1 
1.9 
1.8 
1.8 
1.6 
1.4 
1.2 
1.0 
1.0 
0.8 
0.8 
0.7 
0.5 
0.5 
0.5 
0.2 
0.2 
0.2 
0.2 
0.1 
0.1 
0.1 
0.0 
0.0 
157.1 
%tot 
16.9 
11.0 
7.9 
7.4 
7.1 
6.6 
6.4 
6.4 
4.4 
3.3 
3.2 
2.3 
1.7 
1.7 
1.5 
1.3 
1.2 
1.1 
1.1 
1.0 
0.9 
0.8 
0.6 
0.6 
0.5 
0.5 
0.4 
0.3 
0.3 
0.3 
0.1 
0.1 
0.1 
0.1 
0.1 
0.0 
0.0 
0.0 
0.0 
cum% 
16.9 
27.9 
35.8 
43.2 
50.3 
56.8 
63.3 
69.7 
74.1 
77.5 
80.7 
83.0 
84.8 
86.5 
88.0 
89.4 
90.6 
91.8 
92.9 
93.9 
94.8 
95.6 
96.3 
96.9 
97.4 
97.9 
98.4 
98.7 
99.0 
99.3 
99.5 
99.6 
99.7 
99.8 
99.9 
100.0 
100.0 
100.0 
100.0 
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In this population gravy is very often prepared from pan-residues and eaten with most 
meat dishes. Therefore, gravy contributes substantially to the total intake of HCAs. The 
dishes contributing the most were ground beef patties, pork filet, loin of pork, pork 
chops, entrecote, meat stew, beefsteak, and, finally, pork belly. 
When ranking the top 10 dishes according to the explained percentage of the between-
person variance in the total intake (Table 4.2), 9 out of 10 were the same dishes as when 
ranking according to the total intake, but the dishes appeared in an alternative order. 
Considering the contribution from both meat and gravy, the 10 dishes contributing the 
most, in descending order, were fried pork chop, bacon, ground beef patties, entrecote, 
loin of pork, pork belly, pork filet, chicken, breaded fish, and minced meat sauce. These 
dishes accounted for 98 percent of the variance and 72 percent of the total intake of 
HCAs. A daily mean intake of HCAs based on these dishes would be 113 ng. The 
cumulative R2 (percentage of the between-person variance) and the percentage of the 
daily intake of HCAs accounted for by varying numbers of dishes, as selected by these 
two principles, is shown in Figure 4.1. 
120 
100 -
a. 
Cum. R1 
H 1 h H 1 h H 1 h H 1 h 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
No. of dishes 
Figure 4.1. Cumulative R2 and percentage of heterocyclic amines accounted for according to number of meat 
dishes included, in controls. 
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Table 4.2. Ranking of most informative dishes according to between-person 
variance in intake of heterocyclic amines using stepwise regression analysis. 
no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
meat dish 
pork chops, fried 
bacon, fried 
minced beef patties, fried 
entrecote, fried 
loin of pork, fried 
pork belly, fried 
pork fillet, fried 
chicken, fried 
fish, fried (breaded) 
minced meat sauce 
cumulative R2 
0.48 
0.70 
0.83 
0.89 
0.93 
0.94 
0.96 
0.97 
0.98 
0.98 
correlation 
coefficient* 
0.70 
0.63 
0.60 
0.35 
0.44 
0.56 
0.60 
0.22 
0.22 
0.39 
cum% 
total intake 
6.4 
23.3 
34.3 
38.7 
45.1 
51.7 
59.6 
67.0 
68.5 
71.8 
* simple Pearson coefficient of correlation for each dish to the total daily intake 
Sensitivity and specificity for different reduced sets of questions compared to the 
reference method are shown in Table 4.3. For sets of questions including 20 and 15 
dishes, sensitivity and specificity were equally good, regardless of the selection principles. 
A reduced questionnaire including 10 dishes performed less well, but the sensitivity was 
somewhat better for dishes selected according to their contribution to the total intake 
than for dishes selected according to variance. When only 5 dishes were used, the 
reduced methods performed even worse, and again, sensitivity was better for dishes 
selected according to contribution to the total intake than for dishes selected according to 
the amount of between-person variance explained. Concordance was measured as the 
ability of a reduced set of questions to categorize each person into the same quintile as 
the reference method. The concordance increased rapidly from 5 to 15 dishes, however, 
only small improvements were seen for a total of 20 dishes. Dishes selected according to 
the total intake generally performed better than dishes chosen by variance. The Pearson 
correlation coefficient increased with an increasing number of dishes, but performed 
equally well in the two methods of selecting dishes. Kappa, a measure of concordance 
accounting for chance, increased rapidly with the number of dishes, but dishes selected 
according to the total intake gave higher values. The sensitivity and specificity of the 
"Dutch module" including 18 dishes, were higher than 0.85 in all quintiles. More than 90 
percent of the subjects were classified into the same quintile as when using the reference 
method, 9 percent were classified one quintile higher or lower than in the reference 
method, and none were classified more than one quintile higher or lower. The 
correlation between the "Dutch module" and the reference method was also high. The 
short Swedish method comprising 6 dishes performed less well. 
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Table 4.4. The effect of misclassification, for reduced sets of questions, on relative risk estimates for each 
quintile (Q) of exposure. 
methods dishes 
simulated "true" RR 
39 
total intake 
5 
10 
15 
20 
Q1 
1.00 
1.00 
1.00 
1.00 
1.00 
between-person variance 
5 
10 
15 
20 
Swedish method 
6 
Dutch method 
18 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
Q2 
1.24 
1.41 
1.57 
1.49 
1.30 
1.34 
1.40 
1.52 
1.32 
1.45 
1.50 
Q3 
1.50 
1.85 
1.64 
1.74 
1.68 
2.11 
1.56 
1.62 
1.50 
2.08 
1.47 
Q4 
1.72 
1.62 
1.96 
2.00 
1.83 
1.67 
1.84 
1.93 
1.95 
1.95 
1.89 
Q5 
2.00 
2.15 
2.22 
2.18 
2.06 
2.20 
2.14 
2.13 
2.00 
2.33 
2.18 
Q1 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
1.00 
Q2 
1.50 
1.49 
1.84 
1.72 
1.47 
1.52 
1.56 
1.83 
1.55 
1.61 
1.81 
Q3 
2.02 
2.35 
2.12 
2.30 
2.19 
2.68 
1.99 
2.12 
1.97 
2.70 
1.95 
Q4 
2.48 
2.22 
2.83 
2.87 
2.56 
2.25 
2.43 
2.74 
2.75 
2.61 
2.72 
Q5 
3.03 
3.02 
3.26 
3.25 
3.02 
3.14 
3.04 
3.18 
2.97 
3.33 
3.29 
The effect of decreased sensitivity and specificity on the estimated relative risks is shown 
in Table 4.4. Only small effects on the relative risks were seen for the reduced methods 
comprising 10, 15 or 20 dishes, regardless of the selection criteria. Relative risks based on 
truncated modules comprising only 5 dishes deviated markedly from the simulated "true" 
relative risks, especially for the 5 dishes selected according to the between-person 
variance. 
DISCUSSION 
We studied the loss of information when reducing an extensive food frequency 
questionnaire designed to estimate human intake of HCAs, as part of a population-based 
study of cancer risk. The findings of this study indicate that the loss of information is 
limited when the number of enumerated dishes was reduced from 39 to 15 or 20. Results 
were similar for the two principles of selection, when using 15 or 20 dishes. Using 5 or 10 
dishes, estimates of intake based on dishes selected according to the total intake of HCAs 
were more accurate than those based on dishes selected according to the between-
person variance. The reference method in this study was an extensive semi-quantitative 
food frequency questionnaire, designed to estimate human cancer risks as related to 
HCAs in a Swedish population 134. The selection of dishes was based on previous studies 
of frequently eaten fried foods in an elderly population in Stockholm. The total intake of 
HCAs was estimated using questionnaire-data on the cooking method, frying 
temperature, portion size, intake frequency, intake of gravy, and data on the 
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concentration of HCAs in various dishes from chemical analyses. The extensive food 
frequency questionnaire was used as a reference method, but cannot be considered as a 
"gold standard". Validation of HCA intake by identifying DNA adducts 140143, excretion of 
HCAs in urine 14\ or collecting double portions of food for chemical analysis 133 may be 
possible. However, these approaches have their own methodological and analytical 
limitations. To compose a database of HCA content in cooked meat, 22 dishes and 
corresponding gravies were cooked in a standardized manner at different temperatures, 
resulting in 152 samples. Subsequently, these were chemically analyzed for the five 
heterocyclic amines, IQ, MelQ, MelQx, DiMelQx and PhlP. If the chemical analysis of 
these samples suffered from systematic errors, this would result in a systematic shift in the 
magnitude of the estimated HCA intake in both cases and controls. However, random 
analytical errors may result in nondifferential misclassification, diluting the association and 
therefore increasing the chance of missing a possible real carcinogenic effect of HCAs (B-
error). 
The 22 analyzed dishes, of a total of 39 dishes in the questionnaire, account for 79 
percent of the total intake of HCAs among controls, as estimated when using the 
reference method. The remaining 17 dishes were not cooked and analyzed, but data on 
HCA content were taken from similar dishes, which may have introduced some 
additional measurement errors. Considering the large number of dishes cooked and 
analyzed, the magnitude of these errors is probably relatively small. 
As shown by others 139;145 using the percentage contribution to the total intake, or the 
percentage explained of the between-person variance derived by stepwise regression, are 
legitimate methods to reduce the number of items in a questionnaire. Of course, subjects 
may answer differently to n items in an extensive 188-item questionnaire, than to a short 
questionnaire including the n items only. It is difficult to argue which of those approaches 
would lead to the most valid estimate. 
In this study the reduced methods biased some of the 'true' relative risks upward, instead 
of towards the null. This may be caused by the fact that a continuous variable is 
categorized into five categories, which is known to sometimes result in bias away from 
the null 146;147. Furthermore, the selection of dishes is based on the controls, which may 
lead to some bias if patterns of consumption of meat dishes are substantially different in 
cases. 
When studying the effect of exposure to HCAs on cancer risk, one should study 
individual HCAs, because they occur in varying concentrations and may have different 
mutagenic and carcinogenic effects. In this study we summed the intake of five HCAs to 
estimate total intake. When a specific HCA is the relevant exposure in studies of cancer 
risk, an estimation of the total intake of HCAs may be a suboptimal surrogate variable, 
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especially if the amine occurs in relatively low concentrations compared to other HCAs. 
Indeed, intake of individual HCAs may be better estimated by different sets of dishes, as 
was recently shown by Byrne et al. 148. 
In conclusion, a limited amount of misclassification was introduced when the number of 
fried/baked/grilled meat and fish dishes was reduced. This may imply that food frequency 
questionnaires focused on intake of HCAs can be relatively short. One reason to shorten 
a questionnaire is to increase the participation rate, which may improve the accuracy of 
the findings more than the decrease introduced by the additional measurement error. 
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CHAPTER 5 MEAT CONSUMPTION AND PREPARATION 
IS RELATED TO SPORADIC BUT NOT TO 
HEREDITARY COLORECTAL ADENOMAS 
Meat consumption and preparation are thought to be associated with the risk 
of colorectal cancer, and possibly also to adenomas. It remains to be elucidated 
whether environmental factors also play a role in hereditary non-polyposis 
colorectal cancer (HNPCC). We examined whether meat consumption and 
preparation are similarly associated with sporadic and HNPCC colorectal 
adenomas. 
A case control study was conducted among 57 sporadic and 62 HNPCC 
adenoma cases. Controls for both groups (65 sporadic and 83 HNPCC controls) 
also underwent full colonic examination to exclude adenomas. To assess meat 
consumption and preparation we used a questionnaire designed especially for 
this purpose. 
Frequency of red meat consumption was positively, although not significantly, 
associated with risk, only in the sporadic group (OR daily vs < 4x /wk, 95% CI: 
sporadic 4.1, 0.7-23.0; HNPCC 0.4, 0.1-2.2). Interestingly, preferred color of 
the meat surface was significantly associated with risk, independent of red meat 
intake, but again only in the sporadic group (OR dark vs light, 95% CI: sporadic 
3.0, 1.2-7.5; HNPCC 0.7, 0.3-1.4). 
Despite limited numbers, our results suggest that meat consumption and 
preparation may only be relevant in sporadic colorectal adenomas. 
INTRODUCTION 
Colorectal cancer is the fourth most common incident cancer throughout the world \ It is 
thought to develop through an adenoma-carcinoma sequence, by accumulation of 
alterations in genes that control cell growth and differentiation 7. This accumulation of 
mutations and the progression to cancer is thought to be promoted by diets high in fat 
and low in fibre 149. 
Several cohort studies 36;150 and case-control studies 68;7°;72;74 have suggested that a high 
intake of red meat may be associated with the risk of colorectal cancer independent of 
the fat content of the diet. Some studies have found this increased risk to be specifically 
associated with fried meat72, high temperature cooking of meat58, meat "well done" 81 or 
meat with heavily browned surface 58. An increased risk of colorectal adenomas with high 
consumption of red meat was also found in some studies 57;64151/ but not in others 44;49. 
Probst-Hensch et a/, reported an increased risk of colorectal adenomas (OR=2.2, 
95%CI = 1.1-4.3) with consumption of red meat more than once a week, of which more 
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than 10% was fried, and a preference for a darkly browned surface, as compared to 
consumption of meat less than once a week, of which less than 10% was fried, and a 
preference for a lightly browned surface 82. 
During the preparation of meat at high temperatures, heterocyclic amines may be formed 
from amino acids, creatine/creatinine and sugars 152. Heterocyclic amines have been 
found to be mutagenic and cause tumors in the colon and various other organs in animal 
models. 
Apart from environmental factors, hereditary factors are known to be important in the 
etiology of colorectal adenomas and carcinomas. Two genetic syndromes leading to 
colorectal cancer develop by an autosomal dominant inheritance pattern. Familial 
Adenomatous Polyposis is caused by a germline mutation in the Adenomatous Polyposis 
Coli (APC) gene, and is characterized by the development of many (>100) colorectal 
adenomas at an early age 153. The second hereditary form of colorectal cancer is 
Hereditary Non-Polyposis Colorectal Cancer (HNPCC), which is caused by a germline 
mutation in one of at least five mismatch repair genes, resulting in microsatellite instability 
(MSI) 18. HNPCC patients develop colorectal adenomas in a similar fashion as sporadic 
patients, however, one of the characteristic features of HNPCC is the very rapid 
progression from adenoma to cancer, due to a defect in the mismatch repair system. 
Besides colorectal cancer HNPCC subjects have a higher risk of developing malignancies 
at several other sites 24. Interestingly, the tumor spectrum in HNPCC has changed over 
generations 26, suggesting a role for environmental factors in HNPCC carcinogenesis. 
Other characteristics of HNPCC (e.g. incomplete penetrance 22, earlier onset of disease in 
successive generations 23;27, somatic mutations in APC, K-ras and p53 genes 12;28;29), point 
in a similar direction. Possibly, similar environmental factors to those in sporadic 
colorectal carcinogenesis, play a role especially in the early stages of colorectal 
carcinogenesis in HNPCC. 
This case-control study of sporadic and HNPCC colorectal adenomas examines whether 
meat consumption and preparation are related to adenoma risk in these two types of 
populations in a similar fashion. 
MATERIALS A N D METHODS 
Study population and data collection 
This case-control study on dietary factors and genetic susceptibility in colorectal 
adenomas was conducted in The Netherlands between December 1995 and February 
1998, and approved of by the medical ethical committies of the Wageningen Agricultural 
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University and the Nijmegen University Hospital. The study population included sporadic 
as well as HNPCC cases with adenomas removed by polypectomy, and control-groups for 
each case group. Sporadic controls were patients examined at the hospital for various 
reasons such as bowel complaints (abdominal pain, rectal blood loss, constipation, 
diarrhoea) and HNPCC controls for screening purposes. All controls had a full colonic 
examination (colonoscopy or sigmoidoscopy combined with barium enema) to exclude 
presence of adenomas, and were not previously diagnosed with colorectal adenomas or 
cancer. 
All participants were Dutch-speaking and of Western European origin, diagnosed before 
the age of 75, without a history of colorectal cancer, colon resection, polyposis coli, or 
inflammatory bowel disease. Sporadic cases were excluded if they had previous 
adenomas more than 3 years before entrance to the study, because of possible changes in 
dietary habits with a long history of repeated endoscopies and colorectal adenomas. The 
possible dietary effects of regular screening are expected to be similar in HNPCC cases 
and controls. Based on this assumption and for reasons of efficiency HNPCC cases were 
allowed to have had adenomas more than 3 years prior to the most recent adenoma. The 
pedigrees of all HNPCC cases and controls fulfilled the Amsterdam criteria n: at least 
three members in at least two successive generations had colorectal cancer, with at least 
one case diagnosed before the age of 50 years; one of the affected members was a first-
degree relative of the other two; familial adenomatous polyposis was ruled out. HNPCC 
cases and controls were first-degree relatives of colorectal or endometrium cancer cases, 
all with a theoretical 50% risk of being a gene-carrier. 
Sporadic cases and controls were recruited by the Departments of Gastroenterology of 
the Nijmegen University Hospital and two regional hospitals (Rivierenland, Tiel; Gelderse 
Vallei, Ede-Wageningen-Bennekom). HNPCC cases and controls were recruited in a 
similar fashion, either by the Nijmegen University Hospital or by the Netherlands 
Foundation for the Detection of Hereditary Tumors which keeps a registry of HNPCC 
families in The Netherlands. Eligible subjects were informed about the study by the 
gastroenterologist participating in the study or by the Netherlands Foundation for the 
Detection of Hereditary Tumors, after approval of their 'physician in attendance'. 
After receiving information about the study, subjects decided whether they wanted to 
participate in the study and subsequently signed for informed consent. Nine percent of 
subjects invited by the Nijmegen University Hospital, and 12% of subjects invited by the 
Netherlands Foundation for the Detection of Hereditary Tumors, were not willing to 
participate in the study. In total, 319 eligible subjects signed for informed consent. 
Subsequently, those who were willing to participate received a set of questionnaires at 
endoscopy (in case of recruitment by one of the hospitals) or by mail (in case of 
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recruitment by the Foundation for the Detection of Hereditary Tumors). The set of 
questionnaires consisted of a general questionnaire on lifestyle and socio-economic 
factors, a semi-quantitative food frequency questionnaire and a questionnaire on meat 
consumption and preparation. The questionnaires were filled out at home and returned 
by mail. 
Clinical information regarding case/control status, endoscopy reports, adenoma 
characteristics, and HNPCC/sporadic status was retrieved from hospital records 
retrospectively, after we received the filled-out questionnaires. Of the 319 patients who 
initially agreed to participate in the study 22 (7%) did not return the questionnaires, and 
21 (6%) did not meet the eligibility criteria retrospectively. Additionally, 9 participants 
incompletely filled out the meat consumption and preparation questionnaire and were 
therefore excluded from the current analyses. This resulted in 119 cases and 148 controls 
available for further study. 
Dietary assessment 
To quantify energy and nutrient intake, a validated semi-quantitiative food frequency 
questionnaire was used, which was developed for the Dutch cohort of the EPIC study 
(European Prospective Investigation into Cancer and Nutrition) 154;155. Frequency of 
consumption of food groups was based on the habitual consumption of 178 food items 
during the year before endoscopy. Nutrient intake was quantified for each individual 
using an extended version of the 1993 computerised Dutch food composition table. In 
the present study this EPIC questionnaire was used for information on nutrient intake and 
frequency of meat consumption. 
To obtain additional information on the consumption and preparation of red meat and 
poultry, a questionnaire was developed especially for this purpose. The questionnaire 
consists of four parts, starting with some general questions regarding frequency of eating a 
hot meal, meat with the hot meal, grilled or barbecued meat, and gravy, as well as a 
question on preference with respect to color of the meat surface. The second part focuses 
on frequency and portion size of 16 types of meat. Intensity of surface browning of four 
types of meat (beef patties, pork chops, steak and bacon) was assessed using four photos 
for each type of meat showing the meat with varying degrees of surface browning (from 
very dark to very light, prepared at 225, 200, 175 and 150°C, respectively). The photos 
originate from a Swedish questionnaire used in a case control study on intake of 
heterocyclic amines in relation to cancer risk 134. In the last part of our questionnaire, 
preparation methods for each of six meat categories were assessed using multiple choice 
questions on factors relevant to the temperature during meat preparation: type of pan 
used, temperature of cooking fat when meat is added, height of the heat source, addition 
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of water, use of a lid, color of surface just after browning compared to the end stage of 
cooking. 
Data analysis 
Differences in general characteristics between groups were tested using x2-tests for 
categorical and t-tests for continuous variables. All analyses were stratified for HNPCC 
and sporadic groups. Multivariate logistic regression analyses were used to estimate the 
relative risk for adenomas and simultaneously adjust for possible confounding factors. 
Nutrients were adjusted for energy intake by using residuals from linear regression 
modelling of energy intake. 
Odds ratios for nutrients were calculated for tertiles based on the distribution in controls, 
as well as using the continuous variable and expressing the odds ratio for quartile ranges. 
Associations with total meat, red meat, white meat (including fish), and gravy were 
assessed for frequency categories as well as using a test for trend. To group types of meat 
according to the general method of preparation, the 16 types of meat in the frequency-
part of the questionnaire were categorized in 3 groups: 'low risk cooking types' (i.e. 
simmered meat), 'medium risk cooking types' (i.e. meat shortly browned then cooked), 
and 'high risk cooking types' (i.e. meat fried at high temperatures). To take habitual meat 
preparation practices into account, subjects were categorized based on multiple choice 
questions (for 6 types of meat) regarding height of the heat source, use of a lid, and 
addition of water. Usual color of the meat surface after preparation was assessed using an 
average score for the four photo-questions. The minimum score of one means the person 
scored the lightest surface color in each of the four photo-questions, whereas the 
maximum score of four means the person scored the darkest surface color in each of the 
four photo-questions. If people did not fill out all four photo-questions on meat surface, 
because some types of meat were not eaten, the average score was based on the mean of 
the remaining photo-questions. 
To control for potential confounding by energy intake, all nutrients have been adjusted 
for energy using the residuals from linear regression of energy intake, and additionally, 
both nutrients and food groups are adjusted for total energy intake by including total 
energy intake in the logistic regression models. As the age and gender distribution differs 
between cases and controls and between both populations, all analyses are adjusted for 
age and gender. As the cases in this study may have a generally 'less healthy' pattern of 
other lifestyle related risk factors (i.e. higher BMI, less never-smokers, less physically 
active, more regular alcohol drinkers and less regular aspirin users), these factors could act 
as possible confounders, and were each separately taken into account by including them 
in the logistic regression models (in combination with energy, age, gender). None of the 
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for total meat and red meat separately, but this did not markedly change the odds ratios 
(data not shown). 
Table 5.2. "Meat related" nutrient intakes and the risk of colorectal adenomas in sporadic and HNPCC 
groups separately. 
Nutrient intakes* 
Total protein 
Low < 76 g 
Medium 76-91 g 
High * 91 g 
Continuous! / 1 8 g 
Animal protein 
Low < 45 g 
Medium 45-59 g 
High * 59 g 
Continuousl / 19g 
Total fat 
Low < 83 g 
Medium 83-97 g 
High * 97 g 
Continuousl / 22 g 
Saturated fatty acids 
Low < 32 g 
Medium 32-38 g 
High a 38 g 
Continuousl /10 g 
N-3 long chain fish fatty acids 
Low < 0.07 g 
Medium 0.07-0.19 g 
High a 0.19 g 
Continuousl /0.14g 
Sporadic 
Controls 
/Cases 
17 
27 
21 
18 
19 
28 
20 
24 
21 
21 
22 
22 
17 
24 
24 
9 
23 
25 
9 
31 
17 
18 
16 
23 
19 
13 
25 
22 
16 
19 
(n = 
OR 
1.0 
1.3 
1.2 
0.9 
1.0 
4.0 
0.5 
0.7 
1.0 
0.5 
0.4 
0.7 
1.0 
0.4 
0.4 
0.8 
1.0 
0.4 
0.4 
0.9 
65, 57) 
(95% Cl)t 
(0.4-3.8) 
(0.3-4.1) 
(0.5-1.6) 
(1.3-12.1) 
(0.2-1.6) 
(0.4-1.2) 
(0.2-1.3) 
(0.1-1.6) 
(0.4-1.5) 
(0.1-1.2) 
(0.1-1.4) 
(0.4-1.5) 
(0.1-1.0) 
(0.2-1.1) 
(0.6-1.4) 
HNPCC 
Controls 
/Cases 
31 
24 
28 
30 
32 
21 
28 
27 
28 
27 
29 
27 
31 
27 
25 
18 
24 
20 
15 
31 
16 
15 
20 
27 
18 
23 
21 
19 
22 
21 
(n= 83 
OR 
1.0 
0.9 
0.5 
0.7 
1.0 
1.3 
1.0 
0.9 
1.0 
1.3 
1.4 
1.3 
1.0 
1.0 
0.8 
1.0 
1.0 
1.2 
1.1 
0.8 
,62) 
(95% Cl)t 
(0.4-2.4) 
(0.2-1.6) 
(0.4-1.2) 
(0.5-3.3) 
(0.4-2.9) 
(0.5-1.5) 
(0.5-3.3) 
(0.4-4.4) 
(0.7-2.4) 
(0.4-2.4) 
(0.2-2.4) 
(0.5-1.8) 
(0.5-2.9) 
(0.4-2.6) 
(0.6-1.2) 
* nutrient intakes are energy adjusted using residual regression analysis, fertile cut-off points are based on 
the distribution in the "pooled" control group 
t all models are adjusted for age and gender as well as energy intake 
11 the odds ratio for the continuous variables of nutrient intakes are expressed for an exposure contrast 
representing the difference between the first and third quartile 
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Table 5.3. Meat consumption frequency and the risk of colorectal adenomas in the sporadic and HNPCC 
group. 
Consumption frequency 
Total meat (excl. fish) 
Low 
Medium 
High 
Trend 
Red meat 
Low 
Medium 
High 
Trend 
s 4x /wk 
5-6x /wk 
7x/wk 
p-value 
s 4x /wk 
5-6x /wk 
7x /wk 
p-value 
White meat (incl. fish) 
Low 
Medium 
High 
Trend 
Gravy 
Low 
Medium 
High 
Trend 
s0.5x/wk 
0.5-2x/wk 
>2x/wk 
p-value 
£ 2x /wk 
s 5x /wk 
> 5x/wk 
p-value 
n=65 
Sporadic 
n = 57 
Controls Cases 
8 
36 
21 
19 
38 
8 
4 
45 
16 
19 
25 
21 
9 
24 
24 
14 
29 
14 
9 
33 
15 
18 
17 
22 
OR (95% CI)* 
1.0 
0.6 (0.2-2.1) 
1.0 (0.3-3.6) 
p=0.63 
1.0 
1.1 (0.3-3.9) 
4.1 (0.7-23.0) 
p=0.08 
1.0 
0.2 (0.0-0.9) 
0.3 (0.1-1.4) 
p=0.36 
1.0 
0.5 (0.2-1.4) 
0.6 (0.2-1.9) 
p=0.38 
n=83 
HNPCC 
n = 62 
Controls Cases 
23 
34 
26 
29 
38 
16 
15 
48 
20 
36 
35 
12 
18 
26 
18 
22 
33 
7 
10 
37 
15 
22 
23 
17 
OR (95% CI)* 
1.0 
0.9 (0.4-2.2) 
0.6 (0.2-1.6) 
p=0.33 
1.0 
1.1 (0.3-3.7) 
0.4 (0.1-2.2) 
p=0.26 
1.0 
1.2 (0.4-3.6) 
1.3 (0.4-4.3) 
p=0.68 
1.0 
1.1 (0.5-2.5) 
1.9 (0.7-5.4) 
p=0.26 
* all models are adjusted for age, gender, energy intake and total meat consumption. 
For each of the 3 variables representing "habitual meat preparation", every possible 
answer was scored as either 'high risk method' or 'low risk method', according to its 
assumed effect on heterocyclic amine formation. Subjects were then categorized based 
on the frequency with which they usually prepare their meat, i.e. always using a 'high risk 
method' or a 'low risk method', or using both methods depending on the type of meat 
(intermediate category). None of the 3 variables regarding preparation methods were 
significantly associated with risk of adenomas in either group. 
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Table 5.4. Meat preparation and the risk of colorectal adenomas in the sporadic and HNPCC group. 
Sporadic HNPCC 
Controls Controls 
/Cases OR (95% CI)* /Cases OR (95% CI)* 
Meat categorized by usual mode of preparation 
Frequency 'low risk meat' (simmered) 
Low < 1 x / w k 53 46 1.0 
High a1x/wk 12 11 1.1 (0.4-2.9) 
Frequency 'medium risk meat' (shortly browned then cooked) 
Low < 4 x / w k 49 36 1.0 
High a4x/wk 16 21 2.4 (0.9-6.3) 
Frequency 'high risk meat' (fried at high temperatures) 
Low <2x /wk 46 39 1.0 
High s2x /wk 19 18 0.8 (0.3-2.0) 
68 
15 
60 
23 
66 
17 
53 
9 
43 
19 
49 
13 
1.0 
0.5 
1.0 
1.6 
1.0 
0.6 
(0.2-1.4) 
(0.6-3.8) 
(0.2-1.5) 
Habitual meat preparationt 
Height of the heat source during browning of meat 
low with every meat type 
low/high depending on meat type 
high with every meat type 
Addition of water 
added directly after browning 
added directly/afterwards 
added afterwards 
Use of a lid 
closed lid with every meat type 
lid/no lid depending on meat type 
no lid with every meat type 
32 
14 
17 
16 
32 
16 
10 
18 
35 
31 
13 
13 
9 
32 
16 
16 
10 
31 
1.0 
0.8 
0.9 
1.0 
1.9 
2.0 
1.0 
0.3 
0.4 
(0.3-2.1) 
(0.3-2.3) 
(0.7-5.2) 
(0.6-6.5) 
(0.1-1.0) 
(0.1-1.1) 
32 
29 
17 
11 
52 
15 
15 
24 
39 
24 
19 
16 
12 
28 
20 
8 
13 
39 
1.0 
0.8 
1.0 
1.0 
0.5 
1.2 
1.0 
0.8 
1.5 
(0.3-1.8) 
(0.4-2.7) 
(0.2-1.4) 
(0.4-3.8) 
(0.2-2.6) 
(0.5-4.6) 
Categories by preferred color of the meat surface 
Color meat surfaced 
Light scores 2 27 10 1.0 
Dark score > 2 38 47 3.0 (1.2-7.5) 
32 
51 
29 1.0 
33 0.7 (0.3-1.4) 
* models are adjusted for age, gender, energy intake and total meat consumption. 
+ categories ordered according to increasing risk 
H 1 = very light, 4=very dark 
Preferred color of the meat surface, as assessed using photos, was significantly associated 
with increased risk of colorectal adenomas, only in the sporadic group. Those with an 
average score of more than two (1 = very light, 4= very dark), had a three-fold increase in 
risk as compared to those with an average score of two or lower (OR, 95% CI: 3.0, 1.2-
7.5). This odds ratio did not markedly change when adjusting the analysis separately for 
total meat, red meat, or 'medium risk' type of meat. 
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DISCUSSION 
In this study of colorectal adenomas a general preference for darkly browned meat 
surface appeared to be associated with an increased risk of sporadic adenomas, but not 
of adenomas among first degree HNPCC family members. Apart from this association and 
a non-significant increase in risk with high consumption of red meat (a7x/week vs s 
4x/week) in the sporadic group, no other factors related to meat consumption and 
preparation were found to be associated with the risk of sporadic and HNPCC adenomas. 
The size of our study is relatively small, especially since strata of the sporadic and HNPCC 
groups were analyzed separately. However, this is one of the first studies to examine 
possible differences or similarities in risk factors for sporadic and HNPCC colorectal 
carcinogenesis. For known risk factors, such as Body Mass Index, smoking, alcohol 
consumption and aspirin use, we found non-significant case-control differences in the 
expected direction. Our results suggests that red meat consumption and especially darkly 
browned meat may be associated to sporadic adenoma risk, but not to HNPCC adenoma 
risk. This does not rule out that other risk factors may be similarly associated to sporadic 
and HNPCC adenoma formation or other phases of colorectal carcinogenesis. 
Selection and recruitment of study subjects and methods of data collection may have 
affected our results. In sporadic cases, the adenomas were diagnosed during the study 
period, and cases were excluded if they had earlier adenomas more than 3 years prior to 
entrance of the study. HNPCC cases however, were allowed to have had adenomas 
previously and may have been diagnosed before the study period. Controls are defined in 
both populations as subjects who have never had any adenomas. Selection of controls 
was very similar to that of cases in both groups and both recruitment procedures. As 
HNPCC cases were allowed to have a longer adenoma history than sporadic cases, they 
may have changed their diet more. However, as HNPCC family members are generally 
considered to be relatively health conscious, irrespective of their adenoma status, this is 
not expected to influence the results to a large extend. There were no marked differences 
between the sporadic and HNPCC populations in several lifestyle characteristics, and 
energy and macro nutrient intakes. Therefore, we do not expect that any small 
differences will have biased the results to a relevant extent. 
The population recruited directly by the gastroenterologist in the hospital (both sporadic 
and HNPCC subjects) may have had different reasons for non-participation than those 
recruited by the Netherlands Foundation for the Detection of Hereditary Tumors 
(HNPCC subjects only). However, since participation rates were high for both recruitment 
procedures, this is thought not to have materially affected the results. 
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At the time of filling out the questionnaires, at home shortly after endoscopy, most 
sporadic patients are unaware of their diagnosis with respect to adenomas. Recall of 
dietary habits is therefore expected to be similar in sporadic cases and controls. HNPCC 
cases and controls are generally more aware of their risk. As HNPCC family members, 
irrespective of their adenoma history, are generally considered to be relatively health 
conscious due to the very strong family history of cancer, this is not expected to have lead 
to differences between cases and controls. 
The meat consumption and preparation questionnaire is designed especially to estimate 
meat consumption and preparation with respect to formation of heterocyclic amines. It is 
adapted to Dutch meat preparation methods and uses photos from a very extensive 
Swedish questionnaire. If linked to a database on contents of specific heterocyclic amines 
in meat, a questionnaire with this limited number of items and type of questions, could in 
theory explain a large part of the variation in heterocyclic amine intake. Byrne et al. 
showed that in 3 prospective cohort studies in the United States, estimates of HCA intake 
and determination of associations with disease risk are feasible148, if additional 
information on meat cooking methods is obtained 156. Meat consumption frequencies 
were assessed using the validated EPIC questionnaire 154 as well as the meat consumption 
and preparation questionnaire. Estimated intakes for total meat, red meat and poultry 
based on these two questionnaires were highly correlated (Spearman correlation 
coefficients ranged between 0.69 and 0.77). With respect to meat preparation we 
observed in an experimental setting (data not shown) that the level of the heat source, 
addition of water, and use of a lid were all related to the temperature at the meat surface, 
which is a determinant of heterocyclic amine formation 157. Those specific aspects of meat 
preparation were however inconsistent in their association with adenoma risk in our 
study. Possibly the color of the meat surface provides an overall estimate of habitual meat 
preparation. 
With respect to the exposure of interest, our hypothesis derives from epidemiologic 
observations in sporadic colorectal cancer populations. However, one may question 
whether associations with dietary factors would be similar in a HNPCC population, which 
is known for its hereditary background risk. Interestingly, there is some evidence that the 
molecular pathways leading to cancer involve steps that are similar in these two groups. 
These steps involve somatic mutations in regulatory genes, which may be caused by 
dietary carcinogens such as heterocyclic amines 158. The APC gene is known to be 
involved in both sporadic colorectal cancer and HNPCC colorectal cancer 9;28. 
Abnormalities in the K-ras and p53 genes, known to be highly frequent in sporadic 
colorectal cancer, also occur in HNPCC carcinomas, but reported frequencies vary 
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between studies 12'2^10610^125, vve have previously shown that in the adenomas in this 
study there are no major differences in gene involvement of k-ras and p53 in the sporadic 
and HNPCC adenomas. 
Despite the similarities regarding the genes involved, our results suggest that there may be 
relevant differences in the etiology of sporadic and HNPCC colorectal cancer, already in 
the early adenoma stage. As APC is considered to be the first gene to become mutated, it 
may be postulated that meat consumption and preparation could be related to APC gene 
involvement in sporadic adenomas, whereas in HNPCC different APC mutations of 
endogenous nature may originate from the mismatch repair phenotype. In studies in rats 
it is shown that heterocyclic amines may induce specific mutations in the APC gene " . 
In conclusion, despite limited numbers, our results suggest that red meat consumption 
and color of the meat surface may be relevant to adenoma formation in sporadic 
colorectal carcinogenesis. These factors appear to be of less importance to risk of HNPCC 
adenomas, or are not detectable among the high background risk in a HNPCC 
population. This does not exclude meat consumption and preparation to be relevant to 
later stages, both in sporadic and HNPCC populations. 
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CHAPTER 6 ANIMAL PRODUCTS AND K-RAS CODON 12 AND 13 
MUTATIONS IN COLON CARCINOMAS 
It is hypothesized that the involvement of the K-ras oncogene and its specific 
mutations in colon tumors may be influenced by the consumption of animal 
products and their constituents. 
Based on a previously conducted case-control study on diet and colon cancer, 
we collected paraffine-embedded carcinoma tissue of the cases to study the 
potential association between K-ras mutational status and the consumption of 
foods of animal origin. K-ras mutations in codons 12 and 13 were determined 
by PCR-based mutant allele specific amplification (MASA) in tumor tissue of 
185 colon cancer patients: 36% harbored mutations, of which 82% were 
located in codon 12. 
Within cases, K-ras mutational status was not markedly associated with the 
consumption of most animal products and their constituents; for fish a slight 
association was observed (Odds Ratio (OR) K-ras mutant versus K-ras wildtype 
per 19 grams = 1.2, 95% Confidence Intervals (CI) = 1.0-1.5). Comparing 
cases to controls showed that this association was confined to those harboring 
K-ras mutations. Interestingly, high intakes of animal protein, calcium and 
poultry were differently associated with codon 12 and codon 13 mutations: OR 
and 95% CI codon 12 versus codon 13 were 9.0 (2.0-42), 4.1 (1.4-12) and 15 
(1.4-160), respectively. In case-control comparisons, high intakes of animal 
protein and calcium were positively associated with colon tumors harboring 
codon 12 mutations: for protein per 17 g OR (95%CI) =1.5 (1.0-2.1); for 
calcium per 459 mg 1.2 (0.9-1.6), while inverse associations were observed for 
tumors with K-ras mutations in codon 13 (for animal protein 0.4 (0.2-1.0); for 
calcium 0.6 (0.3-1.2)). Transition and transversion mutations were not 
differently associated with these dietary factors. 
Although no overall association between animal products and K-ras mutations 
was observed, these data do suggest involvement of their consituents in the 
etiology of colon tumors harboring K-ras codon 12 and codon 13 mutations. 
INTRODUCTION 
Epidemiological studies suggest that diet contributes to over 60 percent of colon cancer: 
diets rich in meat, saturated fat and animal protein are considered to increase risk; 
vegetables, dietary fiber and other plant-related compounds may prevent colon cancer 
159
. Molecular studies have shown that during colon carcinogenesis somatic mutations 
accumulate 7, but the role of diet in their etiology is still under debate. 
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About 50 percent of colon tumors harbor single point mutations in the Kirsten ras (K-ras) 
oncogene 160. G to A transitions at the second base of codons 12 or 13 of K-ras are 
common in human colon tumors and are characteristic effects of alkylating compounds, 
such as N-nitrosocompounds 160. It has been demonstrated in humans that endogenous 
formation of N-nitrosocompounds is raised when red meat intake is increased 32. Other 
potential meat-related carcinogens, such as heterocyclic amines present in meat cooked 
at high temperatures, have been shown to induce K-ras mutations at guanine bases in 
aberrant crypt foci, putative preneoplastic lesions 34, pointing to an early effect of these 
compounds in the carcinogenic process. Dietary factors may also affect clonal selection 
by modifying growth of colon tumors harboring K-ras mutations. Possibly as a result of a 
direct antiproliferation action on hyperplasia, supplemental calcium reduces the 
incidence of K-ras mutations in dimethylhydrazine-induced colon tumors 161. This is in 
line with the results of an epidemiological retrospective study by Bautista and colleagues 
162
, which showed that the intake of calcium was inversely associated with colon tumors 
harboring K-ras mutations. 
About 80 percent of K-ras mutations in colon tumors are located in codon 12, while 
mutations in codon 13 are observed in about 10 percent8;160. Mutations in codon 12 are 
either more likely to occur or they are more likely to exert a selective growth advantage 
when they occur160. Most mutations in codon 13 are transition mutations, while in codon 
12 the C-A transition mutation as well as the G-T transversion mutation are most 
common n. 
We explored whether the consumption of products from animal origin and their 
constituents are associated with the occurrence of K-ras mutations in colon tumors and 
whether these dietary factors may be differently associated with the prevalence of 
transition and transversion mutations in codons 12 and 13 of the K-ras gene. We explore 
these hypotheses in a previously conducted case-control study, in which meat 
consumption and calcium intake increased risk of colon cancer68163. 
MATERIALS A N D METHODS 
Study population 
A population-based case-control study on diet and colon cancer was conducted in the 
Netherlands between 1989 and 1993. Methods have been published in detail previously 
6B
. In total, 232 incident colon cancer cases and 259 population-based controls were 
included. Cases were men and women with colon cancer, newly diagnosed at surgery. 
Population-based controls, frequency matched to the cases by age (5-year intervals), 
gender, region, and degree of urbanization, were recruited randomly by general 
practitioners of the cases. All subjects were of Western-European origin, spoke Dutch, 
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were up to 75 years old at time of diagnosis and did not have previous cancer, polyposis 
coli, or inflammatory bowel disease. Cases were invited by their surgeons within three 
months of diagnosis in regional hospitals from the east and central parts of the 
Netherlands; of all eligible cases 47% was actually invited, which was due to technical 
and administrative reasons. Cancer registries in the study areas were used as a check of 
completeness and provided additional clinical and pathological information. Except for a 
more advanced Dukes' stage, non-invited cases did not importantly differ from those 
invited. The response of cases and controls invited to be interviewed was about 60%. 
Except for Dukes' stage, the distribution of age, gender, tumor site and therapies of the 
interviewed cases was comparable to the distribution among all eligible cases. Among 
controls, participation was higher among younger subjects and those living in urban areas. 
Cases and controls who participated did not differ significantly in the consumption of 
nutrients and food groups of interest from non-participants who filled out a non-response 
questionnaire. 
For 28 of the 232 cases, the cancer registry defined the location of the tumor as 
rectosigmoid in contrast to the surgeon who located the tumor in the colon. Since the 
etiology of rectal tumors might differ from those situated in the colon, the present 
analyses are restricted to colon cancer cases (ICD-O 153). Paraffin-embedded tissue from 
primary colon tumors resected before chemo- or radiotherapy, was collected between 
1995 and 1997 from 185 of the colon cancer cases. Nineteen tumor specimens could not 
be collected for administrative reasons. These cases did not differ materially in 
demographic or dietary factors from those of whom archival material could be collected. 
Dietary assessment 
To assess usual dietary habits, a detailed, structured, interview-based dietary history 
questionnaire was used, referring to the previous full year (in cases before symptoms 
occurred). The consumption frequency per month, number of months during which the 
item was used, number of portions per consumption and portion size of 289 food items 
of 19 food groups were inquired. To be able to estimate portion sizes, the contents of 
frequently used household utensils and cups were measured. To minimize errors, the 
dietary questionnaire was entered in the computer using a specially designed computer 
program which included range-checks and consistency checks with other foods. 
Average daily intake of nutrients was calculated using the Dutch National Food Table 164. 
Nutrient intake was adjusted for energy by the residual method 165 for men and women 
separately. 
In addition to the dietary part, the interview included questions on previous and current 
smoking habits, aspirin and NSAIDs use, family history of colorectal cancer, and medical 
history. 
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DNA-isolation 
DNA was isolated from nine 8 ;Um paraffin sections. Guided by an haematoxylin /eosin 
stained section, tumor tissue was scraped off. After deparaffination and rehydration, tissue 
was incubated for 18 hours at 56°C with 0.5 mg/ml proteinase K (Boehringer Mannheim, 
Almere, The Netherlands) in 500 /JI cell lysis solution (DNA-isolation kit; PureGene 
Gentra Systems Inc, Landgraaf, The Netherlands) and additional 72 hours at 37°C. After 
cooling the samples to 4°C, protein was precipitated. To the supernatant, 500 /ui 
isopropanol was added for DNA precipitation. After washing the pellet with 70% ethanol 
at 4°C and centrifugation, DNA was air-dried and rehydrated. 
Mutant Allele Specific Amplification (MASA)-PCR 
Codon 12 and 13 of K-ras were examined by MASA "2 . A mixture of primers for MASA 
corresponds to variants of the first (set A) or the second (set B) nucleotide of codon 12, or 
the first (set C) or the second (set D) nucleotide of codon 13. The following primers were 
used: 
for wild-type Ki-ras: 5'TGTGGTAGTTGGAGCTG3'; 
Set A 5 'TGTGGTAGTTGGAGCTC3', 5 'TCTCGTAGTTGCAGCTA3', and 
5 'TGTGGTAGTTGG AGCTT3'; 
Set B 5'GTCGTAGTTGGAGCTGT3', 5'GTCGTAGTTGGAGCTCA3', and 
5'GTGGTAGTTGGAGCTGC3'; 
SetC 5'GGTAGTTGGAGCTGGTC3', S'GGTAGTTGGAGCTGGTAS', and 
5 'GCTAGTTGCAGCTGGTT3'; 
Set D 5'GTAGTTGGAGCTGGTGC3', 5'GTAGTTCGAGCTGGTGA3', and 
5 'GTAGTTGG AGCTGGTGT3'. 
For all PCR experiments the same reverse primer was used: 
5 'CCAGGTCCTGGTAAGAAAACT3'. 
MASA-PCR was performed as follows: PCR reaction mixture 1 (40 uJ) consisted of 300 ng 
of purified DNA, 20 mmol/l (NH4)2S04, 75 mmol/l Tris-HCI (pH 9.0), 0.01% Tween, 200 
jumol/l of dNTPs, 0.4 nmol/l of reverse primer, 2.5 mmol/l MgCI2. After an initial 
denaturation step of 3 min. at 94°C, mixture 2 (10^1), which consisted of 0.3 units of 
Thermoperfect Plus DNA polymerase (Integra BV, Zaandam, The Netherlands), and 20 
pmol of each of the forward primers, was added immediately to mixture 1. PCR was 
performed in 35 cycles of 30 sec. at 94°C, 30 sec at 60°C and 1 min. at 72°, followed by 
a final extension of 72°C for 5 min., in a Mastercycler 5330 (Eppendorf Geratebau 
GmbH, Hamburg, Germany). Following amplification, 15 /JI of each reaction mixture was 
loaded on a 2% agarose gel containing 100 ng/ml ethidium bromide and 
electrophoresed. 
84 
Animal products and K-ras mutations 
A second PCR was performed on those DNA samples that were found positive. In this 
new PCR single primers that correspond to each of the variant nucleotides of the positive 
first PCR set were added per incubation. Conditions were the same as in the PCR 
described above. 
Since all samples studied contain wildtype K-ras DNA due to the presence of tumor 
stroma in all lesions tested, we used wildtype K-ras DNA as an internal control for the 
quality of the DNA isolated form paraffin-embedded tissue. For each sample we first 
amplified wildtype K-ras by PCR using a primer combination that amplifies the same 
fragment as in the MASA. This wildtype PCR had to be positive, otherwise the sample was 
excluded from mutation analysis by MASA. In our series of lesions we found that in 98% 
of the samples wildtype K-ras could easily be amplified. 
To validate the robustness of MASA we performed sequence analysis on the PCR 
products of a number of samples, each with a different mutation in codon 12 or 13. In all 
cases analyzed we found the same mutation by sequencing as was detected by MASA. 
Data analysis 
The association between diet and K-ras gene mutations was evaluated by comparing the 
mutation prevalence among cases using logistic regression models 166. In addition, odds 
ratios (OR) and 95% confidence intervals (CI) were calculated separately for mutant cases 
and wildtype cases versus the population-based control group. First, quartile analyses of 
dietary intake were conducted. To quantify the associations on a continuous scale, all 
ORs and 95%Cls are expressed for the distance between the first and third quartile. All 
analyses were adjusted for age, sex and total energy intake. Additional adjustment for 
Dukes' stage (in case-case comparisons only), smoking habits, BMI, and other dietary 
factors, such as the consumption of vegetables and fruits, did not change the estimates 
importantly. Data analyses were conducted for all K-ras mutations combined. Moreover, 
analyses were conducted separately for codon 12 and codon 13 and for transition and 
transversion mutations. 
RESULTS 
Of the 185 colon tumors included in this study, 66 (36%) harbored K-ras mutations in 
codons 12 or 13: 55 tumors (82%) showed a mutation in codon 12, and 12 (18%) in 
codon 13. In one tumor, mutations were found in both codons. Of the 55 mutations in 
codon 12 (wildtype GCT), 23 (42%) were transition mutations, of which GAT (96%) was 
most common, and 32 (58%) were transversion mutations of which the CTT mutation 
(53%) was most frequent. In codon 13 (wildtype CCC), GAC transitions (92%) were most 
frequent. 
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Table 6.1 shows characteristics of the study population; cases are categorized by the 
absence or presence of K-ras mutations. The occurrence of K-ras mutations was related to 
advanced tumor stage. There were no marked differences between K-ras mutant and K-
ras wildtype tumors with respect to age, sex, tumor-site and total energy intake. Poultry 
and fish consumption was slightly higher among those with K-ras mutations as compared 
to those without (p<0.1). Fish consumption was also slightly higher as compared to 
controls (p<0.1). The consumption of dairy products was higher among both case-groups 
as compared to controls. Energy intake was significantly higher among both case groups 
as compared to controls, while energy-adjusted total fat intake was significantly higher 
among cases harboring K-ras mutations as compared to controls. 
Table 6 .1 . Characteristics of the study population; cases are categorized by the absence (wildtype) or 
presence (mutant) of K-ras mutations in codons 12 and 13. 
Variable 
Age (years; mean ± SD) 
Sex (% men) 
Smoking status (% never smoked) 
Tumor characteristics 
Tumor site (% proximal) 
Dukes' stage (% C and D) 
Food groups (mean ± SD) 
Red meat (g/day) 
Poultry (g/day) 
Fish (g/day) 
Dairy products (g/day) 
Nutrients (mean±SD) 
Energy (kj/day) 
Total fat (g/day)t 
Saturated fat (g/day)t 
Total protein (g/day)t 
Animal protein (g/day)t 
Calcium (mg/day)t 
Controls 
n=259 
61.8 
52.2 
31.3 
n.a.* 
n.a. 
73.9 
13.8 
18.2 
268.2 
9,362 
100.4 
42.0 
83.2 
56.8 
1,248.5 
+ 
+ 
+ 
+ 
+ 
± 
+ 
+ 
+ 
+ 
+ 
10.0 
34.1 
13.7 
21.2 
244.3 
2,844 
24.9 
10.7 
14.9 
13.6 
406.0 
Colon cancer cases (n = 185) 
wildtype 
61.7 
53.8 
35.3 
46.4 
32.1 
67.3 
13.6 
18.4 
325.6 
10,276 
102.7 
43.0 
83.5 
57.5 
1,273.0 
(n = 119) 
± 10.2 
± 37.0 
± 15.611 
± 21.411 
± 339.1t 
± 3,307§ 
± 23.8 
± 11.4 
± 17.1 
± 14.5 
± 425.9 
mutant (n=66) 
61.7 
56.1 
25.8 
43.5 
43.611 
80.6 
14.7 
28.1 
322.7 
10,511 
106.3 
44.2 
85.5 
59.2 
1,245.0 
± 10.6 
± 34.7 
± 14.3 
± 45.4* 
± 305.4 
±3,140§ 
± 28.6§ 
± 13.0 
± 15.7 
± 16.0 
± 418.4 
* not applicable 
t adjusted for total energy intake by regression analysis 
H wildtype vs mutant p<0.1 
* wildtype or mutant vs controls p<0.1 
§ wildtype or mutant vs controls p<0.05 
Table 6.2 presents odds ratios and 95% confidence intervals for case-case as well as case-
control comparisons evaluating the association between animal products and K-ras 
mutations. Fish consumption increased colon cancer risk only among those patients 
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harboring K-ras mutated tumors. K-ras mutational status did not materially alter the 
associations between other animal food groups, nutrients and colon cancer risk. (Table 
6.2). 
Table 6.2. Animal foods and nutrients as related to K-ras mutations in colon tumors. 
Foods/Nutrients 
Food groups 
Meat 
Beef 
Processed meat 
Poultry 
Fish 
Dairy products 
Nutrients 
Total fat 
Saturated fat 
Cholesterol 
Total protein 
Animal protein 
Calcium 
per 43 gt 
per 26 g 
per 23 g 
per 17 g 
per 20 g 
per 287 g 
per 20 g 
per 16 g 
per 118 g 
per 19 g 
per 17 g 
per 459 g 
Odds ratios and 95% Confidence intervals* 
mutant vswildtype 
n = 66vs119 
1.1 (0.8-1.6) 
1.0(0.7-1.4) 
1.0(0.7-1.5) 
1.1 (0.8-1.5) 
1.2(1.0-1.5) 
1.0(0.7-1.3) 
1.2 (0.9-1.6) 
1.1 (0.8-1.4) 
1.0(0.7-1.3) 
1.1 (0.8-1.6) 
1.1 (0.8-1.6) 
0.9(0.6-1.3) 
mutant vs controls 
n=66vs259 
1.1 (0.7-1.6) 
0.8(0.6-1.1) 
1.1 (0.8-1.5) 
1.0(0.7-1.4) 
1.2(1.0-1.4) 
1.1 (0.8-1.5) 
1.2 (0.9-1.6) 
1.2 (0.9-1.5) 
1.1 (0.8-1.4) 
1.2 (0.8-1.6) 
1.2 (0.9-1.6) 
1.0(0.7-1.4) 
wildtype vs controls 
n = 119vs259 
1.0(0.7-1.3) 
0.8(0.6-1.1) 
1.2(0.9-1.6) 
1.0(0.8-1.3) 
1.0(0.7-1.2) 
1.1 (0.9-1.4) 
1.1 (0.9-1.4) 
1.1 (0.9-1.4) 
1.1 (0.9-1.4) 
1.0(0.8-1.4) 
1.1 (0.8-1.4) 
1.1 (0.8-1.4) 
* adjusted for age, gender and total energy intake 
t continuous variable as distance between third and first quartile 
Table 6.3 shows the odds ratios and 95% confidence intervals for case-case comparisons 
of cases with codon 12 mutations versus cases with codon 13 mutations and cases with 
transition mutations versus transversion mutations in codon 12 . Substantial differences 
were observed according to the codon affected. A high intake of protein, especially 
animal protein, showed a nearly 10-fold risk of K-ras mutations in codon 12 compared to 
mutations in codon 13. For calcium, poultry and dairy products important differences 
were also observed between mutations in codons 12 and 13. Comparing transition 
mutations with transversion mutations in codon 12, showed no important animal 
product-related differences. 
To further evaluate the observed etiologic heterogeneity between codons 12 and 13, 
Table 6.4 presents comparisons with the population-based control group for both case 
groups. For (animal) protein, calcium and poultry consumption, positive associations were 
observed with mutations in codon 12, while mutations in codon 13 appeared to be 
inversely associated with these dietary factors. 
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Table 6.3. Animal foods and nutrients as related to specific K-ras mutations in colon tumors: case-case 
comparisons. 
Food/nutrient 
food groups 
total red meat 
beef 
poultry 
fish 
processed meat 
dairy products 
Nutrients 
total fat 
saturated fat 
cholesterol 
total protein 
animal protein 
calcium 
per 43 g* 
per 26 g 
per 17 g 
per 20 g 
per 23 g 
per 287 g 
per 20 g 
per 16 g 
per 118 g 
per 19 g 
per 17 g 
per 459 mg 
Odds ratios and 95% confidence intervals* 
codon 12 mutations 
vs codon 13 mutations 
n=54 
1.3 
1.7 
15.0 
1.8 
1.0 
2.7 
1.2 
1.4 
1.4 
9.3 
9.0 
4.1 
vs11t 
(0.5-3.4) 
(0.7-4.2) 
(1.4-160) 
(0.8-4.4) 
(0.5-2.2) 
(0.8-9.5) 
(0.6-2.3) 
(0.7-2.6) 
(0.6-3.3) 
(1.9-45) 
(2.0-42) 
(1.4-12) 
transitions mutations 
vs transversions mutations 
n=23 vs32 
1.4 
0.9 
0.9 
0.9 
1.1 
1.2 
0.9 
1.1 
0.9 
1.3 
1.0 
1.4 
(0.7-2.9) 
(0.5-1.8) 
(0.5-1.8) 
(0.7-1.1) 
(0.6-1.8) 
(0.7-2.0) 
(0.6-1.4) 
(0.7-1.6) 
(0.5-1.5) 
(0.7-2.5) 
(0.6-1.8) 
(0.7-2.7) 
* adjusted for age, sex and total energy intake 
t one person harboring mutations in codon 12 and codon 13 was excluded from the analyses 
* continuous variable as distance between first and third quartile 
Table 6.4. Animal foods and nutrients as related to K-ras codon 12 and 13 mutations in colon tumors: case-
control comparisons. 
Foods/nutrients Odds ratios and 95% confidence Intervals* 
codon 12 mutations vs controls codon 13 mutations vs 
(n=55vs. 259) controls (n = 12 vs. 259) 
food groups 
total red meat 
beef 
poultry 
fish 
processed meat 
dairy products 
Nutrients 
total fat 
saturated fat 
cholesterol 
total protein 
animal protein 
calcium 
per 43 gt 
per 26 g 
per 17 g 
per 20 g 
per 23 g 
per 287 g 
per 20 g 
per 16 g 
per 118 g 
per 19 g 
per 17 g 
per 459 g 
1.1 (0.8-1.7) 
0.9 (0.6-1.3) 
1.2 (0.8-1.6) 
1.2 (1.0-1.5) 
1.1 (0.8-1.5) 
1.2 (0.9-1.7) 
1.2 (0.9-1.6) 
1.2 (0.9-1.6) 
1.1 (0.8-1.4) 
1.5 (1.0-2.1) 
1.5 (1.0-2.1) 
1.2 (0.9-1.6) 
0.9 (0.4-1.9) 
0.5 (0.2-1.3) 
0.4 (0.1-1.2) 
0.8 (0.4-1.6) 
0.9 (0.4-2.0) 
0.7 (0.3-1.6) 
1.0 (0.6-1.1) 
0.9 (0.5-1.7) 
0.9 (0.5-1.6) 
0.4 (0.2-1.0) 
0.4 (0.2-1.0) 
0.6 (0.3-1.2) 
* adjusted for age, sex and total energy intake 
t continuous variable as distance between first and third quartile 
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DISCUSSION 
Overall, these data do not support the hypothesis that the occurrence of K-ras mutations 
in colon tumors are importantly influenced by the consumption of animal products. 
However, these data do suggest that colon tumors with codon 12 and codon 13 K-ras 
mutations are related differently to the intake of protein and calcium and the 
consumption of poultry. No diet-related differences were observed for transition versus 
transversion mutations. 
Although this is the largest study on diet and specific K-ras mutations published to date, it 
is still of limited size, since collection of both dietary data and tissue blocks from a large 
number of colon cancer cases is extremely labor intensive. Moreover, it could be argued 
that multiple comparisons increase the possibility of chance findings, especially for the 
codon and mutation specific analyses. However, the differences between the two codons 
appear to be substantial, warranting further investigations. 
In any retrospective case-control study, selection bias and information bias may affect 
internal validity. Our investigation focused primarily on etiological differences between 
cases with mutations in codon 12 or 13 of the K-ras gene compared to cases without 
these mutations. Since cases are unaware of the mutational status of their tumors, in these 
case-case comparisons, systematic errors in dietary recall are less likely to bias study 
results than in traditional case-control comparisons. However, recall of dietary habits can 
still be influenced by (knowledge of) a more severe tumor stage or medical treatment 
influencing appetite. Adjusting all case-case comparisons for Dukes' stage did not change 
the estimates importantly, however. 
The prevalence of K-ras gene mutations (36%) is at the low end of the range reported in 
other studies: from 35% to 65% 12;113;16°. This may be partially explained by a lower 
participation rate among cases with Dukes C and D tumors, who tend to have higher 
mutation prevalences. In addition, we evaluated only codons 12 and 13, thereby missing 
potential mutations in codon 61, which may account for up to 5% of K-ras mutations in 
colorectal cancer 8. On the other hand, we assessed K-ras mutations using the MASA 
method, which is more sensitive than a SSCP method commonly used, or direct 
sequencing. MASA detects less than 1% mutated cells while sequencing needs at least 10 
to 20% mutated cells 167. 
The spectrum of specific K-ras mutations is similar to that observed in a large multi-center 
study evaluating the prognostic significance of K-ras mutations among 2214 colorectal 
cancer patients: 835 (38%) harbored a mutation, of which 81 percent were located in 
codon 12 12. As in our study, the C to A transitions and G to T transversions at the second 
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position of codon 12 were most common, while the GAC mutation occurred most 
frequently in codon 13 12. 
The results obtained from our 185 colon cancer cases do not correspond to a similar 
study by Bautista and associates in Majorca, that included 106 colorectal cancer (62 
colon) cases, 37% harboring a K-ras mutation 162. Among this Spanish population, the 
authors observed an inverse association between high calcium intake and risk of 
developing a K-ras mutation. In the Dutch population described here, in contrast to 
Spain, there is a high level and wide range of calcium intake. We did not observe an 
inverse association between calcium and K-ras gene mutations overall; we did observe, 
however, an inverse association for tumors with codon 13 mutations. 
Our data suggest a different dietary etiology of K-ras codon 12 and 13 mutations: animal 
protein, calcium and poultry, and to a lesser extent dairy products and fish, are differently 
related to codon 12 and 13 mutations. A diet high in meat, animal protein and low in 
dairy products and calcium might optimize the exposure to arylamines, N-nitroso 
compounds and other carcinogens which could directly interact with genomic DNA to 
form bulky adducts ultimately leading to mutations in growth regulating genes 159. It might 
be that certain carcinogenic compounds preferably form adducts on codon 12, while 
codon 13 is not a significant target. Methylnitrosourea (MNU) is known to induce C-A 
transition mutations 16B. However, these transition mutations are common in both codons 
and no important differences between transition and transversion mutations were 
observed in this study. Limited by the size of the study, we could not evaluate specific 
transition and transversion mutations. Whether the G-T (glycine to valine) transversion 
mutation in codon 12, which is observed to be associated with a more severe prognosis 
12
, is associated with specific exposures would be of considerable interest. 
Another explanation for the differences between codons might be that mutations occur at 
a similar rate in both codons, but that dietary factors, such as protein and calcium, 
provide an environment with a specific growth advantage for tumors harboring codon 12 
mutations or an environment which prevents the outgrowth of tumors with K-ras 
mutations in codon 13. 
If our findings can be reproduced in larger studies, the diet-related differences between 
the two main targets of mutations in the K-ras oncogene, may provide further insight in 
the etiology of colon cancer. 
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CHAPTER 7 P53 OVEREXPRESSION AND P53 MUTATIONS 
IN COLON CARCINOMAS: 
RELATION TO DIETARY RISK FACTORS 
Epidemiological studies have suggested that dietary factors may differently 
affect p53-dependent and p53-independent pathways to colon cancer. Results 
of such studies may depend on the method used to assess p53 status. This 
case-control study of 185 colon cancer cases and 259 controls examines this 
relation, using both immunohistochemistry and SSCP(exon 5-8) / sequencing to 
detect p53 abnormalities. 
Of 185 carcinomas analyzed using immunohistochemistry, 81 (44%) were 
categorized as p53 overexpression. P53 mutations were detected in 59 tumors 
(32%). A slight increase in risk observed for intake of saturated fat was largely 
due to an increased risk in cases without p53 overexpression (OR per 16.1 
g/day: 1.46; 95% CI, 1.08-1.97), and no association in cases with p53 
overexpression (OR: 1.07; 95% CI, 0.78-1.47). However, findings were less 
pronounced when cases were classified by mutation analysis (wildtype OR: 
1.33; 95% CI, 1.01-1.75; mutated OR: 1.16; 95% CI, 0.81-1.65). Similar 
results were observed for total fat intake. For other nutrients and for vegetable 
and meat food groups no differences in risk for both p53 pathways were 
observed, independent of the laboratory technique used. Interestingly, in cases 
with transversion mutations in the p53 gene, an increased risk was observed for 
saturated fat (OR: 2.00; 95% CI, 0.97-4.14), in contrast to those with mutations 
at CpG sites (OR: 0.93; 95% CI, 0.55-1.57). 
In conclusion, an increase in colon cancer risk for the p53-independent 
pathway due to fat intake, is more pronounced when using immunohisto-
chemistry. However, mutation analysis is needed to study the possible 
association with a small group of tumors with transversion mutations. 
INTRODUCTION 
Cancer of the colon and rectum is the fourth most common type of cancer and cause of 
death from cancer throughout the wor ld \ The transformation from normal colonic 
mucosa to carcinoma is accompanied by accumulation of genetic alterations, involving 
activation of oncogenes and inactivation of tumor suppressor genes e. Alteration of the 
p53 tumor suppressor gene is one of the most frequent molecular abnormalities observed 
in human cancer and is associated wi th the transition f rom adenoma to carcinoma in 
colorectal cancer 169. Mutations in the p53 gene are mostly missense mutations, which 
result in loss of tumor suppressor function and lead to increased half-life and quantity of 
95 
Chapter 7 
the p53 protein 14. This protein overexpression can be visualized by nuclear staining using 
immunohistochemistry (IHC). 
Epidemiological studies have implicated dietary habits in the etiology of colorectal cancer. 
It has been estimated that over 50% of colorectal cancer cases can be prevented by diet \ 
High intake of red meat and animal fat may increase the risk whereas a high intake of 
fruit and vegetables may decrease risk of colon cancer 3. Some dietary factors may be 
related to specific genetic alterations, such as mutations in the p53 tumor suppressor 
gene. Recently, epidemiological studies have addressed risk factor patterns of colorectal 
carcinomas with and without p53 overexpression 116117-124;17017\ interestingly, Freedman 
et al. found cruciferous vegetables to be protective among cases with p53 positive 
tumors, but not in p53 negative cases, as compared with controls " 7 . In the same study, 
beef consumption increased risk in p53 negative cases, but not in p53 positive cases, as 
compared with controls. So far, studies on risk factors of colorectal cancer and p53 status 
all used p53 overexpression and not mutation analysis. 
The objective of the present analysis is to examine whether the diet-cancer association 
depends on p53 abnormalities in the tumor, and whether mutation analysis using single 
stranded conformational polymorphism (SSCP) of exon 5-8 followed by sequencing, as 
compared to immunohistochemical methods, leads to different associations or yields an 
added value. 
MATERIALS AND METHODS 
Study population and data collection 
Between 1989 and 1993, a population-based case-control study has been conducted in 
The Netherlands to examine the relationship between dietary factors and the risk of colon 
cancer. Details about the design and conduct of this study are described previously 163. In 
short, cases were defined as newly diagnosed patients with histologically confirmed 
adenocarcinoma of the colon (ICD-O 153), as determined at surgery. All Dutch-speaking 
men and women of Western European origin, up to the age of 75 years old at diagnosis, 
without a history of cancer, polyposis coli or inflammatory bowel disease were eligible. Of 
all eligible cases diagnosed, 47% were invited to participate by their surgeon, and of those 
invited 60% agreed to participate. In order to explore potential selection bias, participants 
and non-participants were asked to fill out a short questionnaire on diet and lifestyle 
habits. Although non-participants did have a worse prognosis according to Dukes' status, 
they were similar with respect to the consumption of food groups. A total of 232 cases 
participated in the initial study, including 28 cases whose tumor was classified as 
rectosigmoid according to the cancer registry. To minimize misclassification, resulting 
from potential differences in etiology and p53 mutation spectrum between colon and 
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rectum cancer m, the latter group was excluded from the present analysis. The control 
group (n=259) was recruited randomly by the general practitioners of the participating 
cases, and was frequency matched by age and sex to the cases. Of the 520 controls 
invited, 57% agreed to participate. Dietary and lifestyle patterns were similar for those 
participating and those who refused. Trained dietitians conducted personal interviews at 
the participants homes. The dietary part of the questionnaire requested information on 
frequency and amount of foods consumed in the year before the interview (for cases 
before diagnosis and complaints) and consisted of a detailed, structured dietary history 
questionnaire. 
Tumor material 
For p53 analysis we obtained formalin-fixed, paraffin-embedded tumor material from 185 
of the initial 204 cases of colon cancer in the case-control study. Of the remaining 19 
cases no tumor material could be retrieved, due to administrative reasons. Tumor 
characteristics and dietary habits of these cases did not differ from the cases whose tumor 
material was available for analysis. The tumor samples were analyzed for accumulation of 
the p53 protein by immunohistochemistry, and for mutations in exons 5-8 of the p53 
gene by SSCP followed by sequencing. 
Immunohistochemistry 
From formalin-fixed, paraffin-embedded specimens 4 jL/m sections were mounted on 
charged glass slides (Superfrost) and dried overnight at 60°C. Sections were deparaffinized 
in xylol for 10 min. and rehydrated through graded concentrations of ethanol and water. 
Microwave antigen retrieval was performed by boiling the sections in 10 mM citrate-
buffer pH 6,0 for 5 min. at full power. Additional buffer was added and the sections were 
boiled for another 5 min. and then allowed to cool to room temperature for 45 min. 
Sections were rinsed in PBS. Endogenous peroxidase activity was blocked by incubation 
in 0,6 % H202 for 30 min. Sections were rinsed in PBS. Aspecific antibody binding was 
blocked by pre-incubation of the sections with 10% normal horse serum in PBS/BSA for 
10 min. Sections were incubated overnight at 4°C with a cocktail of two anti-p53 
antibodies: 0,4 (Ug/ml DO-7 (Neomarkers, Fremont, USA) which recognizes both mutant 
and wild forms of p53, and 1 /Jg/ml 240 (Neomarkers, Fremont, USA) which recognizes 
only the mutant form of p53. Negative control sections were treated with PBS/BSA alone. 
Sections were rinsed in PBS, and antibody binding was visualized using the Vector ABC 
Elite kit (Vector laboratories, Burlingame CA, USA) using 3,3'-diaminobenzidine as 
substrate and copper enhancement according to the manufacturer's protocol. Finally, 
sections were dehydrated through graded concentrations of ethanol, incubated in xylol 
and mounted with permount. 
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Stained sections were scored independently by two investigators (A.A. v. K., G.N.P. v. 
M.). As the occurrence of only very few strongly positive cells in a tumor does not seem to 
correlate with p53 mutations 173;174, we used a cut-off point of 20% of tumor cells stained, 
like in other epidemiological studies 116;117. Tumors were scored as p53 negative if less 
than 20% of the cells displayed nuclear positivity and positive if otherwise. 
DNA isolation 
DNA isolation was performed using the Puregene DNA isolation kit (Centrasystems, 
Triangle Park, USA). From the formalin-fixed, paraffin-embedded specimens six to nine 8 
jL/m sections were cut for DNA isolation and one 4 jum section was cut for Hematoxylin 
and Eosin (H&E) staining. Guided by the H&E-stained section, tumor tissue was scraped 
from the 8 £/m thick sections. After deparaffination with xylol and rehydration with 
ethanol the tumor tissue was incubated for 18 hours at 56°C with 0,5 mg/ml proteinase K 
(Boehringer Mannheim GmbH, Almere, The Netherlands) in 500 jul cell lysis solution 
according to the recommendations of the manufacturer and for additional 72 hours at 
37°C . After cooling-down the samples to 4°C, 150 jul of protein precipitation solution 
was added, followed by mixing for 20 sec. and centrifugation for 10 min. at 14,000xg, 
4°C. To the supernatant 500 /JI isopropanol (100%) was added followed by gentle mixing 
and centrifugation for 10 min. at 14,000xg, 4°C. After washing the pellet with 500/JI 70% 
ethanol at 4°C, DNA was air-dried and rehydrated in 100 ^ l hydratation solution for 60 
min. at 65°C. DNA was stored at 4°C until use. Analysis of the quality of the isolated DNA 
by agarose gel electrophoresis showed that the size of the DNA fragments was 200-400 
bp. 
SSCP-analysis 
The highly conserved regions of the p53 gene, exons 5-8 were each amplified separately 
using the following intronic oligonucleotide primers: 
Exon 5: 5F: 5TCACTTGTGCCCTGACTT3' 
5R: 5'GAGGAATCAGAGGCCTGG3' 
Exon 6: 6F: 5'GAGACGACAGGGCTGGTT3' 
6R: 5'GAGACCCCAGTTGCAAAC3' 
Exon 7: 7F: 5'CCAAGGCGCACTGGCCTC3' 
7R: S'CCGGCAAGCAGAGGCTGCS' 
Exon 8: 8F: S'CCTTACTGCCTCTTGCTTCS1 
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8R: 5TGAATCTCACCCATAACT3' 
PCR reaction mixture 1 (40 fj\) consisted of 20 mmol/l (NH4)2S04, 75 mmol/l Tris-HCl (pH 
9.0), 0.01%Tween, 200 /Jmol/I of dNTPs, 0.2 jumol/l of the forward primer, 1.0 mmol/l 
MgCI2 (exon 5,7) or 1.5 mmol/l MgCI2 (exon 6) or 2.5 mmol/l MgCI2 (exon 8). After an 
initial denaturation step of 3 min. at 94°C, mixture 2 (10/71), which consisted of 0.3 units 
of thermoperfect plus DNA polymerase (Integra BV, Zaandam, The Netherlands) and 10 
pmol of the reverse primer, was added immediately to mixture 1. PCR was performed for 
40 cycles as follows: 94°C for 30 sec, 55°C (exon 5) or 60°C (exon 6,7,8) for 45 sec. and 
72°C for 1 min., followed by a final extension at 72°C for 5 min. in a Mastercycler 5330 
(Eppendorf Geratebau GmbH, Hamburg, Germany). A negative control without DNA was 
included in each PCR experiment. After amplification 10JUI of the product was subjected 
to electrophoresis on a 2% agarose gel containing 100 ng/ml ethidium bromide to 
confirm success of DNA amplification. The sizes of the PCR products were as follows: 
exon 5, 292 bp; exon 6,197 bp; exon 7, 212 bp and exon 8, 237 bp. 
For SSCP-analysis 3 JJ\ of the PCR-product was diluted in 3 jul loading buffer (95% 
formamide, 20mM EDTA, 0.05% bromophenol blue and 0.5% xylene cyanol), heated at 
95°C for 3 min. and cooled on ice before loading. The electrophoretic analysis was 
carried out on a Genephor Electrophoresis Unit (Amersham Pharmacia, Uppsala, 
Sweden) using GeneGel Excel 12.5/24 kit (Amersham Pharmacia, Uppsala, Sweden). 
Electrophoresis was performed at 7°C (exon 7) or 18°C (exon 5,6,8) for 2 hours at 25mA, 
15W and 600V. Finally the gels were stained in a Hoefer Automated Gel Stainer 
(Amersham Pharmacia, Uppsala, Sweden) with the PlusOne DNA Silver Staining Kit 
(Amersham Pharmacia, Uppsala, Sweden) according to the manufacturer's instructions. 
For reasons of efficiency not all 4 exons were analyzed in each tumor. As mutations in 
more than one exon are exceptional175;176, we decided that, if a mutation was detected in 
one exon, the tumor would be excluded for analysis of the subsequent exons. According 
to the frequency of mutations in each exon reported in other studies 123;172'177;178/ the 
exons were analyzed in the following order: exon 7, 8, 5 and 6. 
Sequence analysis 
Sequencing was performed on original PCR products of exon 5-8 of p53 for all SSCP-
positive tumors. Where SSCP indicated the presence of a mutation not detected by 
sequencing, the variant band was selected from the gel and reamplified. In 5 tumors a 
mutation still could not be confirmed and were therefore scored as not harboring a p53 
mutation. Sequencing primers were the same as those used for PCR. The PCR product 
was purified using QIAquick purification columns (Qiagen GmbH, Dusseldorf, Germany) 
and followed by Taq cycle sequencing using Dye terminator cycle sequencing ready 
reaction kit (ABI Prism, Perkin Elmer, Branchburg, USA) according to the manufacturer's 
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instructions. Sequence analysis was performed by the Applied Biosystems Model 370A 
DNA sequencer (Perkin Elmer, Branchburg, USA). To avoid false positive results due to 
polymerase errors, all samples showing a mutation after SSCP/sequencing, were tested 
again by performing a new PCR, SSCP and sequence analysis. 
Data analysis 
Results of immunohistochemical analysis were compared with the actual mutation 
spectrum of exons 5-8 of the p53 gene in these colon carcinomas. Sensitivity of IHC is 
defined as the probability of a positive result (20% or more overexpression), given an 
actual mutation in exon 5-8 was determined by SSCP/sequencing. Specificity is defined as 
the probability of a negative result in IHC (<20% overexpression), given no mutation was 
found by SSCP/sequencing of exon 5-8. The proportion of carcinomas with a mutation 
detected by SSCP (exon 5-8)/sequencing was calculated in each category of p53 
overexpression. This was repeated, excluding carcinomas with a silent mutation or a 
mutation leading to a stopcodon, because these are not expected to result in p53 
overexpression. 
Both p53 overexpression and p53 mutation, were used to study the relationship with 
dietary factors. Intake of nutrients and food groups was categorized using quartiles, 
according to the distribution among controls. To test for trend and to quantify the 
associations on a continuous scale, quartile medians were used as an additional exposure 
variable m. All odds ratios (OR) and 95% confidence intervals (95% CI) are expressed for 
the distance between the first and the third quartile cut-off points. To simultaneously 
account for confounding factors, multiple logistic regression models were used. Nutrient 
intake values were adjusted for energy intake by the residual method for men and 
women separately 165, and by adding energy intake to the models. Additionally, to adjust 
for differences in distribution, age and gender were included in all models. Potential risk 
factors such as body mass index, family history, smoking and alcohol intake did not 
change the OR's more than 10% when added individually to the models, and were 
therefore not included in the final models. 
Data analysis was performed using the SAS-system and consisted of several phases. First, 
to identify relevant etiological heterogeneity for specific dietary risk factors, case-case 
comparisons were performed. The resulting OR can be interpreted as the ratio of the 
relative risk for developing p53-positive disease to the relative risk for developing p53-
negative disease. These case-case comparisons were conducted separately for 
immunohistochemistry and SSCP (exon 5-8)/sequencing. Subsequently, it was evaluated 
whether dietary factors were associated with colon cancer in specific subgroups of cases, 
i.e. p53 overexpression, any p53 mutation, or specific p53 mutations. The ORs for these 
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subgroup specific case-control analyses were expressed using all 259 controls as the 
reference group. 
RESULTS 
Results of immunohistochemical detection of p53 overexpression and SSCP/sequencing 
analysis of p53 mutations in exon 5-8 are summarized in Table 7.1. A total of 185 tumors 
were analyzed, of which 81 (44%) were categorized as IHC-positive. Using SSCP analysis 
of exons 5-8 followed by sequencing, a p53 mutation was detected in 59 tumors (32%). 
In total 133 tumors (72%) were consistent for IHC and SSCP/sequencing, 44 (24%) were 
positive in both and 89 (48%) were negative in both. 
Table 7.1. Number of colon carcinomas with p53 protein overexpression and mutation of exon 5-8 of the 
p53 gene. 
SSCP/sequencing 
mutationt 
no 
yes 
stopcodonll 
silent* 
exon 5 
exon 6 
exon 7 
exon 8 
total 
negative 
0% 
66 
13 
9 
2 
3 
3 
4 
3 
79 
(n=104)* 
1-19% 
23 
2 
1 
0 
0 
1 
0 
1 
25 
IHC % of cells positive 
Positive ( 
20-49% 
12 
5 
0 
0 
1 
0 
2 
2 
17 
1=81) 
50-79% 
16 
16 
1 
0 
4 
2 
5 
5 
32 
80-100% 
9 
23 
1 
1 
9 
2 
5 
7 
32 
total (n = 185) 
126 
59 
12 
3 
17 
8 
16 
18 
185 
* <20% positive nuclei of tumor cells was scored 'negative', a20% positive nuclei of tumor cells was scored 
'positive' 
t SSCP/sequencing analysis was done in the following order of exons: 7, 8, 5, 6; if a mutation was found in 
an exon the tumor was excluded for analysis of the subsequent exons 
H in 12 of 59 carcinomas with a mutation a mutation resulting in a stopcodon was found, which is not 
expected to lead to overexpression of the protein 
* in 3 of 59 carcinomas with a mutation a silent mutation was found, which does not lead to an amino acid 
change and thus not to overexpression of the protein 
In 15 of 59 tumors in which a mutation was detected by SSCP/sequencing, no p53 
overexpression was found. In 12 of these the discrepancy could be explained: 10 
mutations resulted in stopcodons (Table 7.1), and 2 mutations did not lead to an amino 
acid change. IHC was positive in 37 tumors (20%) in which no mutation could be 
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detected by SSCP and sequencing of exons 5-8. Thus, taking SSCP (exon 5-8) /sequencing 
as the reference, sensitivity and specificity of IHC were 74% and 71% respectively. 
80. 
7 0 . 
6 0 . 
50 
t/> 
c 
o 
S 40. 
30. 
20. 
10. 
stopcodons + silent mutations 
mutated tumors 
20-49 50-79 80-100 
% positive cells 
Figure 7.1. The proportion of mutations in categories of p53 overexpression. 
Figure 7.1 shows the probability of a mutation in exon 5-8 in different categories of p53 
overexpression. The probability increased with an increasing number of cells with positive 
staining. This was especially clear, when not taking into account silent mutations and 
mutations leading to a stopcodon, which are not expected to result in overexpression. 
Table 7.2 shows potential risk factors in the control group and in the colon carcinoma 
patients stratified by p53 status based on IHC and SSCP (exon 5-8)/sequencing (SEQ). Age 
was similar in all groups. Gender was not significantly different in all case groups as 
compared with the controls, but the proportion of women was higher in those classified 
as IHC negative. The percentage of carcinomas with Dukes' C or D was similar in all case 
groups. No statistically significant differences in mean intake of nutrients and food groups 
were found between the 4 case groups. Energy intake was higher in all case groups as 
compared to controls. Intake of vegetables was significantly lower in all case groups as 
compared to controls. The total red meat intake was highest in cases with a positive result 
in SSCP (exon 5-8)/sequencing, however not significantly different from controls or other 
case groups. In the cases which were negative for both IHC and SSCP (exon 5-8)/ 
sequencing, intake of beef was significantly lower than in controls (p<0.10). Intake of 
processed meat was significantly higher in cases both positive in IHC and SSCP (exon 5-
8)/ sequencing as compared with controls. 
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When comparing risks between cases with and without overexpression, we found ORs 
markedly deviating from 1 for total fat (positive vs negative OR per quartile range of 37.3 
g/day, 0.61; 95% CI, 0.38, 0.98) and for saturated fat (positive vs negative OR per quartile 
range of 16.1 g/day, 0.76; 95% CI, 0.52, 1.09). No statistically significant ORs were found 
for any of the case-case comparisons for other nutrients or food groups (data not shown). 
When comparing mutated and wildtype cases no statistically significant ORs were found 
either, the OR was 1.07 for total fat (95% Cl= 0.65, 1.75) and 0.90 for saturated fat (95% 
Cl= 0.62, 1.32). The ORs did not markedly change when the case-case analyses were 
adjusted for Dukes' stage. 
Table 7.3 presents the ORs and 95% CIs for the risk estimates for nutrient and food group 
intake according to p53 overexpression and according to p53 mutation status, as 
compared with controls. Total fat and saturated fat intake increased the risk of colon 
carcinomas without p53 overexpression (OR, 1.94; 95% CI, 1.32, 2.85, and OR, 1.46; 
95% CI, 1.08, 1.97, respectively), but not of carcinomas with p53 overexpression (OR, 
1.20; 95% CI, 0.81, 1.77, and OR, 1.07; 95%CI, 0.78, 1.47, respectively). When p53 
status was evaluated using mutation analysis, total fat intake was associated with an 
increase in risk in both mutated and wildtype cases (OR, 1.57; 95% CI, 1.00, 2.45, and 
OR, 1.56; 95% CI, 1.10, 2.20, respectively), whereas the OR for saturated fat was slightly 
higher in wildtype cases than in mutated cases (OR, 1.33; 95% CI, 1.01, 1.75, and OR, 
1.16; 95%CI, 0.81, 1.65, respectively). 
The ORs for the remaining nutrients and food groups did not markedly differ between the 
case groups or between methods of assessing p53 abnormalities. The decrease in risk 
associated with vegetables was similar in specific case groups and also comparable to the 
risk in all cases combined. Intake of cruciferous vegetables was only significantly 
associated with a decrease in risk in cases without overexpression (OR, 0.62; 95% CI, 
0.41, 0.95) and in wildtype cases (OR, 0.61; 95% CI, 0.41, 0.91), and the difference in 
ORs between cases with and without p53 abnormalities was more pronounced when 
using mutation analysis. When the analyses for cruciferous vegetables were adjusted for 
total intake of vegetables, the ORs no longer indicated a decrease in risk (data not 
shown), suggesting the inverse association is not specific for cruciferous vegetables. We 
found no significant associations with intake of any of the meat product groups in either 
of the case groups. 
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Chapter 7 
Of the 59 mutations detected by SSCP/sequencing, 7 mutations (12%) consisted of 5 
deletion mutations (1-17 bp) and 2 one base pair insertions, which all lead to stopcodons, 
and 52 (88%) were point mutations (data not shown). Twenty-three G:C to A:T mutations 
at CpC sites (39%) were found in known hotspots for colorectal cancer: 4 at codon 175, 
5 at codon 248, 9 at codon 273, and 5 at codon 282. Of the point mutations 5 led to a 
stopcodon, 4 were mutated in codon 306 or codon 213, also at CpC sites. Thirteen 
tumors (22%) harbored a transversion mutation, which is the type of mutation often 
related to smoking in lung cancers. 
Table 7.4. Risk of colon carcinomas with specific p-53 mutations, for nutrients and food group consumption, 
using quartile medians as continuous variable, expressed per quartile range (Q3-Q1, g/day). 
Dietary factor 
Energy 
Total fat 
Saturated fat 
Protein 
Animal protein 
Dietary fiber 
Calcium 
Alcohol 
Vegetables, 
Fruits 
Meat, 
Fish 
total 
cruciferous 
red meat 
beef only 
poultry 
Processed meat 
(/quartile range) 
(/ 3566 kj) 
(/37.3g) 
(/16.1g) 
(/19.2g) 
(/17.0 g) 
(/10.4g) 
(/ 459 mg) 
(/18.2g) 
(/106g) 
(/28g) 
(/164g) 
(/43g) 
(/26g) 
(/17g) 
(/20g) 
(/22g) 
mutations at CpC-
islands 
vs controls 
(27 vs 259) 
OR (95% CD* 
1.36 
1.52 
0.93 
0.78 
0.96 
0.63 
1.15 
0.89 
0.42 
0.76 
0.78 
1.41 
0.68 
1.34 
1.26 
1.36 
(0.64-2.88) 
(0.80-2.89) 
(0.55-1.57) 
(0.40-1.48) 
(0.50-1.85) 
(0.32-1.26) 
(0.60-2.19) 
(0.51-1.55) 
(0.21-0.83) 
(0.37-1.54) 
(0.44-1.36) 
(0.71-2.80) 
(0.37-1.27) 
(0.76-2.37) 
(0.78-2.05) 
(0.62-2.98) 
transversion mutations 
vs controls 
(13 vs 259 
OR (95% CD* 
2.48 
1.89 
2.00 
2.24 
2.57 
0.63 
1.12 
0.82 
0.38 
0.59 
0.93 
1.08 
0.58 
1.12 
1.32 
1.98 
(0.78-7.93) 
(0.78-4.56) 
(0.97-4.14) 
(0.88-5.70) 
(0.98-6.76) 
(0.24-1.66) 
(0.47-2.65) 
(0.40-1.70) 
(0.14-1.03) 
(0.21-1.65) 
(0.41-2.12) 
(0.40-2.90) 
(0.24-1.42) 
(0.50-2.50) 
(0.66-2.62) 
(0.63-6.22) 
* Odds ratios (OR) and 95% confidence intervals (95% CI), all models are adjusted for age, gender and 
energy intake. 
In Table 7.4 ORs and 95% CIs are shown for intake of nutrients and food groups for cases 
with mutations at CpG islands and transversion mutations. Except for vegetable intake, 
which is inversely associated with mutations at CpC islands as well as transversion 
mutations, none of the nutrients and food groups were significantly associated with 
mutations at CpC islands. However, transversion mutations were positively associated 
with intake of energy, total fat, saturated fat, total protein, and animal protein. Although 
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these nutrients are all significantly correlated with total red meat intake (Pearson r = 0.32, 
0.33, 0.29, 0.33, 0.39 respectively), no positive associations were found with meat 
product groups. 
DISCUSSION 
In this case-control study including 185 colon cancer cases, we evaluated the association 
between dietary factors and p53 abnormalities using both p53 protein overexpression 
and specific p53 mutations as the endpoints of interest. For most dietary factors similar 
observations were found for tumors with and without p53 abnormalities. However, total 
fat and saturated fat were positively associated with colon cancer risk in tumors that did 
not show p53 abnormalities. Although the percentage of cases consistently positive or 
consistently negative for both endpoints was relatively high (72%), differences in ORs 
were more pronounced when p53 abnormalities were determined by immunohisto-
chemistry as compared to mutation analysis. Interestingly, when examining specific types 
of mutations, an increased risk with fat and saturated fat was observed for transversion 
mutations but not for mutations at CpG sites. Although the number of cases was small, 
especially for the evaluation of the specific p53 mutations, this study suggests a role for 
(saturated) fat in the p53-independent pathway to colon cancer (normal protein 
expression), as well as in the p53-dependent pathway (transversion mutations). 
This study was initially designed to address the role of dietary risk factors in the etiology of 
colon cancer 163, and the results were in line with those reported by others 3. In case 
control studies, selection bias and information bias limit the interpretation. In our study, 
however, responders and non-responders, both among cases and controls, had essentially 
similar dietary patterns. In addition, the disease may indirectly have affected reported 
food intake of cases. In this respect, it is relevant that 64% of the responding cases had 
Dukes' stage A or B tumors, whereas in the Dutch Cancer Registry this is 5 1 % 2 . Therefore 
it is less likely that advanced disease has severely influenced the reported food intake. 
Advanced disease, and therefore presence of symptoms and information bias, correlates 
with p53 abnormalities. In our study we found p53 overexpression in 4 1 % of cases with 
Dukes' A or B, and in 48% of cases with Dukes C or D. Moreover, we observed lower 
consumption of vegetables in cases with Dukes' C or D as compared to cases with Dukes' 
A or B. Results of the case-case analyses were not materially changed however, if Dukes' 
stage was taken into account. In conclusion, it seems unlikely that inherent pitfalls in 
design and conduct of case-control studies have seriously affected our results. 
In our data, the percentage of p53 overexpression is similar, but the percentage of p53 
mutations is slightly lower than reported in the literature. This may be due to the 
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overrepresentation of early stage tumors (Dukes' A or B, see above), as well as to our 
restriction to analysis of exon 5-8. 
We have used standard IHC methods to detect p53 overexpression. Like others we used 
20% of cells with nuclear staining as the cut-off point for scoring a tumor as being positive 
in p53 overexpression. Using this method we found 44% of the tumors to show p53 
overexpression. Others have found 40-50% of colorectal cancer cases to show p53 
overexpression 116;117'123'124. j o detect mutations, we used SSCP of exons 5-8 of the p53 
gene as a screening method, after which mutations were confirmed and specified by 
sequencing. To maximize sensitivity, sequencing was performed even if SSCP was only 
marginally positive. Where SSCP suggested the presence of a mutation not confirmed by 
sequencing, the variant band was selected from the gel and reamplified. We found 32% 
of colon carcinomas to harbor a mutation in exons 5-8 of the p53 gene, which is 
somewhat low. In a review on p53 mutations in cancer Creenblatt et al. reported 50% of 
colon cancers to harbor a mutation in the p53 gene, based on studies using PCR-based 
techniques, screening at least exon 5-8 14. This difference may be due to our restriction to 
exons 5-8, the sensitivity and specificity of SSCP, or other factors. Mutations outside 
exons 5-8 are expected to occur in 5-20% of tumors, depending on the tumor site 176, 
and are usually frameshift or null mutations which do not lead to protein overexpression 
and therefore cannot be detected by IHC 14. SSCP is thought to have a sensitivity and 
specificity of 90% for detecting a mutation in the p53 gene u. Therefore, our 32% 
mutations as assessed by SSCP (exon 5-8)/sequencing, should represent about 72-85% of 
all mutations in our cases, the estimated true percentage thus being 38-44%. 
Furthermore, our method is not able to discriminate between one or more mutations in 
exons 5-8, since we stopped analysis of other exons when a mutation was found in one 
exon. Mutations in more than one exon are, however, exceptional175;176. in our study the 
percentage of mutations in each exon was similar as found by others 123;172;177;178. Thus the 
apparently low percentage of mutations (32%) can be partly attributed to the methods 
used. Possible misclassification resulting from this, may explain the weaker associations 
observed with mutation analysis as compared with immunohistochemistry methods. 
Furthermore, the relatively high percentage of Dukes' A & B tumors in our study may 
harbor less p53 mutations than Dukes C & D tumors. 
We found sensitivity and specificity of detecting p53 overexpression using IHC with SSCP 
(exon 5-8)/sequencing as the reference method to be 74% and 71% respectively. In 84 
studies identified by Greenblatt et al. comparing IHC with sequencing, positive staining 
was found in 44% of tumors by IHC, while 36% actually contained mutations 14. The 
sensitivity in these 84 studies was on average 75% (range 36-100%), and the positive 
predictive value was 63% (range 8-100%), with considerable variation among tumors at 
different sites 14, no details were given for specific sites. However, in an evaluation of 
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antibodies for immunohistochemistry, Baas et al observed a sensitivity of 67% and a 
specificity of 90% in 19 colorectal neoplasms in The Netherlands, using information on 
mutations from sequencing analysis as reference 174. There are several possible 
explanations for the inconsistencies between the two methods for detecting p53 
abnormalities. P53 overexpression in tumors where no mutation was detected may be 
due to: the ratio of tumor cells and normal cells in the sample used for PCR being too low 
to detect a mutation; binding to viral or cellular proteins which may lead to 
overexpression without the presence of a mutation; mutations outside exon 5-8 (these 
consist mainly of frameshift or null mutations which are not detectable by IHC) or in 
introns. Nonsense mutations in exon 5-8 which do not lead to overexpression, explained 
most of the cases where no overexpression was detected in the presence of a mutation. 
The moderate sensitivity and specificity, and the fundamental difference between cellular 
and molecular processes related to protein expression and gene mutation may also 
suggest that both markers of p53 involvement in colon tumorigenesis represent different 
entities, with only partially shared etiological determinants. 
To our knowledge we are among the first to report p53 abnormalities in colon cancer not 
only in relation to food groups but also in relation to nutrient intake. When comparing 
cases without p53 abnormalities with controls we observed a positive association with 
total fat and saturated fat intake, which was more pronounced when using 
immunohistochemistry methods instead of mutation analysis. No increased risk was 
observed in cases with p53 abnormalities as compared with controls, except for those 
with transversion mutations in the p53 gene. These latter cases showed a positive 
association with total fat and saturated fat intake. 
Freedman et a/., in their case control study on dietary risk factors and p53 overexpression 
in 163 colorectal cancer cases and 326 controls, found beef intake to be positively 
associated with colorectal cancer when comparing cases without overexpression with 
controls 117. In our data, total fat as well as saturated fat, protein and animal protein were 
correlated with intake of meat. However, no positive associations with (specific) colon 
carcinomas were observed for red meat. As Freedman et a/, did not present results on 
nutrient intakes, we can only speculate that nutrients correlated with beef intake are 
associated with a p53 independent pathway in their study as well. Whether intake of 
specific fatty acids or other substances more specifically associated with meat intake (e.g. 
heterocyclic amines) are the underlying etiologic factors remains to be elucidated. 
Our results are only partially in line with the inverse association between cruciferous 
vegetables and colon cancer in cases with p53 overexpression, as found by Freedman et 
a/. 117 We found cruciferous vegetables to be protective both in cases with and without 
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p53 abnormalities; in contrast to Freedman's findings only significantly so in cases without 
overexpression or mutation. In The Netherlands cruciferous vegetables account for a large 
proportion of the total intake of vegetables. When the analyses for cruciferous vegetables 
were adjusted for total intake of vegetables, there was no longer a marked association 
between cruciferous vegetables and cancer risk in any of the case groups, suggesting that 
the inverse association cannot be explained by consumption of cruciferous vegetables 
only. Freedman et a/, found smoking and family history to be associated with p53 status 
as well117. In our study these factors were also associated with colon cancer risk, however 
the OR's for dietary factors did not markedly change after adjustment for smoking status 
and family history (data not shown). 
In contrast to the study by Freedman et a/., which included both colon and rectum 
tumors 117, our study only included colon cancer cases, which may be a subgroup of 
cancers with a different etiology than rectal cancer. Additionally, Freedman et a/, used 
different antibodies, which could result in differences in sensitivity. 
Although no important effect of dietary factors on overall presence of mutations was 
found, looking at specific mutations showed that intake of total fat, saturated fat, total 
protein and animal protein were all associated with an increased risk of colon tumors 
with a transversion mutation. None of the dietary factors were associated with colon 
cases with mutations at CpG-islands, which are thought to be of endogenous origin. In 
cancer of the lung, transversion mutations, and more specifically C:C to T:A transversions, 
are strongly associated with smoking 15. Adjusting our analyses on transversion mutations 
for smoking did not markedly change the ORs. If transversion mutations can be generally 
seen as mutations caused by exogenous carcinogens, our results suggest that diet may also 
be relevant for a small subgroup of tumors that harbor such a mutation. 
In conclusion, for most dietary factors, results were similar for both p53 pathways in colon 
cancer, both when using p53 overexpression and when using p53 mutation as endpoint. 
However, we observed a positive association between (saturated) fat and colon cancer, 
limited to the p53 independent pathway, which was stronger when using p53 
overexpression as the endpoint. Interestingly, for the subgroup of p53 transversion 
mutations, fat consumption appeared to be important as well. Although this is the largest 
study to date, it obviously is of limited size, requiring confirmation in larger studies. 
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General discussion 
CHAPTER 8 GENERAL DISCUSSION 
INTRODUCTION 
Although diet is assumed to play an important role in the etiology of colorectal 
carcinogenesis, the specific effect of dietary factors remains to be elucidated. As cancer is 
a "disease of the genes", additional clues to the etiology will be provided by studying 
diet-gene interactions in colorectal carcinogenesis. The studies in this thesis were 
conducted with the objective to gain more insight in the etiology of both sporadic and 
HNPCC colorectal carcinogenesis. 
The first section of this general discussion serves to integrate the main findings as 
summarized in Table 8.1. Secondly, methodological considerations regarding statistical 
power and several types of bias are discussed. In this part the methodological study on 
questionnaires to assess meat consumption and preparation (CHAPTER 4) is addressed. In 
the third section the biological plausibility of the examined hypotheses is outlined. Finally, 
conclusions are drawn about the study results, and possible lines of future research into 
diet-gene interactions are presented. 
Table 8.1 . Overview of the main findings of the studies described in this thesis. 
Ch Topic Study population Main findings 
2 Anticipation 
3 Frequency K-ras and 
p53 abnormalities 
4 Questionnaire on 
meat consumption 
and preparation 
5 Meat consumption 
and preparation 
6 Diet in relation to 
(specific) K-ras 
mutations 
7 Diet in relation to 
p53 overexpression 
and mutations 
Successive generations in 
HNPCC families 
Sporadic and HNPCC 
colorectal adenomas 
Swedish case-control 
study on several types of 
cancer 
Sporadic and HNPCC 
adenoma cases and 
controls 
Colon carcinomas 
Colon carcinomas 
Birth cohort effect explains earlier age of onset of 
colorectal cancer 
Similar frequencies of K-ras gene mutation and p53 
protein overexpression 
Limited loss of information for heterocyclic amine 
intake with reduced questionnaire (methodological 
study) 
Red meat and darkly browned meat surface 
associated with risk in sporadic group; no 
associations in HNPCC group 
Positive association with animal protein and 
calcium for codon 12 mutations; inverse for codon 
13 mutations 
Positive association with (saturated) fat for p53-
negative (no overexpression) and 
-positive (transversion mutation) cancers 
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MAIN FINDINGS INTEGRATED 
Dietary factors in HNPCC colorectal carcinogenesis 
AIM 1 of this thesis (CHAPTERS 2, 3 & 5) was: to examine evidence for a role of dietary risk 
factors in the etiology of HNPCC colorectal carcinogenesis; are some aspects of the 
etiology similar to sporadic colorectal carcinogenesis? 
In a descriptive epidemiological study (CHAPTER 2) we found the cumulative incidence of 
colorectal cancer to increase in successive generations of HNPCC families, which could 
be attributed to a birth cohort effect. In the general population, both incidence and mean 
age at diagnosis have gradually increased since the 1960s 2. These increasing trends in 
incidence might suggest that environmental factors similarly affect the etiology of sporadic 
and HNPCC colorectal carcinogenesis. 
The similar frequencies of mutations in the K-ras gene and overexpression of the p53 
protein in HNPCC and sporadic colorectal adenomas (CHAPTER 3), suggest similar 
molecular pathways in early stages of colorectal carcinogenesis with regard to K-ras and 
p53. Possibly, dietary factors are associated with these molecular abnormalities (as 
studied in CHAPTERS 6 & 7) both in sporadic and HNPCC colorectal carcinogenesis. 
Subsequently, we studied directly whether diet (meat consumption and preparation) is 
similarly associated with sporadic and HNPCC adenomas (CHAPTER 5). However, we 
found meat consumption and preparation to be differently associated with risk of 
sporadic and HNPCC colorectal adenomas. Red meat consumption and darkly browned 
meat surface were associated only with an increased risk of sporadic adenomas but not 
with HNPCC adenomas. Thus, meat consumption and preparation may not be relevant 
in the etiology of HNPCC adenomas. These results, although not in line with the trend of 
findings in the previous chapters, do not rule out a possible role for (other) dietary factors 
in these or other stages of HNPCC colorectal carcinogenesis. 
Diet in relation to K-ras and p53 genes in sporadic colon cancer 
AIM 2 of this thesis (CHAPTERS 6 & 7) was: to examine evidence for a differential effect of 
dietary risk factors on K-ras/p53 dependent and independent pathways to colorectal 
carcinogenesis. 
In the studies described in the previous section (AIM 1) we studied trends in cancer 
incidence, molecular abnormalities in K-ras and p53, and dietary factors, to support our 
hypothesis of a role for environmental factors in HNPCC colorectal carcinogenesis. In the 
following section we directly studied the interaction between the latter two, in sporadic 
colon cancer. 
With respect to diet in relation to K-ras mutations (CHAPTER 6), we observed no 
differences in dietary factors between carcinomas with and without a K-ras mutation. 
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Examining specific K-ras mutations, we found high intakes of animal protein and calcium 
to be positively associated with carcinomas harboring codon 12 mutations, and to be 
inversely associated with carcinomas harboring K-ras codon 13 mutations. Transition and 
transversion mutations were not differently associated with dietary factors. 
We studied p53 overexpression and p53 mutations in relation to diet (CHAPTER 7), and 
found intake of total fat and saturated fat to be positively associated with risk of 
carcinomas, especially of the p53 independent pathway. Differences in associations were 
more pronounced with p53 overexpression than with p53 mutations. Interestingly, when 
studying specific p53 mutations, we did observe similar associations of diet with risk of 
carcinomas harboring p53 transversion mutations, but not with carcinomas harboring 
mutations at CpG islands. 
If our findings with regard to K-ras and p53 abnormalities would be confirmed by others, 
this would suggest that especially dietary factors of animal origin could be associated with 
specific mutations in K-ras (codon 12) or p53 (transversions) but also with overexpression 
of p53 protein. 
Secondary objectives of our studies 
Regarding the aims (AIM 1 & AIM 2), the studies in this thesis are among the first to 
examine diet-gene interactions in colorectal carcinogenesis, in the etiology of HNPCC 
and mutations in K-ras and p53 genes, using an epidemiological approach. Such "early" 
studies into a new area, tend to be of small size, and they are therefore not sufficient to 
provide "proof" of diet-gene interactions. Nevertheless, they can suggest directions for 
future research. A secondary objective of our studies was to develop and expand research 
infrastructures relevant to the study of diet-gene interactions in human populations. In 
this way our studies have provided a basis to evaluate methods and study designs. 
METHODOLOGICAL CONSIDERATIONS 
In any case-control study selection of subjects and assessment of exposure may result in 
biases. In the following section the design, conduct and analysis of our studies will be 
discussed in the light of these biases and their effect on the interpretation of our study 
results. Sections are ordered with respect to selection of subjects, assessment of molecular 
abnormalities, and assessment of exposure, addressing both non-differential and 
differential misclassification. Potential confounding of the associations by disease 
characteristics and several lifestyle factors will be discussed. Subsequently, some remarks 
about power considerations will be made. 
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Selection of adenoma/carcinoma cases and controls 
In the studies described in this thesis both colon carcinomas and colorectal adenomas are 
used as endpoints, and control groups are derived from the general population and a 
hospital population (i.e. endoscopy patients), respectively. Assessment of endpoints may 
have been subject to misclassification. The choice of these case groups and their 
respective control groups may have led to selection bias, if differentially associated with 
exposures understudy. 
Colon carcinoma cases have been verified by histology and registered by the Netherlands 
Cancer Registry, reducing possibility of false positive cases (CHAPTERS 6 & 7). The control 
group consists of "healthy" population subjects randomly selected from the files of the 
general practitioners of the cases. As cumulative incidence at age 75 (the maximum age 
in this population) is only about 5% 94, the number of undetected colon carcinomas in 
our control group is expected to be very low. 
Non-participation (or non-response) of both cases and controls may lead to selection bias 
if differentially associated with dietary factors. As participating controls (participation rate 
50%) did not markedly differ from non-participating controls with respect to age, gender, 
and dietary habits, no relevant selection bias is to be expected with respect to the 
relevant exposure among controls. The case group in this study (participation rate 60%) 
consisted of relatively more Dukes' A and B carcinomas than overall in colon carcinoma 
patients. As dietary habits might be associated with severity of the disease, selection bias 
could have been introduced. However, this higher percentage of Dukes' A and B cases 
may actually benefit the quality of the dietary data, as these cases are less likely to have 
changed their diets as a result of the disease. Moreover, adjustment of the analyses for 
Dukes' stage did not markedly change the results. 
Colorectal adenomas are highly prevalent (35-60%), especially with increasing age, in 
populations at high risk for colorectal cancer180, and frequently occur without presenting 
symptoms. Therefore, the adenoma control group (CHAPTER 5) underwent full colonic 
examination to exclude adenomas. The adenomatous component in polyps of all cases 
has been verified by histology. Because of full colonic examination and histopathologic 
review, misclassification of disease status is expected not to have markedly influenced the 
results. Subjects harboring hyperplastic polyps, verified by histopathology, have been 
included in the control group, as hyperplastic polyps are generally not considered to be 
precancerous lesions. However, hyperplastic polyps may also be associated with dietary 
factors; this may therefore have led to a dilution of associations. As this study involves 
only few controls with hyperplastic polyps (10%), this bias is expected to be small. 
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In both the sporadic and the HNPCC case groups the participation rates were high (90%). 
Sporadic adenoma cases and controls both underwent endoscopy, came to hospital for 
similar indications, and fulfilled the same eligibility criteria. Indications for endoscopy, e.g. 
abdominal pain, diarrhea, and constipation, may be related to dietary factors, but are 
usually not related to having adenomas. Rectal blood loss, another frequent indication for 
endoscopy, may be related to having adenomas, but is usually not related to dietary 
habits. Therefore, these indications for endoscopy are unlikely to have affected our 
results. With respect to the HNPCC group, both adenoma cases and controls are 
generally thought to be relatively health conscious, with more favorable dietary habits 
than the general population. This health consciousness, however, is thought to be a 
characteristic of HNPCC family members, irrespective of whether they have been 
diagnosed with adenomas, and is not related to screening, participation or enrollment in 
our study. These assumptions suggest selection bias will not have seriously influenced our 
results. 
The HNPCC population Both the 'true' HNPCC status of the families included in these 
studies, as well as the gene carrier status of adenoma cases and controls may affect 
interpretation of the results. 
The HNPCC families are ascertained as such using the "Amsterdam criteria" 25. These are 
based on family history data and have been designed to establish uniformity in studies of 
HNPCC. This approach leads to both false positive families (when chance aggregation 
leads to high numbers of cases in a family) and to false negative families (when families 
are too small to include enough cases). Since 1993 five genes have been found 
responsible for the defects in the mismatch repair system which cause HNPCC 18. Only a 
small percentage of the HNPCC families included in our studies have been examined for 
germline mutations in these genes, and therefore these mutations could not be used to 
confirm HNPCC-status. However, in a similar Dutch population of HNPCC families it was 
found that the Amsterdam criteria strongly correlate with mutations in mismatch repair 
genes n\ 
Gene carrier status in the source population of HNPCC family members is unknown. The 
underlying assumption in the studies among first degree HNPCC family members 
(CHAPTERS 2, 3 & 5) is that the first degree relatives of colorectal cancer cases have a 50% 
chance of harboring a germline mutation in one of the mismatch repair genes. The 
proportion of non-carriers in both adenoma cases and the control group may influence 
interpretation of the observed associations. Adenoma cases are assumed to be gene-
carriers. However, if they are diagnosed at a relatively old age, they may also be non-
carriers, i.e. sporadic adenoma cases. If HNPCC adenoma cases partly consist of non-
carriers and if risk associated with diet is actually higher in a sporadic population, this 
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could have led to an upwards biased estimate of the relative risk in the HNPCC 
population, by making the groups more similar. Thus, with respect to the relative risk 
associated with meat consumption and preparation, we can safely assume that if such a 
bias occurred, the true association in the HNPCC group would be even less. In contrast to 
our assumption in the adenoma cases, we expect the controls to consist of both gene-
carriers and non-carriers. As gene-carriers and non-carriers among HNPCC controls are 
assumed to have similar dietary patterns, no biased estimates are expected to result from 
incorporating both types of controls. 
Assessment of K-ras and p53 abnormalities 
Molecular abnormalities of the K-ras and p53 genes are studied both with respect to their 
frequency in HNPCC and sporadic adenomas, and with respect to their relation to dietary 
risk factors in sporadic colon carcinomas. As in any laboratory method, detection of these 
abnormalities may be accompanied by false positive as well as false negative results. The 
sensitivity and specificity of the methods are discussed in detail in CHAPTERS 3, 6 & 7. 
K-ras mutation frequency in the colon carcinomas (36%) seems relatively low in 
comparison with findings of others (see Figure 8.1), but can be explained by the relatively 
early Dukes stage of the carcinomas in our study and our restriction to analysis of codons 
12 and 13. We have used the same method on colorectal adenomas and found a similar 
percentage of mutations (32%), which is within the range that could be expected in 
relatively small adenomas. As the distribution of different types of mutations in both 
carcinomas and adenomas was very similar to those found by others, we do not expect to 
have missed a large percentage of mutations using this method. 
P53 abnormalities have been detected using both immunohistochemical methods and 
PCR-based methods. Concordance between the two methods was 72% in our study of 
colon carcinomas, similar to other studies of colorectal cancer (68-82%) 181. Frequencies 
of mutation (32%) and overexpression (44%) in colon carcinomas and overexpression 
(31%) in sporadic colorectal adenomas are also within the range found by others (see 
Figure 8.1). The use of both methods to detect p53 abnormalities showed that use of 
either method may lead to somewhat different results in epidemiological studies of 
dietary risk factors in relation to p53. Depending on the aim of the study, a choice should 
be made between p53 mutation analysis (i.e. when aiming to find dietary causes for 
specific mutations) and assessment of p53 overexpression (i.e. when aiming to evaluate 
overall involvement of p53 in relation to diet). 
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Figure 8.1. The range of frequencies of K-ras mutations and p53 mutations or overexpression, reported in 
studies of K-ras and p53 abnormalities in sporadic and HNPCC colorectal adenomas and carcinomas. 
Assessment of dietary exposures 
Measurement errors in assessment of dietary factors, and more specifically meat 
consumption and preparation, may have occurred due to limited validity and 
reproducibility of the instruments used to assess dietary intake. As far as random 
measurement errors are concerned, we assume this may have led to minor bias towards 
the null hypothesis. If differential for cases and controls, misclassification will have caused 
information bias in our studies. The studies in CHAPTERS 5, 6 & 7 may be especially prone 
to information bias due to differential measurement errors, as these studies involve the 
retrospective assessment of diet in a case-control setting. 
In the adenoma study on meat consumption and preparation (CHAPTER 5) we used a 
validated semi-quantitative food-frequency questionnaire designed for the European 
Prospective Investigation into Cancer to assess dietary intake of macro-nutrients and food 
groups 154;155. To assess meat preparation a questionnaire was developed especially for 
this purpose. The photos used in this questionnaire are derived from a very extensive 
Swedish questionnaire designed to assess the intake of heterocyclic amines. The food 
frequency questionnaire and the meat preparation questionnaire correlated well with 
each other with respect to the consumption of total meat, red meat and poultry. 
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The methodological study In this study (CHAPTER 4) we examined whether a reduced set of 
questions on meat consumption and preparation provides sufficient information to 
correctly categorize subjects with regard to exposure to heterocyclic amines. The analyses 
were performed on data from a Swedish case control study which used a very extensive 
questionnaire to assess the intake of heterocyclic amines in a population of Stockholm 
elderly 134. Reduction of the number of items in the questionnaire did not substantially 
change the estimated relative risks in that case control study. Thus, the number of items 
and the type of questions used in our meat preparation questionnaire should in theory be 
sufficient to give a relatively good estimate of heterocyclic amine intake. Ideally, one 
would use a valid biomarker for the exposure to heterocyclic amines. However, methods 
such as measurement of DNA-adducts in colon tissue 140-141^43
 0 r metabolites in urine 144 
have their own methodological and analytical limitations. 
In this adenoma case control study (CHAPTER 5) information bias may have occurred if 
cases and controls report their past diet differently. Differences in recall between cases 
and controls in the HNPCC group are thought to be minimal, as this population is 
generally thought to be relatively health conscious, and very aware of their risk of 
colorectal cancer, irrespective of whether they had adenomas at their most recent colonic 
examination. In contrast to HNPCC family members, the sporadic population frequently 
does not know if they have adenomas shortly after endoscopy, which is the time of filling 
out the questionnaires in the majority of our study population. Moreover, controls in the 
sporadic group reported having bowel complaints more often than did the cases. All 
analyses have been adjusted for bowel complaints, but this did not markedly affect the 
results. 
In the case control study on colon cancer (CHAPTERS 6 & 7) an interview-based dietary-
history questionnaire was used. It was an adapted version of a validated questionnaire 
used in a study on breast cancer 182. When studying K-ras and p53 abnormalities as 
endpoints, cases are generally not aware of their K-ras or p53 status. However, molecular 
abnormalities may be related to severity of disease, which may cause differences in recall 
or changes in dietary habits. Therefore, all case-case analyses were adjusted for Dukes' 
stage of the tumors, but again, this did not markedly alter the associations. 
Confounding 
Several dietary and other lifestyle factors may be related to the endpoints as well as to the 
exposures, especially in the studies focusing on dietary risk factors (CHAPTERS 5, 6 & 7). In 
each of these studies, total energy intake is taken into account as a possible confounder 
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by using energy adjusted nutrient intakes 165 and by including energy intake in the logistic 
regression models. Other potential risk factors in colorectal carcinogenesis are: 
• high Body Mass Index, as a measure of long term energy imbalance 149 
• low physical activity, a sedentary lifestyle is thought to increase risk 149 
• smoking, may increase risk especially of adenomas 183;184 
• alcohol intake, may increase risk especially in combination with low folate intake 
185; 186 
• regular aspirin or NSAIDs use, has been shown to be protective in both adenomas and 
carcinomas 1B7;188. 
As these risk factors may be associated with dietary risk factors such as meat consumption 
and preparation, they were all included in the logistic regression models separately, but 
none markedly changed the associations with the exposure under study. 
Molecular abnormalities were studied as endpoints in CHAPTERS 3, 6 & 7. Clinical 
characteristics of the adenomas or carcinomas, such as size and localization of the tumor, 
multiplicity, stage, may all be associated with these molecular abnormalities and, where 
possible, have therefore been taken into account in the analyses. 
Power considerations 
The studies described in this thesis are among the first epidemiological studies to 
investigate diet-gene interactions in colorectal carcinogenesis, with respect to 
environmental factors in the etiology of HNPCC and molecular abnormalities in the K-ras 
and p53 genes. As little knowledge is available on these diet-gene interactions in humans, 
very large and expensive studies are not justifyable at this time. Therefore, the objective is 
to identify directions for future studies, by conducting studies with smaller sample sizes. 
In the interpretation of the results, larger confidence intervals are acceptable, to serve 
identification of major factors or generating new hypotheses. 
Originally the case control study on colorectal adenomas also aimed to examine whether 
meat consumption and preparation are differently associated with adenomas with and 
without abnormalities in the K-ras and p53 genes. However, as the frequency of K-ras 
and p53 abnormalities was lower than anticipated in these adenomas, and the variation 
in variables regarding meat intake and preparation is relatively small in a Dutch 
population, the estimates obtained appeared to be very imprecise and therefore not 
informative. 
BIOLOGICAL PLAUSIBILITY 
In the following paragraph the plausibility of the diet-gene interactions that we have 
observed is discussed, both with respect to the etiology of HNPCC colorectal 
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carcinogenesis, and to molecular abnormalities in the K-ras and p53 genes in colon 
cancer. This will be done by comparison with other studies and by providing a biological 
rationale. 
Molecular pathways and environmental factors in HNPCC 
The high cumulative incidence of colorectal cancer and the relatively young age at 
diagnosis as described in HNPCC families (CHAPTER 2), are well known characteristics of 
HNPCC 22. They are due to the genetic defect in the mismatch repair system, which leads 
to genetic instability and therefore to high frequencies of mutations in regulatory genes18. 
Anticipation (i.e. earlier onset of disease in successive generations) however, is a far more 
difficult phenomenon to explain. We have provided evidence that the younger age at 
diagnosis in successive generations of HNPCC families is mainly due to a birth-cohort 
effect, which resembles the secular trend in cancer incidence in the general population. 
Similar features have also been described in other hereditary diseases 101;102. The 
comparability of these trends in sporadic and HNPCC cancer incidence indicate that the 
inherited genes may not be solely responsible for the incidence of cancer in HNPCC 
families. This hypothesis is further supported by findings of changes in the tumor 
spectrum of HNPCC over time 26. Experimental evidence from studies in mice also 
suggest that the HNPCC tumor spectrum is determined by exposure to exogenous factors 
If environmental factors are postulated to play a similar role in HNPCC and sporadic 
colorectal cancer, one might expect the same genes to be involved. Mutations in K-ras 
and p53 may both be related to environmental factors, but reports on small series of 
HNPCC colorectal carcinomas have resulted in inconsistent findings with regard to 
mutation frequencies of K-ras and p53 (Figure 8.1). We report similar frequencies of K-ras 
and p53 abnormalities in HNPCC and sporadic colorectal adenomas (CHAPTER 3). 
Distinctly different molecular pathways to sporadic and hereditary colorectal cancer have 
been suggested, because of the underlying germline defect in the mismatch repair system. 
The resulting microsatellite instability occurs in about 80-90% of HNPCC colorectal 
cancers and only 10-15% of sporadic colorectal cancers 16"18. Mutations in the 
Transforming Growth Factor 6 type II receptor (TGFB-RII) are found almost exclusively in 
tumors with microsatellite instability 1<M. However, the detection of high frequencies of 
somatic APC mutations in both sporadic and HNPCC tumors2B, has cast some doubt on 
the hypothesis of distinctly different pathways to sporadic and HNPCC colorectal cancer. 
With respect to K-ras and p53, the few studies with relatively small series of cases, as 
mentioned earlier, provided a wide range of reported frequencies in HNPCC colorectal 
cancer (Figure 8.1). 
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Our results suggest that K-ras and p53 genes may be involved in a similar fashion in the 
early stages of sporadic and HNPCC carcinogenesis. Do the similar frequencies of 
mutations in K-ras and p53 in sporadic and HNPCC adenomas imply that environmental 
factors play a similar role in the etiology of HNPCC carcinogenesis? 
We did not find similar associations with meat consumption and preparation for HNPCC 
and sporadic colorectal adenomas (CHAPTER 5). High red meat consumption and darkly 
browned meat surface were positively associated with sporadic adenomas but not with 
HNPCC adenomas. Possibly meat consumption and preparation are associated with 
inducing early molecular alterations, such as somatic APC mutations, in sporadic 
adenomas. In HNPCC adenomas however, mutations in APC might be largely due to the 
defect mismatch repair system. To our knowledge no published papers have yet reported 
on dietary risk factors in HNPCC colorectal carcinogenesis. 
In conclusion, it appears likely that dietary factors play a role in the etiology of HNPCC 
colorectal carcinogenesis. However, it remains to be elucidated to which genes diet is 
related and in which phase of the carcinogenic process. 
Association of diet with K-ras and p53 genes 
Diet-related carcinogens such as alkylating agents have been suggested to cause point 
mutations in the K-ras gene, especially at the second nucleotide of codons 12 and 13 160. 
Possibly, dietary factors may also affect clonal selection by modifying growth of colon 
tumors harboring K-ras mutations. Some studies suggest that aggressiveness, prognosis 
and survival may differ for cancers with or without K-ras mutations and for cancers with 
specific K-ras mutations126;190192. These results have been rather inconsistent, but recently 
a very large multi-center study showed that some specific mutations (i.e. C to T 
transversions at codon 12) are associated with poorer prognosis 12. 
We found high intakes of calcium and protein to be inversely associated only with 
carcinomas with K-ras codon 13 mutations, but positively associated with carcinomas 
with K-ras codon 12 mutations (CHAPTER 6). In contrast to our study, Bautista et a/, 
reported an inverse association for calcium in the K-ras-mutated pathway and for mono-
unsaturated fatty acids in the K-ras-wildtype pathway only 162. We did not find total fat, 
saturated or unsaturated fatty acids to be associated with K-ras mutations. These apparent 
inconsistencies may in part be due to large differences in dietary patterns between the 
Spanish population in the study by Bautista et a/. 162 (low calcium intake, high olive oil 
consumption) and the Dutch population in our study (high calcium intake, low olive oil 
consumption). 
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Environmental factors such as smoking cause mutational fingerprints in the p53 gene (i.e. 
C:C to T:A transversion mutations) in lung cancer. This type of mutation also occurs in 
colorectal carcinomas, although in lower frequencies, and might also be caused by 
smoking or other exogenous factors. The type of p53 mutation which occurs most 
frequently in colorectal carcinomas (i.e. C:C to A:T transitions at CpG-dinucleotides) is 
thought to be endogenous of origin, resulting from spontaneous deamination of 
methylated cytosine 14. Unknown is whether dietary factors might be involved in the 
methylation process, e.g. folate, vitamin B12, alcohol. 
In our study, high intakes of nutrients of animal origin, such as total fat and saturated fat, 
were associated with an increased risk of colon carcinomas, especially of the p53 
independent pathway (CHAPTER 7). These differences between the p53 dependent and 
independent pathways were more pronounced when studying overexpression as 
compared to mutations. Although total and saturated fat intake are highly correlated with 
meat consumption, we did not find total meat and beef to be associated with risk. In 
contrast to this, Freedman et a/, did report beef consumption to be associated with the 
p53 independent pathway only, but did not report associations with nutrients 117. 
Interestingly, when examining specific mutations we found that the same dietary risk 
factors (i.e. total fat, saturated fat) were associated with an increased risk for carcinomas 
with transversion mutations, but not with mutations at CpC islands. 
It appears from the combined results of our own studies as well as those of others, that 
the dietary factors that interact with K-ras and p53 abnormalities still have to be 
identified. However, the results prompt to further research on the overall involvement of 
p53 (possibly using p53 overexpression as endpoint) in the association between dietary 
factors and colon cancer risk. Additionally, the role of nutrients and food groups of animal 
origin in the etiology of both specific K-ras (codon 12) and p53 (transversion) mutations 
should be subject to further study. 
CONCLUSIONS AND PERSPECTIVES 
General remarks 
Cancer is known as a "disease of the genes". Simultaneously, environmental factors such 
as diet are held responsible for causing 90% of colorectal cancer. Therefore, it is merely 
rational to postulate that these two, genes and environment, may interact in causing the 
disease. In this thesis two types of diet-gene interaction have been studied: (1) genetic 
susceptibility as expressed in a dominant monogenetic trait (HNPCC) and the relevance 
of dietary factors in its etiology; (2) dietary factors in relation to somatic mutations which 
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may lead to cancer, i.e. dietary factors causing these mutations or differential effect of 
environmental factors depending on these mutations. 
In our studies we found suggestive evidence for both types of diet-gene interaction. 
Although meat consumption and preparation appear not to be associated with risk of 
HNPCC adenomas, the rationale for an association with (other) dietary factors in all 
phases of HNPCC colorectal carcinogenesis remains. Our finding of associations between 
dietary factors of animal origin and specific K-ras and p53 mutations needs confirmation. 
As our studies are of limited size, they have not provided scientific proof of these 
associations, in terms of statistical significance at p<0.05. Therefore, no definite 
conclusions will be drawn from these studies with respect to the studied diet-gene 
interactions. The limited body of empirical knowledge in this field however, together with 
our own results suggest that further research may indeed provide clues to the etiology of 
colorectal carcinogenesis. Moreover, our results may serve as a basis for new hypothesis 
to be tested in future, larger, studies. 
Future studies 
• A substantial role for dietary factors in the etiology of sporadic colorectal 
carcinogenesis is already well established. However, we not only need to know what 
the attributable risk in the general population is. We may also want to know whether 
a relevant proportion of the colorectal carcinomas in a high risk group such as HNPCC 
families, is preventable by dietary changes. 
• Evidence for a possible role of environmental factors in the etiology of HNPCC, will 
be gained from currently conducted and future studies addressing the spectrum of 
genes, such as TCFfi-RII, IGF-RII, BAX, APC, K-ras, p53. The frequencies and type of 
mutations in these genes and the stage in HNPCC carcinogenesis in which they occur, 
may provide additional links to which environmental factors are relevant. 
• Most promising, in directly studying dietary risk factors in HNPCC, may prove to be 
dietary intervention studies. A very large contrast of exposure to a specific dietary 
factor will probably be needed to discern the risk associated with this dietary factor 
from the high background risk due to mismatch repair deficiency. Studies on 
colorectal adenomas are likely to be the most appropriate stage to study, as the effects 
of the genetic instability may increase from there onwards. Controlled trials are 
currently being initiated in Europe, to study the protective effect of resistant starch 
and aspirin in HNPCC families, i.e. the Concerted Action Polyposis Prevention 
(CAPP)-studies193. 
• A potential source of evidence regarding effects of a specific dietary factor on the 
molecular level, lies in analysis of mutations in multiple genes in archival tissue of 
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ongoing or already conducted large cohort and intervention studies with primary or 
recurrent adenomas as endpoints. With new rapid and efficient methods for mutation 
analysis in view (e.g. gene chips), multiple genes may be scanned for mutations in 
large series of tissue samples. Our case control studies into colorectal adenomas and 
carcinomas have already been extended to include mutations in the APC gene. 
The use of early biomarkers of cancer risk in such studies may help to disentangle the 
"molecular effect" of a specific dietary factor. With respect to potential early 
endpoints of both sporadic and HNPCC colorectal carcinogenesis, processes that 
occur even before gene mutation may be relevant. (Epi)genetic changes such as 
methylation of specific genes (e.g. mismatch repair genes, oestrogen receptor, insulin 
growth factor) and DNA damage due to oxidative stress, might be influenced by diet. 
However, their predictive value should first be evaluated. 
Such studies on a molecular level should be conducted in sporadic colorectal cancer, 
however, studies in HNPCC colorectal adenomas and carcinomas may also provide 
evidence which could be extended to sporadic colorectal carcinogenesis. 
Meat consumption and preparation was the main dietary exposure of interest in part 
of this thesis. Future studies with the aim to investigate the causal agent(s) in meat 
with respect to the etiology of colorectal cancer, need to assess: (1) preparation 
methods using specially designed questionnaires, (2) exposure to specific heterocyclic 
amines, if possible using biomarkers such as DNA adducts or urine metabolites, and 
(3) exposure to other possible (pro)carcinogens related to meat consumption, e.g. N-
nitroso-compounds and iron. 
Accounting for genetic polymorphisms of metabolizing enzymes, may serve to 
discriminate between groups with a genetic susceptibility to DNA damage caused by 
environmental factors such as meat consumption and preparation. Our case control 
study on sporadic colorectal cancer has already been extended into this direction. 
CONCLUDING, future studies may clarify the role of environmental factors in the etiology 
of monogenetic traits such as HNPCC. Based on our results, it should be doubted 
whether HNPCC is a purely hereditary disease, and the search for environmental causes 
should be continued. Moreover, further studies in the field of gene-environment 
interactions in colorectal cancer are needed to disentangle the effects of diet in all 
molecular phases of the adenoma carcinoma sequence. 
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SUMMARY 
Cancer is a genetic disease, requiring accumulation of alterations in regulatory genes for a 
tumor to develop. A familial component in colorectal carcinogenesis is suggested by an 
increased risk for persons with a positive family history of colorectal cancer. Hereditary 
factors are clearly present in two autosomal dominantly inherited syndromes (i.e. Familial 
Adenomatous Polyposis (FAP) and Hereditary Non-Polyposis Colorectal Cancer 
(HNPCQ), for which the genetic basis has now been discovered. 
Although cancer is known as a disease of the genes, environmental factors are also 
suggested to play a major role. For many decades diet is suggested to be an important risk 
factor for colorectal cancer and for colorectal adenoma as its precursor lesion. However, 
the mechanisms by which specific dietary components affect carcinogenesis remain 
unclear. Studies of diet-gene interactions may provide further clues to the etiology of 
colorectal carcinogenesis. 
Diet-gene interactions may not only be relevant in sporadic but also in hereditary forms 
of colorectal cancer. Since the development of adenomas in HNPCC patients has 
characteristics in common with adonoma development in sporadic patients, adenomas in 
HNPCC patients may also be related to dietary factors. Additionally, these adenomas may 
serve as a model in studies of sporadic colorectal carcinogenesis. HNPCC adenomas are 
usually diagnosed at a younger age and recurrences occur over a shorter time interval 
than in sporadic adenoma patients. Therefore, diet-gene interactions may be more 
efficiently studied in HNPCC family members. 
This thesis examines diet-gene interactions in the etiology of colorectal cancer from two 
different epidemiological perspectives (as in AIM 1 & 2). 
CHAPTER 1 introduces some of the basic concepts in the etiology of colorectal cancer. 
Colorectal cancer is described as a genetic disease, which develops through the 
adenoma-carcinoma sequence, by accumulating alterations in regulatory genes such as 
APC, K-ras, p53, and others. These alterations may be caused by exogenous factors as 
well as endogenous processes. Hereditary Non-Polyposis Colorectal Cancer (HNPCC), 
has its genetic basis in a germline defect in the mismatch repair system, but also has 
characteristics in common with sporadic colorectal carcinogenesis and may well share 
similar molecular pathways with sporadic colorectal cancer. Some of the acquired genetic 
alterations may be induced by dietary factors and alternatively, altered gene products 
may function differently depending on diet. Diets high in meat and fat have long been 
thought to increase the risk of both colorectal adenomas and carcinomas, but the 
evidence is inconsistent. Some experimental studies in animals suggest that factors 
relating to meat consumption and preparation, such as heterocyclic amines, may cause 
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mutations in regulatory genes. The fact that such mutations may occur both in sporadic 
and HNPCC colorectal carcinogenesis, was an important consideration to study diet-gene 
interactions in the general population as well as in HNPCC families. 
AIM 1: To examine evidence for a role of dietary risk factors in the etiology of hereditary 
non-polyposis colorectal carcinogenesis; are some aspects similar to the etiology of 
sporadic colorectal cancer? 
In CHAPTER 2 we assessed the cumulative incidence of colorectal cancer in different age 
categories of family members from 51 HNPCC families selected according to the 
"Amsterdam criteria", in order to quantify lifetime risk. In this descriptive epidemiological 
study the cumulative incidence at age 75 increased from 19% in the ancestors, to 32% in 
the first generation and 55% in the second generation, which is largely attributable to a 
birth-cohort effect. The earlier age of onset in successive HNPCC generations thus 
appears not to be a biological feature of HNPCC, but reflects a time trend in cancer 
occurrence which is similar to trends in the general population. 
To examine whether HNPCC and sporadic adenomas may represent similar molecular 
pathways to cancer, we investigated the frequency of mutations in codons 12 and 13 of 
the K-ras gene, and overexpression of the p53 protein in these adenomas (CHAPTER 3). 
The K-ras and p53 genes are both commonly mutated genes in colorectal carcinogenesis, 
and may be influenced by exogenous or endogenous factors. In 48 HNPCC adenomas 
and 59 sporadic adenomas the frequency of abnormalities in these genes were similar: 
25% and 32% respectively for K-ras, and 25% and 31% respectively for p53. When taking 
adenoma size into account, the frequencies of abnormalities in HNPCC and sporadic 
adenomas were even more similar. 
In a methodological study performed on data from a Swedish case-control study (CHAPTER 
4), we reported limited loss of information regarding heterocyclic amine intake 
(concordance was 90% and 95% with 15 and 20 of 39 items respectively) when reducing 
an extensive questionnaire on meat consumption and preparation. This supports the use 
of relatively short questionnaires on meat consumption and preparation (including photos 
to assess color of meat surface). 
In CHAPTER 5 we focus on differences in the associations of meat consumption and 
preparation with risk of sporadic and HNPCC colorectal adenomas respectively, using 
such a questionnaire. In this case-control study of adenoma cases and adenoma-free 
controls, red meat consumption was positively, but not significantly, associated with the 
risk of colorectal adenomas in the sporadic population (Odds ratio (OR) 4.1, 95% 
Confidence Interval (95% CI) 0.7-23.0), but not in the HNPCC population (OR 0.4, 95% 
CI 0.1-2.2). A preference for a darkly browned meat surface significantly increased the 
risk of sporadic colorectal adenomas (OR, 95% CI: 3.0, 1.2-7.5). Again this increased risk 
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was not observed for HNPCC adenomas (0.7, 0.3-1.4). Possibly, factors related to meat 
consumption and preparation such as heterocyclic amine intake may be relevant only to 
the etiology of sporadic colorectal adenomas. However, this does not rule out a potential 
role for these or other dietary factors in other stages of HNPCC colorectal carcinogenesis. 
Concluding, similar time trends in incidence and similar involvement of K-ras and p53 
suggest a role for environmental factors in the etiology of HNPCC colorectal 
carcinogenesis. However, meat consumption and preparation were not similarly 
associated with risk of HNPCC and sporadic adenomas. 
AIM 2: To examine evidence for a differential effect of dietary risk factors on K-ras/p53 
dependent and independent pathways to colorectal carcinogenesis. 
In CHAPTER 6 we examine whether dietary factors of animal origin are associated with 
(specific) mutations in the K-ras gene. K-ras codon 12 and 13 mutations were detected in 
36% of 185 colon cancers (82% in codon 12) from a previously conducted case-control 
study on diet and colon cancer. Food groups and nutrients of animal origin were not 
differently associated with colon cancers with or without K-ras mutations. However, high 
intakes of (animal) protein and calcium were positively associated with tumours harboring 
K-ras codon 12 mutations (for protein per 19 g: OR 1.5, 95% CI 1.0-2.1; for calcium per 
459 mg: OR 1.2, 95% CI 0.9-1.6), while inversely associated with tumors harboring with 
codon 13 mutations (for protein: OR 0.4, 95% CI 0.2-1.0; for calcium: OR 0.6, 95% CI 
0.3-1.2). Transition and transversion mutations were not differently associated with these 
dietary factors. These data suggest a different dietary etiology of colon tumors harboring 
K-ras codon 12 and codon 13 mutations. In combination with a suggested difference in 
prognosis for cancers with specific K-ras mutations, these results warrants further research. 
In CHAPTER 7 we concentrated on the question whether dietary risk factors may be 
differently associated with colon tumours with or without p53 abnormalities, and whether 
these associations depend on the endpoint used (i.e. mutation vs overexpression). Of 185 
colon carcinomas 81 (44%) were categorized as p53 overexpression, whereas 59 of 185 
(32%) were found to harbor a mutation in exon 5-8 of the p53 gene. Concordance 
between these two methods was 72%. Using p53 overexpression as endpoint, an 
increased risk with high intakes of total fat and saturated fat was observed for colon 
carcinomas without p53 overexpression only (OR for saturated fat per 16 g, 95% CI: 1.1, 
0.8-1.5 with overexpression; 1.5, 1.1-2.0 without overexpression). When cases were 
classified by mutation analysis, the difference between cases with and without p53 
abnormalities was less pronounced (1.2, 0.8-1.6 mutation; 1.3, 1.0-1.8 wildtype). 
Interestingly, for cases with transversion mutations in the p53 gene, we observed an 
increased risk for similar dietary factors, in contrast to cases with mutations at CpG sites. 
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Concluding, both studies on K-ras and p53 in colon cancer suggest dietary factors may be 
differently associated with tumors harboring specific mutations in these genes. Whether 
diet has a role in inducing mutations or acts differently depending on the (altered) 
function of the gene remains to be elucidated. 
In CHAPTER 8 we summarize the results of our studies and discuss these in the light of 
possible biases. The biological plausibility of the studied diet-gene interactions is 
discussed, endorsed by results from experimental research. 
Our studies are among the first to examine diet-gene interactions in colorectal 
carcinogenesis, with respect to environmental factors in the etiology of HNPCC and 
molecular abnormalities in the K-ras and p53 genes. The results could therefore be 
compared to only few other published studies. As there is still little knowledge available 
on these diet-gene interactions, statistical testing in our studies was accompanied by the 
acceptance of a larger range of type a-errors. Consequently, our studies have mainly 
served as a basis for new hypotheses and to expand research infrastructures. 
Future studies should continue to aim at clarifying a possible role of environmental factors 
in HNPCC. Any proportion of cancers preventable by diet is relevant to HNPCC families. 
Furthermore, HNPCC adenomas may serve as a model to study colorectal carcinogenesis, 
which may be extended to colorectal carcinogenesis in the general population. To 
disentangle the effects of diet in all molecular phases of the adenoma-carcinoma 
sequence, several intermediate molecular biomarkers of cancer risk should be evaluated. 
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SAMENVATTINe 
Voor een ieder die geinteresseerd is in het onderzoek beschreven in dit proefschrift 
Kanker is een ziekte van de genen (ons erfelijk materiaal). Voor het ontstaan van kanker 
zijn meerdere veranderingen in regulerende genen nodig. 
Dikke darmkanker is na long-, maag- en borstkanker, de meest voorkomende vorm van 
kanker in de wereld. In Nederland wordt ieder jaar bij ongeveer 8000 personen dikke 
darmkanker vastgesteld. Hoewel dikke darmkanker in bepaalde families vaker lijkt voor te 
komen, is slechts in ca. 5% van alle gevallen van dikke darmkanker echt sprake van 
erfelijkheid. HNPCC (Hereditair Non-Polyposis Colorectaal Carcinoom) is zo'n erfelijke 
vorm van dikke darmkanker. Hoewel kanker dus een ziekte van de genen is, neemt men 
aan dat leefstijlfactoren een prominente rol spelen. Gedurende tientallen jaren van 
onderzoek zijn aanwijzingen verkregen dat voedingsgewoonten een belangrijke risicofactor 
zijn voor het ontstaan van dikke darmkanker en adenomateuze poliepen (adenomen, 
goedaardige voorlopers van kanker). Het is nog niet bekend via welke mechanismen 
specifieke voedingscomponenten invloed hebben op het ontstaan van kanker. Bestudering 
van het samenspel tussen voeding en genen (voeding-gen interacties) kan mogelijk verdere 
aanwijzingen leveren over het onstaan van dikke darmkanker. 
Voeding-gen interacties zijn mogelijk niet alleen relevant voor het onstaan van "gewone" 
vormen van dikke darmkanker (in het vervolg sporadische dikke darmkanker genoemd), 
maar ook voor erfelijke vormen van dikke darmkanker (zoals HNPCC). De vorming van 
adenomen bij patienten uit HNPCC-families vertoont vergelijkbare eigenschappen met 
de vorming van sporadische adenomen, en wordt daarom misschien ook wel beinvloed 
door voedingsgewoonten. Adenomen bij HNPCC-familieleden worden gewoonlijk op 
jongere leeftijd ontdekt en komen eerder terug dan bij sporadische patienten. Om die 
reden kunnen voeding-gen interacties mogelijk efficienter bestudeerd worden in HNPCC 
families. 
Dit proefschrift onderzoekt voeding-gen interacties tijdens het ontstaan van dikke 
darmkanker vanuittwee verschillende epidemiologische invalshoeken. 
In HOOFDSTUK 1 worden een aantal van de basisbegrippen over het ontstaan van dikke 
darmkanker geintroduceerd. Dikke darmkanker wordt beschreven als een genetische 
ziekte. De kanker ontwikkeld zich vanuit een adenoom, doordat een aantal 
opeenvolgende veranderingen plaatsvindt in regulerende genen zoals APC, K-ras, p53. 
Deze veranderingen kunnen veroorzaakt worden door factoren van buitenaf (bv. 
voeding), alsook door processen in het lichaam. HNPCC wordt veroorzaakt door een 
aangeboren verandering in een reparatiesysteem van het erfelijke materiaal. Ondanks 
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deze duidelijke aangeboren oorzaak, vertoont de vorming van adenomen in HNPCC en 
sporadische patienten een aantal overeenkomsten. Mogelijk ontstaan beide vormen van 
dikke darmkanker op gen-nivo gedeeltelijk op dezelfde manier. Sommige van de 
verworven (niet aangeboren) beschadigingen aan de genen worden mogelijk veroorzaakt 
of beinvloedt door voedingsfactoren. Van een voedingspatroon met veel vlees en vet 
wordt al heel lang gedacht dat dit het risico op het ontstaan van dikke darm adenomen 
en kanker verhoogd, maar de aanwijzingen zijn niet eenduidig. Een aantal experimentele 
dierstudies suggereert dat factoren die samenhangen met vleesconsumptie en -bereiding, 
mogelijk mutaties (beschadigingen) in regulerende genen veroorzaken. Het feit dat 
dergelijke mutaties ook bij mensen voorkomen, zowel tijdens het ontstaan van 
sporadische als HNPCC dikke darmkanker, was een belangrijke overweging om voeding-
gen interacties te bestuderen in zowel de algemene bevolking als ook in HNPCC families. 
We zijn bij ons onderzoek naar voeding-gen interacties tijdens het onstaan van dikke 
darmkanker uitgegaan van twee doelstellingen: 
DOELSTELLING 1: Het onderzoeken van aanwijzingen voor een mogelijke rol van 
voedingsfactoren in het ontstaan van HNPCC; zijn bepaalde aspecten in de ontstaanswijze 
vergelijkbaar met het ontstaan van sporadische dikke darmkanker? 
In HOOFDSTUK 2 hebben we het optreden van dikke darmkanker in verschillende 
leeftijdscategorien van familieleden van 51 HNPCC families berekend. Op de leeftijd van 
75 jaar had 19% van de stamoudsten in deze families dikke darmkanker ontwikkeld, 
terwijl dit 32% was in de eerstvolgende generatie en 55% in de daaropvolgende 
generatie. Dit verschil tussen generaties was toe te schrijven aan de periode waarin deze 
personen geboren waren. De jongere leeftijd waarop dikke darmkanker ontstaat in de 
opeenvolgende generaties van deze HNPCC families, is daarom niet zozeer een 
biologische eigenschap van HNPCC. Het laat een trend zien in het optreden van kanker 
die vergelijkbaar is met de tijdtrend die men waarneemt in de algemene bevolking. 
Om te onderzoeken of HNPCC en sporadische adenomen op gen-nivo gedeeltelijk op 
eenzelfde manier ontstaan, hebben we onderzocht hoe vaak afwijkingen in de K-ras en 
p53 genen voorkomen (HOOFDSTUK 3). Mutaties in de K-ras en p53 genen zijn 
gebruikelijk bij dikke darmkanker, en worden mogelijk veroorzaakt door factoren van 
buitenaf of door processen in het lichaam. In de 48 HNPCC adenomen en 59 
sporadische adenomen vonden we een vergelijkbaar aantal afwijkingen. Afwijkingen aan 
het K-ras gen vonden we bij 25% van de HNPCC en 32% van de sporadische adenomen. 
Bij respectievelijk 25% en 31% vonden we p53 afwijkingen. 
In een methodologische studie (HOOFDSTUK 4) hebben we het gebruik van een vragenlijst 
over vleesconsumptie en -bereiding onderzocht. Hiermee probeert men in te schatten 
hoeveel de inneming is aan heterocyclische amines (stoffen die onstaan bij de bereiding 
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van vlees bij hoge temperatuur). We rapporteren een beperkt verlies aan informatie over 
de inneming van heterocyclische amines, wanneer het aantal vragen in de vragenlijst 
wordt gehalveerd (van 39 naar 15 of 20). Dit ondersteunt het gebruik van een relatief 
korte vragenlijst over vleesconsumptie en -bereiding, inclusief foto's om de kleur van het 
vlees vastte stellen, zoals wij die gebruikt hebben in ons verdere onderzoek bij patienten 
met dikke darm adenomen. 
In HOOFDSTUK 5 richten we ons op de relatie tussen vleesconsumptie en -bereiding en 
het risico op het ontstaan van respectievelijk sporadische en HNPCC adenomen, 
gebruikmakend van een dergelijke vragenlijst. In dit zogenaamde patient-controle 
onderzoek vergelijken we de voedingsgewoonten van personen met dikke darm 
adenomen en controle-personen zonder adenomen. De consumptie van rood vlees 
(rund- en varkensvlees, geen kip) leek geassocieerd met het risico op dikke darm 
adenomen in de sporadische groep, maar niet in de HNPCC groep. Personen met een 
voorkeur voor donkerbruin vlees hadden vaker dikke darm adenomen, maar weer alleen 
in de sporadische groep en niet in de HNPCC groep. Mogelijk zijn factoren die 
gerelateerd zijn aan de consumptie en bereiding van vlees, alleen relevant voor het 
ontstaan van sporadische adenomen en niet voor HNPCC adenomen. Echter, het blijft 
mogelijk dat vleesbereiding of andere voedingsfactoren in eerdere of latere fasen van het 
onstaan van HNPCC dikke darmkanker een rol spelen. 
Concluderend, vergelijkbare tijdtrends in het voorkomen van dikke darmkanker en een 
vergelijkbare betrokkenheid van de K-ras en p53 genen suggereren een rol voor 
omgevingsfactoren in het ontstaan van HNPCC dikke darmkanker. Echter, 
vleesconsumptie en -bereiding lijken geen vergelijkbaar effect op het risico op HNPCC 
en sporadische dikke darm adenomen te hebben. 
DOELSTELLING 2: Het onderzoeken van aanwijzingen voor een mogelijk verschillend 
effect van voedingsfactoren op het ontstaan van dikke darmkanker met en zonder mutaties 
in de K-ras en p53 genen. 
We hebben hierbij gebruik gemaakt van eerder uitgevoerd patient-controle onderzoek 
met dikke darmkanker patienten, van wie de voedingsgegevens al verzameld waren. 
In HOOFDSTUK 6 hebben we onderzocht of voedingsfactoren van dierlijke oorsprong 
geassocieerd zijn met (specifieke) mutaties in het K-ras gen. Mutaties in codon 12 en 13 
(verschillende delen van het K-ras gen) werden gevonden in 36% van de 185 dikke 
darmkankers (82% in codon 12). Bij deze dikke-darmkankerpatienten waren 
voedselgroepen en voedingsstoffen van dierlijke oorsprong niet verschillend geassocieerd 
met dikke darmkankers met of zonder een mutatie in het K-ras gen. Echter, we vonden 
wel dat een hoge inneming van (dierlijk) eiwit en calcium geassocieerd was met een 
hoger risico op kanker met een mutatie in codon 12 van het K-ras gen. Voor mutaties in 
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codon 13 van het K-ras gen vonden we het tegenovergestelde. Deze gegevens suggereren 
een verschillende rol van voeding in het onstaan kanker met mutaties in codon 12 en 
codon 13 van het K-ras gen. 
In HOOFDSTUK 7 hebben we ons geconcentreerd op de vraag of voedingsfactoren 
verschillend geassocieerd zijn met dikke darmkanker met of zonder afwijkingen aan het 
p53 gen. Verder wilden we bestuderen of de gevonden associaties afhankelijk zijn van de 
methode die gebruikt wordt om de afwijkingen waar te nemen (mutatie of 
overexpressie). We vonden p53 overexpressie in 44% van de 185 dikke darmkankers en 
een p53 mutatie in 32%. Als overexpressie werd bestudeerd, werd voor personen met 
een hogere inneming van totaal vet en verzadigd vet een hoger risico op dikke 
darmkankers zonder overexpressie gevonden. Als de patienten werden ingedeeld op 
basis van mutaties, was het verschil tussen patienten met en zonder een mutatie minder 
duidelijk. Alleen zeer specifieke mutaties (transversies) leken wel geassocieerd met 
dezelfde voedingsfactoren. 
Concluderend, deze studies over K-ras en p53 in dikke darmkanker suggereren dat 
voedingsfactoren mogelijk verschillend geassocieerd zijn met kankers met specifieke 
mutaties in deze genen. Of voeding een rol speelt in het veroorzaken van mutaties of 
verschillend werkt afhankelijk van de (eventueel veranderde) functie van het gen moet 
onderzocht worden. Tevens zou de invloed van vleesconsumptie en -bereiding op het 
ontstaan van specifieke mutaties verder onderzocht moeten worden. 
In HOOFDSTUK 8 vatten we de resultaten van onze studies samen en bediscuseren deze in 
het licht van mogelijke methodologische beperkingen. De biologische plausibiliteit wordt 
besproken binnen het kader van de huidige kennis, aangevuld met resultaten uit 
experimented onderzoek. 
Aangezien zo weinig bekend is over voeding-gen interacties bij het ontstaan van dikke 
darmkanker, zijn deze eerste studies van beperkte omvang en daardoor statistisch minder 
overtuigend. Als gevolg hiervan zijn de studies vooral gebruikt om nieuwe hypothesen te 
ontwikkelen en de infrastructuur voor verder onderzoek uit te breiden. 
Toekomstige studies moeten bevestigen of HNPCC adenomen mogelijk als model 
kunnen dienen voor het bestuderen van dikke darmkanker, zowel in HNPCC families als 
de algemene bevolking. De vraag blijft of voeding mogelijk een rol speelt in het ontstaan 
van erfelijke dikke darmkanker, want zelfs als een klein aantal kankers voorkomen kan 
worden door voeding, is dat relevant voor HNPCC families. Om de rol van voeding te 
ontrafelen in alle fasen van de vorming van adenomen en kanker, moet het effect van 
specifieke voedingsfactoren vaker op gen-nivo geevalueerd worden. Interventie studies, 
waarbij voor bepaalde tijd de voeding door de onderzoekers wordt vastgesteld en 
gecontroleerd, bieden hiervoor de beste mogelijkheid. 
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